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Abstract 
The interaction between the mapping/ablation catheter and left atrial (LA) 
myocardium potentially affects the LA electrical and mechanical properties and impacts 
on ablation efficacy.  Using catheters able to provide real-time contact force (CF) 
measurement, it has become possible to explore these relationships in vivo. 
 In 60 persistent atrial fibrillation (AF) patients, ablation CF was higher in the 
right than left wide area circumferential (WACA) lines and where steerable transseptal 
sheaths were used.  Differences were also apparent in the burden of WACA segment 
reconnection but did not just reflect differences in ablation CFs, suggesting factors other 
than CF contribute to ablation efficacy. 
 Relationships between ablation force time integral (FTI), impedance drop and 
electrogram attenuation were assessed in 15 persistent AF patients.  FTI significantly 
correlated with electrogram attenuation and impedance drop from ablation.  The 
relationship was stronger for the former but in both cases plateaued at 500g.s, 
suggesting no ablation efficacy gains beyond this.   
 Factors further affecting CF and ablation efficacy, the latter judged by 
impedance drop, were assessed in 30 patients.   The variability of the CF waveform and 
catheter locational stability were both affected by factors including atrial rhythm and 
catheter delivery mode.  Greater CF variability, catheter drift and perpendicular catheter 
contact were associated with reduced ablation efficacy. 
 The relationship between CF and the electrogram was assessed in 30 patients.  
The size of the electrogram complexes was affected by CF increases but only where 
initial CF was <10g.  This was also the case for electrogram fractionation 
measurements.  Increasing CF was associated with an increasing incidence of atrial 
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ectopics during sinus rhythm.   Spectral parameters (dominant frequency and 
organisation index) were unaffected by CF.   
 Various factors affect the contact between the catheter and LA myocardium.  In 
turn, catheter contact significantly affects the electrogram during LA mapping and the 
efficacy of clinical radiofrequency ablation. 
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1. Introduction 
1.1 Abbreviations 
ADC: Analogue-to-digital converter  
AF: Atrial fibrillation  
AFCL: Atrial fibrillation cycle length 
AFFIRM: Atrial Fibrillation Follow-Up Investigation of Rhythm Management  
AV: Atrioventricular 
ACI: Average complex interval 
CFAE: Complex fractionated atrial electrograms 
CF: Contact Force  
CFV: Contact Force Variability  
DE-MRI: Delayed enhancement MRI  
DF: Dominant frequency 
ERP: Effective refractory period  
ETI: Electrode Tissue Interface  
FFT: Fast Fourier transform 
FTI: Force Time Integral 
ICL: Interval confidence level  
LAA: Left atrial appendage  
LA: Left atrium  
OI: Organisation index 
PAF: Paroxysmal AF  
PV: Pulmonary Vein  
PVI: Pulmonary vein isolation  
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QoL: Quality of life  
RACE: Rate Control and Rhythm Control in Patients With Recurrent Persistent Atrial 
Fibrillation  
RRN: Remote Robotic Navigation  
SCI: Shortest complex interval  
SAECG-P: Signal averaged ECG p-wave analysis  
SR: Sinus Rhythm  
SAC: Stretch Activated Channels  
WACA: Wide area circumferential ablation  
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1.2 Atrial Fibrillation - Background 
Atrial fibrillation (AF) is characterised by chaotic electrical activation of the left 
atrium leading to discordant mechanical contraction, manifesting on the 
electrocardiogram as a loss of the normal sinus p-wave.  In the presence of intact atrio-
ventricular conduction, an irregularly irregular pulse is noted.  Different types of AF 
have been defined according to international consensus
1
:  
 Paroxysmal AF (PAF) - recurrent ≥2 episodes of AF terminating 
spontaneously within 7 days (or episodes ≤48 hours that are 
cardioverted). 
 Persistent AF - continuous AF sustained beyond 7 days and those 
episodes cardioverted between 48 hours and 7 days into an episode. 
 Longstanding persistent AF – continuous AF for >12 months.   
 Permanent AF – if a patient is in persistent AF and there is an acceptance 
that the patient will remain in this rhythm. 
AF is associated with a significantly increased mortality, with a risk factor–
adjusted odds ratio for death of between 1.5 and 1.9 in the Framingham Heart Study 
population
2
.  AF also confers an almost five-fold increased risk of suffering a stroke
3
 
and increases the risk of heart failure admissions
4
.  Common symptoms due to AF 
include dyspnoea, palpitations and fatigue, with only around 15% of patients in one 
registry being asymptomatic
5
.  In a study of 152 consecutive arrhythmia clinic 
outpatients, both general and disease specific quality of life (QoL) scores were 
significantly worse compared for AF patients compared with healthy controls, with 
similar scores these patients as for those with heart failure, or post-infarction or 
angioplasty
6
.  From a psychological viewpoint, around one-third of patients with AF 
were found in one study to have persistently elevated levels of depression and anxiety
7
.   
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AF therefore poses serious risks in the longer term as well as having a more immediate 
impact on sufferers’ quality of life.   
In a large general practice research database in England and Wales, the 
incidence of this arrhythmia was just over 1%, increasing with age up to over 10% in 
those over 85 years old
8
.  With our aging population, one would expect the prevalence 
of this condition to increase with time, but in addition to such a rise, an increase in 
prevalence independent of age has also been observed
8
.  In 2000, the direct cost of AF 
was between 0.9-2.4% of overall health care expenditure in the UK, almost double the 
level it had been in 1995
9
.  AF therefore represents a health problem with serious 
consequences, which is becoming increasingly common and is therefore a growing 
burden on the health service.  
 
1.3 Management of Atrial Fibrillation 
Presently, the principal intervention with proven prognostic benefit is 
anticoagulation.  Compared with placebo, warfarin leads to a 62% relative (3.1% 
absolute) risk reduction for stroke
10
.  Patients are started on anticoagulation based on 
their risk of stroke using scores such as the CHA2DS2-VASc score
11
 which take into 
account their clinical profile to assign them to an overall stroke risk category.  Warfarin 
has been the most widely used anticoagulant in AF but now newer agents have become 
available which may offer advantages over this established drug
12,13
.  An alternative 
strategy to anticoagulation to reduce the risk of stroke is the use of left atrial appendage 
occlusion devices
14
. 
Beyond stroke risk reduction, the management of AF generally involves 
commitment to either a rate or rhythm control strategy.  In the case of the former, this 
involves accepting the patient is in AF but aiming to regulate the ventricular response 
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rate.  Strategies for achieving this involve utilising rate-controlling medications, 
permanent pacemaker implantation and atrioventricular node ablation.  Conversely, a 
rhythm control strategy aims to maintain patients in sinus rhythm and this is achieved 
by using antiarrhythmic drugs, cardioversion and catheter-based ablation.  Comparison 
of the benefit of these strategies has been the subject of several studies
15–17
, and on 
meta-analysis, no significant difference with regard to mortality or morbidity
18–20
, has 
been demonstrated.  On grouping the thromboembolic stroke and mortality end point, a 
significant increase in those undergoing rhythm control has been observed
19
.  No 
difference has been demonstrated in QoL scores between patients randomised to either 
strategy, regardless of their rhythm
21
.  The underperformance of the rhythm control arm 
in these studies has been subjected to further analysis:  the rhythm control strategy has 
been mainly pharmacological, only 14 of the 4060 patients in the largest study, the 
Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) trial had 
an ablation for AF (or atrial flutter)
16
.  Antiarrhythmic drugs were associated with more 
drug intolerances and by the third year there was a 37.5% actuarial cross-over rate from 
the rhythm to the rate control arm due to ineffectuality and intolerance of these drugs in 
AFFIRM
16
.  In the Rate Control and Rhythm Control in Patients With Recurrent 
Persistent Atrial Fibrillation (RACE) trial of persistent AF patients, only 39% of 
patients in the rhythm control arm were in sinus rhythm at the end of follow-up and 
again there were more adverse drug effects
15
.  In an on-treatment analysis of the 
AFFIRM study, sinus rhythm per se  was associated with a lower risk of death while a 
higher risk of death was associated with rhythm-control drug use
22
.   
Whether a therapy that is better able to maintain sinus rhythm without requiring 
the use of potentially toxic anti-arrhythmic drugs has benefit is unclear, but catheter 
ablation shows promise in this regard.  A retrospective epidemiological study of 37,908 
~ 21 ~ 
 
patients has suggested that patients who have had ablation for AF have a lesser risk of 
dementia, stroke and death compared to those who do not have an ablation of AF, 
although differences in the study population demographics do make this harder to 
interpret
23
.  A further registry study comparing 1273 ablated patients with medically 
managed and control, non-AF patients suggested that freedom from AF was 
significantly associated with a reduction in the risk of stroke and death compared to 
medically managed AF patients, and no difference compared to the control non-AF 
population
24
.   
These results suggest the prognostic benefit of achieving sinus rhythm through 
ablation, and the NHLBI sponsored trial Catheter Ablation Versus Antiarrhythmic 
Drug Therapy for Atrial fibrillation (CABANA), Clinicaltrial.gov registration: 
NCT00911508, is currently underway to prospectively compare medical management 
with catheter ablation.    
From the point of view of quality of life, a prospective study of 133 ablated 
patients showed that QoL scores improved after an ablation and that successful ablation 
caused a significantly greater improvement than unsuccessful ablation, with benefits 
maintained at four years
25
. 
A 2005 world-wide survey of over 9000 patients having undergone catheter 
ablation suggested an overall success rate of 75.9% (of whom 53% were no longer on 
anti-arrhythmic drugs)
26
.  Almost a quarter of the patients required a second ablation 
procedure and there was around a 6% major complication rate which included deaths 
and strokes
26
.  This survey included patients with persistent AF and PAF, as well as 
ablations done in by a variety of methods at varying stages after the introduction of AF 
ablation.  More recent data from a single centre demonstrates an 86% long-term rate of 
freedom from PAF and 68% rate for persistent AF; the former patients requiring a mean 
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of 1.7 procedures and the latter a mean of 2
27
.  The major complication rate in this 
analysis was 3.1%
27
.  In a multicentre registry, the rates of freedom from AF (off drugs) 
post-ablation were 76% for PAF and 60% Persistent AF, with over half the patients 
needing more than one ablation procedure
24
.  A further prospective registry of 1410 
patients demonstrated a single procedure success rate of 40.7% for AF ablation at one 
year, with a 2.5% adverse event rate during follow-up
28
. 
From the above it will have been noted that ablation of AF is a procedure with 
some risk.  Generally, patients require repeat procedures to improve success rates and 
this further subjects them to risk.  Combined with the modest success rates for the 
procedure in persistent AF, this suggests that there remains scope to improve the 
efficacy of the procedure.   
 
1.4 Atrial remodelling in Atrial Fibrillation 
Atrial fibrillation results in electrical remodelling of the atrium.  Recurrent AF 
induced by atrial pacing results in an increase in the length of the induced episodes until 
after around two weeks the AF becomes persistent
29
.  With the increasing length of 
these episodes, the rate of the AF increases and the atrial electrogram becomes more 
fragmented
29
.  The duration of the action potential also reduces in pacing induced 
animal models
30
.  There is also an associated reduction in the atrial ERP and these 
changes take a week to normalise following reversion to sinus rhythm
29
.  Therefore, AF 
is associated with progressive electrical remodelling of the atrium and this persists 
beyond restoration of sinus rhythm.  This remodelling has been studied at a subcellular 
level. 
At an ion channel level, sustained AF was found in dogs to cause a reduction in 
outward currents, calcium currents
30
 and sodium currents
31
.   
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Gap junctions are responsible for ion conduction between cells and therefore 
facilitate transmission of the electrical impulse.  These structures are formed of 
connexions, and connexin 40 is specific to the atrium and conducting system.  Mice 
with the gene for this protein knocked out spontaneously develop AF
32
 and have a 30% 
reduction in atrial conduction velocity
33
.  In a model of persistent AF, as the AF became 
more persistent, the distribution of connexin 40 became more heterogeneous and its 
levels reduced
34
.  In a porcine model with AF induced by recurrent burst atrial pacing, 
burst pacing was associated with a reduction in the time in sinus rhythm, reduced atrial 
conduction velocity and reduced expression of connexion 43 and 40
35
.  Gene transfer of 
either connexion 40 or 43 prevented the reduction in the expression of these proteins 
with burst pacing and prevented the reduction in atrial conduction velocity and 
protected against the development of AF in the model
35
.   
In patients with longstanding AF, there is a redistribution of intercellular gap 
junctions.  At the tissue level, there is decrease in the amount of connexin 43 and 40, 
with increased heterogeneity in the distribution of the latter
36
. 
A canine sustained AF model demonstrates fibre disarray and early hypertrophy 
with AF
37
.  In a goat model, changes in myocytes including myolysis and glycogen 
accumulations have been observed secondary to sustained AF
38
.  Myocytes from 
patients with AF demonstrate increased contraction bands and in addition, in patients 
with persistent AF there are an increased number of hibernating (myolytic) cells, and 
the latter increase with the duration of AF
39
.  Further investigation of atrial tissue from 
patients with chronic AF has demonstrated that the myolytic cells observed are in a 
dedifferentiated state with characteristics of embryonic muscle cells
40
.  Thick layers of 
fibrosis between myocytes forming collagenous septa have been observed in the atria of 
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patients with long standing AF
40
 and significantly more collagen type I is seen in the 
atria of these patients compared to patients without AF
36,41
. 
Atrial fibrillation therefore leads to electrical remodelling of the atrium in 
association with changes to myocytes at the cellular and subcellular level as well as 
remodelling of the extracellular matrix. 
 
1.5 Left Atrial Compliance 
Stress (σ) is defined as the force per unit area exerted on a material, while strain 
is the deformation caused by this stress, and is the change in length per unit length (ϵ).   
The ratio of stress to strain for a material is the elastic modulus (E), known as Young’s 
Modulus and is measured in Pascals (N/m
2
).   This is a measure of the resistance of the 
material to deformative force, the elasticity or stiffness.  A stiffer material has a higher 
elastic modulus (for a given stress, the strain is small).  Compliance is the inverse of 
stiffness, with units of m
2
/N, and a more compliant material has a lower elastic modulus 
(for a given stress, the strain is large).  The elastic modulus applies while the ratio 
between stress and strain is constant – while the material obeys Hooke’s Law.  Beyond 
the elastic limit, the relationship is no longer linear and plastic behaviour (where a 
material does not return to its baseline shape on removal of the stress) can be observed.   
 The left atrium (LA) makes several important contributions to cardiovascular 
function:  in sinus rhythm, the LA contracts immediately prior to LV systole, therefore 
elevating the LV end diastolic pressure; the LA also has a reservoir function for 
pulmonary venous return during ventricular systole and isovolumic relaxation, and it 
also functions as a conduit that empties blood down a pressure gradient into the left 
ventricle on opening of the mitral valve
42
.  A loss of coordinated atrial contraction (as 
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occurs with AF)  results in a reduction in the ventricular stroke volume, with a greater 
effect at higher heart rates
43
. 
In response to increasing LA pressure, a greater change in the atrial volume is 
noted in non-hypertensive than hypertensive rats and greater stiffness is also observed 
in left atrial tissue strips taken from the latter rats
44
.   From canine studies, a regional 
difference in the compliance of the left atrium has been observed, with the appendage 
having a lower elastic modulus (higher compliance) than the left atrium
45,46
 and 
following appendectomy, or ligation of the appendage, the stiffness of the left atrial 
chamber is increased
46,47
.  The relationship between the left atrial pressure and volume 
has also been found to be different depending on whether the left atrial pressure is 
increasing or decreasing, being greater if the pressure was falling than rising
47
.    
Left atrial compliance can be determined invasively at cardiac catheterisation, 
where the systolic rise in the left atrial pressure is divided into the stroke volume
48
.   
Comparison of the dynamic echocardiographic left atrial area, as determined by an 
automated boundary detection application, with the invasively determined left atrial 
pressure has also been used to determine compliance
49
.   Using echocardiographic 
assessment of transmitral velocity profiles, it is possible to determine the net 
atrioventricular compliance
50
 and in the presence of normal left ventricular compliance, 
this compliance has been taken as a surrogate of left atrial compliance, and correlates 
with peak pulmonary systolic and diastolic flow velocity as well as the pulmonary 
artery systolic pressure
51
.   An acoustic microscope has also been used in a post-mortem 
human tissue study, and found that the speed of sound through left atrial tissue 
specimens increased with increasing subject age, this increase was felt to reflect an 
increase in the elasticity of the tissue with ageing
52
.   
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There is a suggestion of a relationship between the left atrial compliance and 
AF: in a canine study, the increase in left atrial dimensions for a given rise in left atrial 
pressure was larger in the LA before it was induced to fibrillate, reflecting a reduced 
compliance during AF acutely
53
.  Similarly, in a porcine study, the induction of AF 
resulted in a smaller end systolic LA volume, larger end diastolic volume and a 
reduction in the compliance of both atria
54
.   In contrast to these findings though, in 
patients with mitral stenosis undergoing echocardiographic left atrial compliance 
assessment, no difference was found in the left atrial compliance comparing those who 
were in AF to those who were not
51
.   In another study though, using echocardiography 
and invasive left atrial pressure measurement, left atrial stiffness was higher for patients 
with atrial fibrillation compared to control patients
55
, findings more in keeping with the 
preclinical studies described above.    
Compliance has been postulated to be lower during AF acutely for a number of 
reasons
54
: unsynchronised myofibre contractions, greater myocardial turgor due to 
increased blood flow in the atrial myocardium during AF
56
 or due to increased cytosolic 
calcium concentrations.  Further to this, one would also expect a contribution secondary 
to the structural remodelling discussed above secondary to sustained AF.   
In AF, the LA loses its contractile contribution to cardiac output.  An increase in 
the stiffness of the left atrium, certainly acutely, may be an important response to this 
loss as it results in an elevation in the left atrial pressure, allowing for increased blood 
flow down the higher pressure gradient into the left ventricle and so reduces the decline 
in stroke volume from the loss of atrial systole
54
. 
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1.6 Mechanisms of Atrial Fibrillation 
The underlying electrical mechanism of AF is the subject of several theories.  
Support for an ectopic focus as a source of AF came from the experiments by Scherf et 
al., in which aconitine applied to the atria resulted in AF or atrial flutter, but removal of 
the aconitine exposed area by excision, cooling or clamping would terminate the 
arrhythmia
57,58
.  Interestingly, whether AF or atrial flutter was induced depended on the 
atrial firing rate induced by the aconitine.  Above a certain threshold, the atrium was 
unable to conduct in a 1:1 manner and conduction degenerated, a phenomena known as 
fibrillatory conduction.  Such fibrillatory conduction was experimentally demonstrated 
in an isolated sheep right atrial preparation where pacing Bachman’s Bundle above a 
threshold frequency led to a breakdown of uniform conduction
59
.    Support for a focal 
source of AF in humans was provided in 1998 by Haïssaguerre et al who reported the 
initiation of paroxysms of AF by ectopics, most commonly from the pulmonary veins
60
.   
 An alternative theory for the cause of AF was proposed by Moe and 
Abildskov
61
, with the theory tested by computer modelling
62
.  This was called the 
multiple re-entrant wavelet hypothesis and suggested that AF was the result of multiple 
wandering wavelets across the atrium independent of their initiating event.  AF 
becoming sustained was postulated to be dependent on the number of such wavelets 
within the atrium at a single moment (to prevent the rhythm organising through wavelet 
fusion and termination).  The number of wavelets supported by the atrium depended on 
the mass of atrial tissue, its refractory period and conduction velocity.  Support for the 
multiple wavelet hypothesis can be found in humans during epicardial mapping studies 
of electrically induced AF where multiple re-entrant wavelets, displaying random re-
entry and leading circle re-entry have been observed
63
. 
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In an isolated canine right atrial model, where extrastimuli were added at 
decreasing coupling intervals with increasing acetylcholine levels, it was observed that 
during repetitive firing there were increasing numbers of re-entrant wavelets.  This was 
concordant with predictions from the multiple wavelet hypothesis.  Interestingly though, 
when stable AF was induced, a small stable re-entrant circuit supervened
64
.  Such 
activity, termed a rotor, was also observed in a Langendorff-perfused sheep heart 
model, and was one of the mechanisms for spatiotemporal periodicity seen in the left 
atrium
65
. 
A computational mapping approach to human AF has suggested the presence of 
stable sources within the atria, both rotors and focal sources, with persistent AF patients 
having more such sources
66
.  Conduction from these sources degenerates to become 
fibrillatory.  This therefore suggests that AF is the result of stable sources driving the 
atria with fibrillation ensuing through a breakdown of 1:1 conduction. 
One would postulate that a combination of mechanisms therefore underlies AF.  
It may be that a focal source generates impulses that undergo fibrillatory conduction 
with an increasing number of wavelets generated and establishment of rotors that then 
maintain AF, with or without continuing firing from the focal source.  The transition 
from PAF to persistent AF may be related to the atrial tissue having negatively 
remodelled such that these rotors are more likely to be generated and have increased 
stability (either individually or as a group through increased numbers of rotors in 
persistent AF guarding against the effects of rotor extinction), or simply from the 
presence of more focal sources. 
Based on the finding of pulmonary vein-based ectopics, pulmonary vein 
isolation (PVI) has become the cornerstone of AF ablation and is recommended by 
current guidelines as the strategy for PAF ablation
1
.  In patients with persistent AF 
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though, such an approach in isolation is associated with lower success rates
67,68
 and 
therefore more extensive ablation is undertaken such as the additional ablation of 
CFAE
68,69
 or linear lesions
70
.  
 
1.7 Atrial Fibrillation Electrograms  
1.7.1 Fractionated Atrial Electrograms 
In patients undergoing surgical resection of accessory pathways, Konings et al 
studied electrically-induced AF using a 244 pole electrode applied to the epicardial 
surface of the right atrium
71
.  They specifically correlated the unipolar signals observed 
at each pole with the underlying fibrillation wave activity and found that fragmented 
signals occurred with high specificity at points of slow conduction and wavefront 
pivoting, and postulated the former were important in AF to allow shortening of the 
fibrillation wavelength and so accommodate more wavelets, while the latter would 
prevent wavelet extinction by increasing their propagation pathway.  In this study, 
collision of wavefronts did not cause fractionated unipolar signals, causing instead long 
double potentials. 
Bipolar signals were used in another study, in a canine model of persistent AF 
induced by prolonged atrial pacing to identify areas of complex fractionated atrial 
electrograms (CFAE), with the wavefront activity underlying these signals subsequently 
investigated by non-contact mapping
72
.  In this case, the fractionated signals seen were 
found to relate to the centre of re-entrant wavefronts, at collision of wavefronts and 
during conduction through channels with wavebreak.  Contrary to this, in an optical 
mapping murine monolayer model of AF, the centre of a rotor was not found to show 
fractionation (unless two pseudo bipoles were recorded and the signals combined), 
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whereas the presence of a meandering rotor or sites of wavebreak or collision were 
associated with fractionation of pseudo-bipolar signals
73
.   
Studies of PAF patients in AF have demonstrated that CFAE genesis is preceded 
by an acceleration in the AF rate
74,75
.  The transition to fractionation has been noted to 
be associated with a re-entry pattern around a line of functional block and activation 
breakthrough across a line of slow conduction
74
.  The increase in rate responsible for 
these changes has been suggested to be secondary to a wandering rotor or change in the 
rate of a remote source
74
, though in a minority of cases, there was a suggestion of local 
complex activation or reentry
75
.   The relationship with a remote source is further 
suggested by optical mapping studies in explanted sheep hearts which have suggested 
that fractionation occurs at the edge of a domain of high dominant frequency with 
fractionation due to increased beat to beat variation in the direction and conduction 
velocity of AF waves
76
.   
As well as the pulmonary veins, regions of CFAE have also been shown in 
patients with AF to produce spontaneous discharges initiating AF
77,78
.  Such 
spontaneous discharges, whether from the pulmonary veins or CFAE regions, result in 
an increase in left atrial activation time and initiate AF if at a short enough coupling 
interval to impair conduction in regions of CFAE allowing a meandering re-entrant 
wave to become established
78
.  Once initiated, these regions then maintain AF through 
slow conduction and pivoting of waves leading to wave break and fusion
77
.  
CFAE therefore reflect a variety of underlying wavefront mechanisms and 
CFAE are likely to represent areas responsible for both the initiation and maintenance 
of AF. 
While the wavefront activity underlying CFAE, and the potential causes of 
fractionation have been studied, their importance to the maintenance and initiation of 
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AF, as evidenced by the response to ablation is less certain.  The initial published trial 
where CFAE were ablated as a sole strategy resulted in a highly impressive 91% (110 
out of 121 patients) freedom from arrhythmia and symptoms at one year
79
.  In this trial, 
CFAE were defined as either electrograms with a very short cycle length (≤120ms) 
averaged over a ten second recording period or atrial electrograms that had fractionated 
electrograms composed of two deflections or more, and/or perturbation of the baseline 
with continuous deflection of a prolonged activation complex over the same recording 
period
79
.  However, subsequent trials of CFAE ablation either alone
80–82
 or in 
combination with PVI
81–86
 have met with varying success.  On meta-analysis though, 
the combination of PVI with CFAE ablation leads to significantly improved outcomes 
in the ablation of persistent AF (though not PAF)
87
. 
CFAE have been shown to have a reasonable degree of temporal and spatial 
stability with 73-78% concordance between different maps during the same
88,89
 and 
different
90
 episodes of AF.  Common sites of CFAE include the base of the left atrial 
appendage and the pulmonary vein antra
88,89
.   In a study of patients undergoing PAF 
ablation where AF was induced, comparison of bipolar contact mapped points with non-
contact mapping of wavefront propagation suggested that different patterns of bipolar 
CFAE related to different underlying wavefront activity
91
.  Rapid repetitive bipolar 
CFAE (cycle length under 120ms, separated by isoelectric interval) were predominantly 
due to either arrhythmogenic sites or pivot points, whereas fragmented bipolar CFAE 
(continuous fractionated activity)  was mainly caused by passive activation and slow 
conduction
91
.   
While these studies demonstrate that CFAE are a reasonably stable phenomenon 
they also tell us that not all CFAE are equally important to the AF process: some are 
purely passive epiphenomena.  Further evidence for this is the finding that PVI results 
~ 32 ~ 
 
in a reduction in CFAE burden
92,93
  as does linear ablation
93
, with a reduction even at 
regions distant to the ablation.  It may be that these passive CFAE are secondary to 
wave collision or other causes such as activation of overlying structures
94
.  Certainly, a 
mapping study comparing monophasic action potentials to local bipolar signals found 
that the CFAE seen with the latter in 67% of cases represented farfield signals (with 
other mechanisms seen in other cases including rapid localised organised AF activity, 
possibly consistent with AF drivers and acceleration related changes)
95
. 
Therefore, as CFAE can be caused by a variety of active and passive 
phenomena, an understanding of the mechanism underlying a particular CFAE signal 
would help focus ablation efforts.  The above studies suggest that such identification 
may be possible on morphological grounds.  To this end, the definition of a CFAE 
becomes very important.  An epicardial mapping study found that CFAE defined by an 
atrial fibrillation cycle length (AFCL) of <120ms and those defined by 
continuous/multicomponent activity have different distributions, with the area under the 
receiver operator curve for the former predicting a site of the latter being only 0.59
96
.  
Takahashi et al found that ablation at signals displaying continuous fractionation for 
≥70% of the time in a 4 second sample or a temporal gradient of activation across 
bipoles was associated with significantly more AFCL prolongation or AF termination
97
.  
Using a visual fractionation scale to grade signals from 1 to 5 where grade 1 are the 
most fractionated signals and grade 5 normal
98
, Hunter et al studied the effect of 
ablating different CFAE grades
99
.  Of note grade 1 and 2 signals in this scheme are 
those with fractionation for ≥70% of the 10 second sample.  Following PVI, the 
remaining CFAE were on average less fractionated
99
 (a mean increase in CFAE).  
Ablating more fractionated CFAE signals first was found to reduce the incidence of less 
fractionated signals (grade 3 and 4) whereas the converse was not true.  There was also 
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a differential effect on the AFCL from ablating different grades of CFAE, with grade 1, 
2 and 4 having a significant effect while grade 3 had no effect
99
.   
These studies therefore suggest that certain types of CFAE are actively involved 
in driving AF, whereas others are passive phenomena, and highlight the importance of 
the electrogram in guiding ablation of AF. 
 
1.7.2 Spectral Analysis of Electrograms 
 The use of spectral analysis represents an attempt to study in more detail the 
multiplicity of signals forming the fibrillatory electrogram.  This method allows the 
frequency of the superimposed components of an AF electrogram to be analysed 
separately and the relative contribution of each to the final electrogram weighted, 
resulting in the establishment of a dominant frequency (DF) for the complex 
electrogram.   
 In AF, a DF gradient from the left to right atrium has been observed in an 
isolated sheep heart AF model and also in patients with PAF
100,101
 and persistent AF
101
, 
(though not in persistent AF patients in one study
100
).    Spectral analysis has shown that 
the overall DF is higher in patients with persistent AF than PAF and that DF sites (sites 
with a 20% higher DF than surrounding atrial tissue with a 20% frequency gradient 
from them) are more often situated in the atrium itself rather than the pulmonary vein 
region in persistent AF atria
101
; moreover, the sites with maximal DF were less likely 
localised to the pulmonary vein in persistent AF: these findings are consistent with a 
more advanced atrial substrate in persistent AF maintaining the arrhythmia.    
In terms of the change in DF in response to ablation, in one study the DF 
measured at single points in the LA, CS and RA were significantly reduced by PVI in 
PAF but not persistent AF patients
100
, whereas in another study, PVI reduced the mean 
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DF in persistent AF patients as well
102
.  In patients with PAF, isolation of pulmonary 
veins harbouring DF sites leads to a reduction in AFCL or termination of AF, whereas 
this is not the case in pulmonary veins without DF sites
101
.   Spectral analysis of PAF 
patients in sinus rhythm has demonstrated that the majority of high DF sites are at the 
pulmonary veins with patients with larger left atria having more non-pulmonary vein 
high DF sites
103
.  Patients with high DF sites outside the pulmonary vein regions were 
more likely to remain inducible following PVI, with further substrate ablation required 
to reduce this inducibility
103
.  Two main patterns of DF distribution have been seen in 
persistent AF patients: in one there is a large gradient (>20% compared to average LA 
DF) between the sites of maximal DF and the surrounding atrial tissue, and in the other 
there is less of a gradient
104
.  Patients with the latter pattern had a lower proportion of 
termination to sinus rhythm during the procedure and a greater AF recurrence rate
104
.   
It is therefore postulated that regions of higher dominant frequency are drivers of 
AF, representing rotors.  One source of variability in the literature though is the 
definition of a high DF site.  Some investigators have counted this as those sites with 
DF values 20% higher than neighbouring sites
101
 (though clearly what constitutes a 
neighbouring site is affected by the density of the map collected) and others have taken 
those values as 20% higher than the mean DF for the LA map
104
 and in a prospective 
DF-guided ablation study, sites with a DF higher than the mean for the LA map were 
targeted
105
. 
 CFAE ablation has been found to reduce the mean DF in both persistent AF and 
PAF patients
102
.  Lin et al studied the interaction of CFAE and DF in patients with 
persistent AF
104
.  The most fractionated signals were found in the centre or at the 
boundary of the maximal DF sites, with the most temporal and regional CFAE 
consistency found at these sites
104
.  In an epicardial mapping study, it was found that 
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CFAE defined as continuous/multicomponent electrograms localised to DF sites in 
around 20% of cases, while in around 80% of cases these electrograms were found in 
the boundary regions of the DF sites (CFAE defined purely on the basis of cycle length 
<120ms were found to poorly localise to DF sites)
96
.  An endocardial study also found 
similar results, with there being poor point-by point correlation of CFAE and high DF 
sites but a high incidence (80%) of DF sites within 10mm of CFAE areas
106
.  The 
finding of CFAE in the boundary regions of high DF sites seems a more common 
observation than finding CFAE at DF sites themselves and correlates with previous 
optical mapping studies in explanted sheep hearts
76
. 
CFAE and DF measurements may therefore be of use in delineating regions 
actively involved in driving AF.  Any factors which can affect the electrogram could 
therefore impact on the efficacy of targeting driver regions based on the above types of 
analyses in a proposed ablation strategy.  Nothing is known regarding how catheter 
contact may affect CFAE or spectral analysis measurements per se and knowledge of 
the mechanoelectric relationship of these signals may further our understanding of them. 
1.8 Mechanoelectric Coupling 
1.8.1 Atrial Mechanoelectric Coupling 
 Cardiac tissue demonstrates electromechanical coupling whereby electrical 
impulses are converted into mechanical responses to allow the heart to contract.  There 
is also the reverse relationship whereby mechanical inputs such as stretch and 
compression have electrical consequences.  
 Historical studies suggested that mechanoelectric coupling may be present in 
man.  Ventricular repolarisation was noted to lengthen in patients undergoing balloon 
valvuloplasty for pulmonary vein stenosis as the right ventricular systolic pressure 
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dropped, and as the pressure in the right ventricle was increased by blocking of the right 
ventricular outflow tract, monophasic action potentials shortened and early after 
depolarisations developed
107
.  Similarly, in patients being weaned off bypass, as the 
ventricle is increasingly stretched, the monophasic action potential has been observed to 
shorten
108
. 
In a canine study, increases in the intraventricular volume caused changes in the 
duration of the epicardial monophasic action potential, with a shortening earlier in 
repolarisation and a lengthening due to early after depolarisations later in 
repolarisation
109
.  Another group did not demonstrate such a relationship though
110
, and 
another only observed changes epicardially (lengthening of the monophasic action 
potential) and not endocardially in response to stretch
111
.  A stretch-related reduction in 
the monophasic action potential amplitude has also been noted 
109,112
.  Acute stretch can 
cause ventricular ectopics to be generated, with the probability of an ectopic correlating 
positively with the rate of rise of volume and the peak volume of a pulse administered 
to the chamber
109,112
.
 
The ventricle is a thicker walled and morphologically more complex structure 
than the atrium.  Using a Langendorff-perfused rabbit heart preparation, Ravelli and 
Allessie investigated the effect of stretch on the electrical properties of the atrium
113
.  
The model involved biatrial dilation with the interatrial septum perforated to ensure 
equalisation of pressures and the atrioventricular node ablated with the ventricle paced 
into ventricular fibrillation to control for any atrial pressure changes caused by 
ventricular activity.  Premature stimulated beats were used to gauge the vulnerability of 
the atrium to arrhythmia – at baseline, no arrhythmia could be induced.  With increasing 
intra-atrial pressure and consequent increasing stretch, abnormal electrical activity, 
ranging from repetitive firing to atrial flutter to AF, was induced.  There was a 
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significant relationship between rising intra-atrial pressure and the incidence of AF, 
with termination of the arrhythmia by release of the pressure.  Electrically, an increase 
in pressure led to a shortening of the refractory periods of both atria, taking around 3 
minutes of sustained pressure to reach steady state.  The change in refractory period 
correlated with a shortening of the action potential.  The latter was mainly due to an 
increase in the rate
 
of early repolarisation, and loss of the plateau phase of the action
 
potential
113
.   
In an isolated guinea pig heart model, different parts of the action potential were 
differentially affected by a stretching stimulus, with a decrease in the action potential 
duration at 50% repolarisation and an increase at 90% repolarisation
114
, similar to the 
findings in the canine ventricle
109
.   With increasing stretch, increasing spontaneous 
premature atrial beats were also noted in the guinea pig model
114
.  A decrease in the 
monophasic action potential amplitude with increasing stretch has also been observed in 
the atria
113,114
.  These results contrast with the findings in an isolated rat right atrial 
model where no change in the action potential duration was seen but there was an 
increase in action potential amplitude and atrial conduction velocity with stretch
115
.  In 
the latter study, atrial stretch was found to increase the incidence of delayed 
afterdepolarisations and ectopics
115
.  
Globally, acute atrial stretch reduces atrial conduction velocity and increases the 
number of areas of slow conduction and conduction block
116
.  This spatial heterogeneity 
is felt to be due to the differential distribution of stretch within the atrium in response to 
increased intra-atrial pressure.  Stretch has also been found to increase the atrial 
effective refractory period (ERP) and, interestingly, this increase is greater in the thinner 
walled parts of the atria which are subject to greater stretch by an increase in global 
pressure
117
.  Therefore an increase in intra-atrial pressure leads to an exaggeration of the 
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ERP differences already present at different parts of the atrium.  This increasing 
dispersion of atrial refractoriness is felt to contribute to the increased propensity for AF 
in the stretched atrium. 
In humans, increasing the right atrial pressure through atrioventricular (AV) 
pacing results in a reduction of the right atrial ERP and an increased propensity for AF, 
with the latter correlating with the increase in right atrial pressure
118
.  Note that different 
studies have suggested that atrial stretch has different effects on the atrial ERP, with an 
increase in some cases
117,119
 and a reduction
113,118,120,121
 in others.  One explanation put 
forward for this disparity is that ERP may depict the action potential duration at 
different stages of repolarisation depending on the stimulus strength
121
, and as stretch 
has different effects on the action potential depending on the stage of 
repolarisation
109,114
, this would have a significant impact.  It is not difficult to propose 
that a shortening of the ERP could facilitate the maintenance of AF by allowing the 
atrium to support more wavelets.  A direct relationship between the shortening of the 
atrial ERP in response to stretch and the inducibility of AF has been observed
113
.   
Aside from changes in ERP, synchronously AV paced patients demonstrate a 
slowing of atrial conduction velocity and a higher incidence of slow conduction and 
intra-atrial conduction block sites
122
.  These changes are also associated with an 
increased incidence of AF. 
In man, at the junction between the left atrium and the pulmonary veins, 
increasing stretch leads to an increase in the dominant frequency significantly more than 
at the left anterior free wall
123
.  Moreover the number of spatio-temporally periodic 
wavefronts increases with the increasing intra-atrial pressure
123
.  In patients undergoing 
ablation for AF, the intra-atrial pressure is higher in those with persistent AF rather than 
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PAF and the mean dominant frequency of the left atrium has been found to correlate 
with the observed left atrial pressure
124
.   
The mechanoelectric properties of the pulmonary veins have also been 
investigated.  Isolated pulmonary veins demonstrate increased spontaneous firing in 
response to mechanical stretch as well as a reduction in action potential amplitude and 
duration with an increase in delayed and early afterdepolarisations
125
. 
Based on the above discussion, mechanoelectric coupling can be implicated in 
both the genesis and maintenance of AF. 
 
1.8.2 Localised Mechanoelectric Coupling 
The experiments discussed above have investigated the effect of increasing the 
pressure within cardiac chambers and looked at the electrical response.  While increased 
intracavitary pressure does lead to mechanical deformation, it is an indirect, and at the 
organ level inhomogeneous, means of achieving this.  To examine in more detail the 
influence of stretch per se requires study at a more localised level.  In the in situ pig 
heart, local stretch of the right atrium using a tripodal suction device causes shortening 
of the action potential, early afterdepolarisations and atrial tachyarrythmias
126
.  In a 
study investigating an explanted rat atrial tissue preparation, stretch led to differential 
effects on the action potential, with a shortening mid-way through and a lengthening at 
the end of repolarisation, and beyond a threshold, premature atrial beats were 
induced
127
.  These findings are similar to those seen with global stretch of the atrium
114
 
and ventricle
109
.   
The study of mechanoelectric coupling at the cellular level has presented great 
methodological difficulties, with the aim being to mechanically manipulate cells 
without damaging them
128
. 
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Myocytes isolated from rats
129,130
, guinea pigs
130
 and man
130
 (but not frogs
131
)  
demonstrate stretch-induced cell depolarisation, with the possibility of causing 
extrasystoles if beyond a threshold.   In guinea pig and human myocytes, stretch 
accelerated repolarisation in the first part of the action potential and lengthened it in the 
second phase, leading to an overall increase in the action potential duration
129,130
.  In rat 
myocytes, an increase in the action potential duration is also observed with lengthening 
of the mid and late parts of the action potential
129
.  Stretch was associated with an 
inward current, mainly carried by sodium ions, and this current was maintained during 
the stretch without inactivation or adaptation and stopped when the stretch stimulus 
ended
129,130
.  
Interestingly, the orientation of mechanical deformation relative to the axis of a 
cell has been found to exert different effects on myocytes
132
.  Compression of cells 
along their long axis causes them to depolarise and compression perpendicular to this 
causes them to hyperpolarise.  These changes in the membrane potential from 
compression are potassium mediated (rather than sodium mediated as in the case of 
stretch induced changes)
132
. 
Myocytes are not the only cells which have mechanosensitive properties.  In 
fibroblasts, stretch has been found to hyperpolarise the zero current potential by 
reducing membrane conductance while compression depolarises the holding current 
potential by increasing membrane conductance
133
.  In isolated right atrial and cultured 
cell preparations, fibroblasts and myocytes have been shown to display electrotonic and 
capacitive coupling
134
.  Fibroblasts have demonstrated in cell culture experiments to be 
capable of transmitting electrical impulses over short (a few cells)
135
 and long (up to 
300μm)136 distances (albeit with conduction delay) mediated by connexin43136.  In the 
sinus node, mathematical modelling has suggested that stretching these electrically 
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passive cells may exert an effect on myocyte function by affecting the spontaneous 
depolarisation of pacemaker cells
134
.  The contribution of the mechanosensitivity of 
fibroblasts to cardiac electrical properties in situ has not yet been clearly defined. 
 
1.8.3 Localised, Catheter-Mediated, Stretch in vivo 
As can be seen from the above, myocardial stretch, and even the orientation of 
stretch relative to a myocyte, has a significant impact on electrical behaviour.  In 
humans, there is iatrogenic exposure to localised myocardial stretch at the time of an 
electrophysiological procedure such as an ablation for AF.  In this circumstance, the 
stretch stimulus is mediated by the contact force from the catheter placed within the 
heart.  Electrogram amplitude has been shown to correlate with increasing contact force 
in canine atria
137,138
 but not ventricles
139
.  In clinical studies, the bipolar and unipolar 
electrogram amplitude has been shown to be higher at increasing contact forces in the 
ventricle (though there is a threshold beyond which higher contact forces are not 
associated with a change in the electrogram), and more ventricular late potentials are 
seen at higher contact forces
140
.   The reason for a change in electrogram properties with 
increasing contact may simply represent better transmission of electrical signals to the 
electrode, or it could be that the catheter is actively affecting the electrical properties of 
the myocardium by the mechanisms discussed above.   
During bipolar recordings, atrial electrograms have been found to vary with 
electrode orientation both prior to and following ablation within porcine atria in sinus 
rhythm
141
.  Such a relationship is predictable from the nature of bipolar recordings, and 
in conjunction with catheter contact could have a significant bearing on the 
electrograms recorded from fibrillating human myocardium. 
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The effect of localised stretch, including its orientation, on the human atrium has 
not been studied.  This effect may be especially of relevance to any drivers of AF that 
are present as one would postulate that changing their electrical behaviour could have 
wide ranging effects on the fibrillating atrium.  In this context, the effect of contact 
force on CFAE merits further investigation.  If contact force affects the expression of 
CFAE, then this would be of significance for clinical ablation.  It may be the case that 
contact parameters are contributory to the variation seen in CFAE maps
88–90
 and even 
the outcomes from strategies incorporating CFAE ablation in persistent AF
79–87
. 
 
1.9 Steerable Sheath Technology 
Two types of steerable sheath technology are currently available: manual 
steerable sheaths (Figure 1.1) and remote robotic navigation systems.  In a case-control 
study of 105 patients ablated using a steerable sheath were matched to 245 control 
patients ablated with a conventional manual non-steerable sheath: the rate of sustained 
atrial tachyarrhythmia was significantly reduced in those in the former group at six 
months follow up
142
.  These results were then expanded upon in a prospective 
randomised study of 130 patients which again found a significant benefit from the use 
of steerable sheaths at 6 months follow up in terms of success rates, as well as a 
significantly lower fluoroscopy time during the procedure
143
.  The advantages of 
steerable sheath technology are felt to relate to the improved access and contact to 
ablation target sites, improving the efficacy of lesion delivery. 
Figure 1.1 Agilis NxT manual 
Steerable Trans-septal Sheath 
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Another system using steerable trans-septal sheath technology is the Sensei
®
 
Robotic Catheter System from Hansen Medical Inc. (Mountain View, California, USA).  
This system obtained its CE mark in 2007.  The system incorporates an inner and outer 
sheath, each containing pull wires enabling deflection of the sheaths and a conventional 
catheter is passed through the inner sheath.  This system has the advantage of having the 
controls placed outside of the radiation field (remote from the patient, Figure 1.2), and 
is used with the operator seated.  The movements of the catheter are controlled using a 
3D joystick (Figure 1.2).  
 Two randomised trials comparing manual to robotic ablation have been 
published
144,145
.  These data plus registry studies suggest a benefit from RRN use in 
terms of fluoroscopy time
144–149
, catheter stability
145,148,150
 and more rapid and greater 
electrogram attenuation
151,152
 without an impact on success rates
144,145,147,148
. 
Figure 1.2 The Sensei Robotic 
Navigation System Control 
Console at St Bartholomew’s 
Hospital.  The console is placed 
outside of the radiation field 
and is therefore used without 
radiation protection equipment 
(and with the operator seated).  
The 3D joystick which is used to 
control the deflection of the 
steerable robotic trans-septal 
sheath is highlighted. 
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1.10 Contact Force Sensing Technologies 
1.10.1 Sheath-Based Technology 
The longest established contact force sensing technology is incorporated in the Sensei
®
 
Robotic Catheter System.   The force sensing system incorporated in this robotic system 
is known as IntelliSense
®
.  This pulses the catheter at 4Hz proximally and extrapolates 
the catheter contact force (CF) with the myocardium by the resistance to motion of the 
catheter in response to this proximal pulsation.    
1.10.2 Catheter-Based Technology 
The first of the catheter-based technologies to obtain a CE mark (2009) was the 
TactiCath
®
 from Endosense (Geneva, Switzerland).  This catheter uses three optical 
fibres between the second and third electrodes of the catheter and an elastic polymer 
catheter tip
153
.  The latter undergoes microdeformations in response to contact which 
changes the wavelength of reflected infrared light transmitted by the optical fibres: from 
the wavelength of reflected light at the three fibres, the orientation and magnitude of 
Figure 1.3 The Thermocool 
SmartTouch catheter.  On 
the left side of the image is 
a cartoon representation of 
the distal end of the 
catheter and on the right 
side, a photograph of a 
catheter.  The spring 
element is annotated. 
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contact force is derived
153
.  In so doing, information regarding catheter tip contact force 
and the orientation of this is derived. 
The most recently CE marked of the contact force sensing technologies is the 
ThermoCool® SmartTouch™ Catheter from Biosense Webster (Diamond Bar, CA, 
USA).  Here the catheter the tip electrode is mounted on a precision spring permitting a 
small amount of electrode deflection (Figure 1.3).  By measuring this deflection using 
location sensor coils at the proximal end of the spring, the system can calculate the force 
being exerted (and its orientation) using the known characteristics of the spring.  The 
Figure 1.4 The Display of Contact Force Data Measured by the SmartTouch Catheter on 
the Carto3 Screen.  Displayed is a left atrial geometry created using the Carto3 
electroanatomic navigation system.  Highlighted are the contact force, contact force vector 
and the contact force waveform for the contact between the catheter and the myocardium.   
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SmartTouch catheter integrates with the Carto3 platform.  During a case, the magnitude 
of contact force and its vector are displayed in real-time on the Carto3 display screen as 
well as the contact force waveform (Figure 1.4). 
For the SmartTouch catheter, the reported sensitivities reported by the 
manufacturer is less than 1g of contact force.  Data has been published for the Tacticath, 
where a comparison has been made between the measurements made by the catheter 
and a calibrated balance: this demonstrated the measurements by the catheter were 
highly sensitive and accurate (mean error ≤1g)153. 
 
1.11 Biophysics of Ablation 
 
Catheter-based radiofrequency ablation utilises alternating electrical current to 
create a tissue lesion through resistive heating (which occurs at the electrode-tissue 
interface (ETI)), and conductive heating spreading away from this latter zone.  One 
method of increasing efficacy is to produce larger volume lesions during ablation.  This 
ensures continuity and transmurality of lesions to make reliable lines of block.   
Initial studies demonstrated that lesion size correlates positively with catheter tip 
temperature
154,155
.  The threshold temperature for tissue viability has been calculated to 
be between 46.6 and 48.9°C, with tissue temperature being inversely related to the 
distance from the electrode
154,156
.  If the temperature at the ETI exceeds 100°C then 
blood boils and a coating of coagulum and char on the electrode forms which 
electrically insulates the electrode and causes a rise in impedence
157
, preventing further 
delivery of energy to the tissue.   
Cooling the catheter tip through irrigation prevents the formation of coagulum 
and char by reducing the temperature at the ETI, and allows for greater power delivery, 
resulting in larger lesions compared with non-irrigated catheters
158
.  The degree of 
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cooling, as dictated by the rate of irrigation flow, also affects lesion size, with a very 
high rate associated with a reduced lesion width
159
.  A by-product of catheter tip 
irrigation though is that temperatures deeper in the tissue can rise to the extent that 
superheating occurs with a sudden explosion of steam (which can be heard as a pop) 
associated with crater formation and an impedance rise
158
.   
As one would expect, cooling the catheter tip changes the relationship between 
the catheter-tip temperature and lesion size: from animal models, there is no correlation 
between the ETI temperature or the electrode temperature and the lesion depth or 
maximal temperature in irrigated ablation, while the converse is true in non-irrigated 
ablation
158
. 
The diameter of the catheter also makes a difference: with non-irrigated 
catheters, larger lesions are caused by catheters with a larger diameter
156
, while the 
converse is true with irrigated catheters
160
.   
The duration of ablation also affects lesion size.  A monoexponential increase in 
lesion size with time at a target electrode temperature has been noted with non-irrigated 
catheters, with a plateau when a steady state of tissue temperature is reached after 
around sixty seconds
161
.  With irrigated catheters, the temperature at deeper levels 
continues to rise at sixty seconds, with a suggestion that lesion size may also follow this 
trend
158
.   
Electrode orientation also affects lesion size
162,163
, with a vertical orientation 
increasing, and a horizontal orientation reducing lesion sizes with irrigated 
catheters
162,163
 and the converse the case with non-irrigated catheters in vitro
163
. 
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1.11.1 Contact Force and Ablation 
Aside from the variables detailed above, another important factor is the degree 
of contact between the catheter and the tissue.  Earlier in vitro work with non-irrigated 
catheters in temperature-controlled ablation demonstrated a linear relationship between 
contact force and lesion size, with the largest difference between no contact and being 
in contact with tissue
161
.  Over a wide range of contact forces (0-400N), there was only 
a small increase in lesion size with increasing contact force (as long as the electrode tip 
temperature was maintained at the pre-set value and contact was maintained)
161
.  The 
modest nature of this relationship in this setting was further highlighted by a study 
comparing 10g to 20g of contact, and in this narrow range no difference in lesion size 
was found
162
.  With non-irrigated catheters and temperature controlled ablation, as the 
power output during ablation can be titrated to achieve target temperatures, the effect of 
degrees of contact will be reduced.  Poorer contact entails more power output to reach 
the same temperatures
161
 and since lesion size relates to temperature at the electrode 
tip
154
, similar lesion sizes are therefore produced.   
An in vivo study of epicardial ablation compared good with bad contact (the 
latter defined as light or no contact) with power-controlled ablation and found that 
lesion size correlated with the degree of contact
164
.  In this case, there were more pops 
and impedance rises with greater contact at higher powers and these were associated 
with rapid, excessive electrode temperature rises.  The importance of contact force in 
irrigated catheters has been studied in vitro with lesion size significantly greater at a 
force of 30g compared to 10g in one study
165
, and another finding that 0.5N of force 
(but only with a perpendicular orientation) created significantly deeper lesions than 
lesser contact forces, but with also a higher incidence of pops
159
.  In another study 
examining temperature controlled power limited ablation in excised porcine ventricle, 
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where fluid flow external to the catheter was utilised to cool the catheter tip, lesion size 
increased with catheter contact before a plateau was attained
166
.   
The above studies of catheter contact force during ablation extrapolated the 
force at the catheter tip from the force loaded onto the catheter, with for example a 
dynamometer.  Such a method could not be used in the endocardial clinical in vivo 
setting.  Electrical impedance has been used as an in vivo marker of contact.  Impedance 
is the opposition to flow of a current through a circuit in response to a voltage.  
Impedance has been suggested to fall during ablation as a rise in temperature is felt to 
increase the conductivity of cardiac tissue
166
.  Impedance at baseline has been observed 
to be higher in the pulmonary veins  than the body of the atrium 
167
.   Impedance falls 
with ablation, and this fall correlates with the temperature at the catheter tip
164,167
, with a 
steeper relationship in the pulmonary veins than the left atrium
167
.  Greater contact force 
between the ablation catheter and tissue results in a greater impedance drop
164,166
 and 
later plateau of this fall with ablation in animal studies, with an excessive drop (>20Ω) 
associated with tissue overheating, a subsequent rapid rise in impedance  and tissue 
explosions
164
.  The impedance drop has also been found to correlate with lesion 
depth
166
.  These studies have examined impedance during non-irrigated ablation.  
Animal studies have also looked at this measure during irrigated ablation.  There is a 
small but significant increase in the impedance with the start of irrigation and the 
baseline impedance is higher when the catheter is in contact with tissue rather than in 
the blood pool
168
.  With irrigated ablation, the magnitude of the impedance drop is not 
predictive of pops but a greater drop is predictive of thrombus formation
168
.   
In a study of 394 ablation points in 35 patients undergoing AF ablation, the 
maximum impedance drop with ablation was found to correlate with the CF during 
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ablation, and a more perpendicular catheter contact orientation was associated with a 
lesser impedance fall (but also lesser CF) than a more parallel contact orientation
169
. 
Bipolar voltage amplitude significantly correlates with increasing contact: while 
this cannot differentiate between consistent contact and tenting, there is a significant 
difference between no contact, minimal contact and consistent contact
137
. 
Studies using sheath-based force sensors in vivo have shown increased CF is 
associated with larger and more transmural lesions
137
 but also more pops
170
.  Irrigated 
tip force-sensing catheters have further examined the impact of different levels of 
contact force on lesion size and also the interplay of this variable with the ablation 
power.  Increased contact force is associated with increased tissue temperature at 3 and 
7 mm away from the ETI, and is associated with increased lesion size at a given level of 
CF, as is increasing ablation power
153
.  Increasing CF  is also associated with an 
increased incidence of thrombus formation at the electrode edge, especially with 
increasing power, and a similar relationship is also apparent for steam pops
153,168
.   
Within the beating heart, even within the fibrillating atrium, it would be 
expected that contact will be dynamic rather than static.  Such dynamic contact has been 
simulated in an in vitro setting where constant (static) contact has been found to 
produce the largest lesions while variable and intermittent contact produce progressively 
smaller lesions
171
.  Therefore the dynamic quality of the contact between electrode and 
tissue is also of great importance in the efficacy of lesion formation.  In addition to 
motion from the beating heart, respiratory motion also affects the contact force from the 
catheter, with apnoea, as expected, leading to higher average contact force and force 
time integral during ablation
172
. 
Better electrode-tissue contact results in a greater proportion of the delivered 
power contributing to the resistive heating of the tissue, rather than wasted in the blood 
~ 51 ~ 
 
stream.  Consequently, this can lead to larger, more likely transmural lesions but also 
increases the risk of complications through excessive tissue heating.   
The LA is not a uniform structure: there is a normal variation in its wall 
thickness and texture
173
.  During electrical isolation of the pulmonary veins, areas which 
are more frequently resistant to electrical isolation have been identified
174
.  Moreover 
there is also a preferential distribution of sites of acute and chronic reconnection
175
.  The 
intervenous ridges and pulmonary vein-left atrial appendage ridge are important areas in 
this respect
174,175
.  The reason for this locational variation in the efficacy of ablation 
may relate to variations in wall thickness making transmural lesions harder to produce, 
epicardial connections or difficulties achieving optimal contact in those regions.  A 
significant variation of the contact forces exerted within the atrium during ablation has 
in fact been observed: for example the left anterior inferior ridge area has lower catheter 
contact
176
.  Contact force during ablation also predicts acute reconnection in patients 
with PAF, with sites of pulmonary vein reconnection having a lower average contact 
force
172,177
 and force time integral during ablation
172
.   At 3 months’ follow up, 
segments within a wide area circumferential ablation (WACA) line ablated with a 
minimum force time integral (FTI: the area under the force-time curve) below 400g.s 
had a greater chance of reconnection among PAF patients
178
.  At 12 months of follow 
up, the average contact force, force time integral and incidence of low contact force 
during ablation are predictive of procedural success in PAF patients
179
.   
The use of CF sensing catheters, in small non-randomised studies, has been 
found to be associated with a reduction in fluoroscopy
180,181
, procedure
180–182
 and 
ablation times
180,181
, as well as AF recurrence rates at 12 months in some studies
180,183
, 
but not in another
181
.  In these studies, generally a minimum average CF during ablation 
of 10g was targeted.  The FTI achieved during ablation also has a bearing on procedural 
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parameters: in one study an average ablation FTI of  under 543g.s was found to be 
associated with longer procedure and fluoroscopy times
184
.   
In an ex vivo porcine heart study, a force of 417±167g could perforate un-ablated 
left atrium, while ablation reduced the force needed to perforate
185
.  A further study of 
in vivo porcine hearts found that the lowest contact force recorded to cause perforation 
was 77g, with a force of 158.4 ± 55.4 needed to perforate unablated left atrium
186
.  A 
study in patients undergoing AF ablation demonstrated that the actual contact forces 
exerted on the myocardium vary significantly among operators during mapping and 
ablation when they were asked to maintain what they perceive (without CF-sensing 
technology) to be ‘good contact’176.  This included multiple high force events defined as 
the contact force exceeded 100g for 200ms, with six of the thirty four patients having 
over 40 such instances
176
.  These episodes occurred during catheter manipulation as 
well as ablation.  Therefore, knowledge of the CF even while not actively ablating may 
be important from the point of view of safety. 
 
1.12 Ablation Efficacy 
The aim of a radiofrequency application during AF ablation is the generation of a 
transmural lesion.  This results in a persistent barrier to electrical conduction or the 
elimination of a driver.  At a procedural level, this is best reflected by an improvement 
in the single procedure success rate for the ablation.  Clearly, this is the most relevant 
outcome measure clinically.  CF parameters have been compared between cases with 
and without a recurrence of symptoms by Reddy et al.,
179
 (Table 1.1), with higher CFs 
during ablation observed in those without recurrence. An improvement in success rates 
may not necessarily mean that the ablation procedure has been more efficient: this 
would be reflected by a reduction in the procedure length, for example.  In order to 
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Table 1.1 Clinical studies assessing ablation efficacy with respect to catheter contact 
force: methods used to assess efficacy and cut off values for effective ablation 
make procedures more efficient, the aim should be for every radiofrequency application 
to be contributory to the success of the procedure.  This would lead to shorter 
procedures and potentially less risk.  Moreover, suboptimal applications may lead to 
short term procedural success but long-term failure – by causing tissue oedema and an 
incomplete transmural lesion.  Consequently, it is useful to be able to assess the efficacy 
of individual radiofrequency applications. 
 In preclinical studies, the efficacy of an individual ablation is relatively 
straightforward to judge as histological lesion dimensions are available
158,161
.  Lesion  
histology is not available for clinical studies though and therefore alternative measures 
of the effect of ablation are used. 
Author Number 
of 
Patients 
AF 
Subtype 
Method to 
judge ablation 
efficacy 
Suboptimal 
Ablation 
Effective 
Ablation 
Reddy179 32 PAF 12 months 
recurrence of 
symptoms 
CF <10g; 
FTI<500g.s 
CF>20g 
FTI>1000g.s 
Haldar177 40 35% PAF Acute PV 
reconnection in 
a 7 segment 
model per PV 
pair 
CF 14.5g CF 19.6g 
Kumar172 12 PAF Acute PV 
reconnection in 
a 5 segment 
model per PV 
pair 
LPV: CF 9g, 
FTI 173g.s  
RPV: CF 11g, 
FTI 282g.s 
LPV: CF 20g, 
FTI 436g.s 
RPV: CF 24g, 
FTI 609g.s 
Kumar187 20 PAF EGM criteria for 
transmurality141 
 CF>16g, FTI 
>404g.s 
Neuzil178 40 PAF PV reconnection 
at 3 month 
protocol-driven 
restudy in a 5 
segment model 
per PV pair 
 
CF 15.5g 
Minimum CF 
3.6g 
Minimum FTI 
118g.s 
FTI>400g.s 
CF 19.5g 
Minimum CF 
8.1g 
Minimum FTI 
232g.s  
Sohns188 6 PAF MRI-defined scar 
in 5mm2 zone 
 >1,200g.s 
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 Classically, the attenuation of the electrogram has been used to judge the 
efficacy of an individual ablation.  Unipolar atrial electrogram attenuation has been 
found to be associated with transmurality of ablative lesions
189
.  Significantly more 
amplitude reduction in the bipolar signal during sinus rhythm and AF with transmural 
lesions is seen in vitro, with a reduction of ≥ 60% having a high specificity for lesion 
transmurality
190.  In clinical studies, an ≥80% reduction in electrogram amplitude has 
been targeted
175,191
.  The location of the lesion, whether in smooth or trabeculated atrial 
tissue affects the ability to attain target reductions in electrogram amplitude, likely due 
to the non-uniformity of electrode contact in the latter regions
192
. 
Changes in electrogram morphology have also been shown to be predictive of 
transmurality of ablation lesions in a porcine model by Otomo et al.,
141
.  This approach 
is limited clinically in that it has been validated only in sinus rhythm cases.  One group 
have used these criteria for bipolar signals to judge ablation efficacy
187
. 
 The most commonly employed model for assessing ablation efficacy is 
reconnection of the pulmonary vein isolation (PVI) lines which are used to isolate the 
pulmonary veins from the left atrium
172,177,178
 (Table 1.1).  In this approach, the 
ipsilateral paired PVI line is divided into five to seven segments and efficacy is based 
on whether that segment reconnects or not.  The disadvantage here is that target 
parameters for individual radiofrequency applications are being assessed based on the 
response of a region, quite often with overlapping ablations, to ablation.  In all but one 
of these studies, operators were blinded to CF measurements (in the other study, the 
operators were blinded in only half the cases).  This blinding serves to exaggerate the 
differences between ineffective and effective ablations as a lack of knowledge of CF 
allow for a greater range of CF to be applied and therefore makes it difficult to establish 
where the actual threshold for effective ablation lies.  Based on these studies, a mean 
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ablation CF of at least 15g and FTI of >400g would appear to be associated with a 
reduced risk of an ablation being in a reconnecting segment. 
 While histological lesion parameters are not available for clinical cases, work 
has been done using cardiac MRI to attempt to image ablation lesions.  McGann et al., 
described a methodology for imaging LA scar using delayed enhancement MRI (DE-
MRI) following pulmonary vein isolation, and the burden of LA scar they observed 
correlated with arrhythmia recurrence
193
.  This group went on further to demonstrate 
that areas of DE-MRI enhancement correlate with areas of electrical scar (R
2
=0.57) and 
that DE-MRI imaging could be used to identify breaks in the pulmonary vein isolation 
lines
194
.  In a blinded analysis using pre- and post-ablation MRI images, another group 
found that investigators were able to identify ablated LA myocardium in only 60% of 
cases, with a poor ability to distinguish ostial from circumferential ablation lesions
195
.  
This contrasts with another report in which ablated myocardium could be identified in 
100% of cases on DE-MRI
196
.  These findings suggest MRI may be useful in 
determining the sites of ablation lesions but the difference in the reported reliabilities 
may relate to the signal intensity thresholds being used to assign scar on MRI.  To 
address this, recent work has correlated macroscopic scar volumes with DE-MRI 
imaging scar volumes in the right atria of 8 swine: based on this, DE-MRI signal 
intensity thresholds have been proposed which allow the best approximation of the 
macroscopic scar volume
197
.   
 Contact force parameters have been compared with MRI-imaged atrial scar by 
Sohns et al.
188
, Table 1.1.  In this study of six patients, the FTI of ablation was 
correlated with DE-MRI scar.  In order for this comparison to occur though, the FTI 
was not examined from the perspective of a single radiofrequency application, but in a 
subdivision of 1cm zones.  Increasing FTI above 1,200g.s was associated with a 
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significant increase in the proportion of a 5mm
2
 region of myocardium exhibiting DE-
MRI scar (below this FTI value, the increase in the scar burden in that zone with an 
increase in FTI was small).  This study therefore raises the possibility of using cardiac 
MRI to assess ablation efficacy clinically.  The drawback here though is that the 
efficacy is being assessed at a MRI-zone level (albeit a small zone) rather than an 
individual radiofrequency application.  This therefore relies on extremely accurate 
registration of each radiofrequency application between the electroanatomic navigation 
system and the MRI being used to judge scar.  Moreover, this method is unable to 
account for any overlap in applications (for example through catheter drift even during a 
putative static application). It may be for these reasons that the threshold for effective 
ablation is much higher in this study compared with the other work presented in Table 
1.1. 
 
1.14 Conclusions and formulation of current studies 
The human left atrium is an important structure and the disruption of its normal 
function through the onset of the chaotic electrical activity associated with AF has 
important symptomatic and prognostic implications, and is becoming increasingly 
common at a population level.  With the advent of contact force sensing catheter 
technology, as well as the detailed information available from electroanatomic mapping 
systems, it is possible to increase our knowledge of in vivo human left atrial mechanical 
and electrical behaviour.  Moreover, catheter contact has been found to be an important 
determinant of radiofrequency ablation efficacy in preclinical studies
161,164
.  The use of 
CF sensing catheters also allows us to assess the importance of catheter contact to 
clinical ablation.  The initial goal of this thesis is to explore the effect catheter contact 
on the electrogram.   Following on from this, it is hoped to investigate factors affecting 
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the contact between the catheter and the atrial myocardium,to examine the nature of 
catheter contact in more detail.  The effects of catheter contact on ablation will also be 
studied.. 
The interaction between the catheter and myocardium results in a stretch 
stimulus and this may affect the measured electrical properties of the tissue as suggested 
by previous work
122,130
.  Such an effect could impact on the targets identified for an 
ablation such as fractionated electrograms or regions with high dominant frequency.  
Aside from CF, an important component of catheter contact is the catheter’s orientation, 
especially for bipolar electrograms
141
.  Therefore, in Chapter 3, the impact of catheter 
contact on the electrogram is studied.  The hypothesis for this experiment is that 
catheter CF (and the contact orientation) significantly affects the electrogram, including 
CFAE and spectral parameters.  In the first instance, knowledge of the relationship 
between the atrial electrogram and CF has direct clinical utility as the data can be used 
to assess whether CF-sensing technology is necessary, or whether electrogram 
characteristics can be used as a surrogate for this.  Whether the degree of contact 
between the catheter and myocardium causes clinically relevant changes in the 
fibrillatory electrogram is also assessed, based on the effect on automated CFAE 
analysis scores and the DF of the electrogram.  In sinus rhythm, the relationship 
between catheter contact and the incidence of atrial ectopics is investigated.   
In Chapter 6, the effects of different catheter delivery mechanism on catheter 
contact during ablation are examined.  The hypothesis here is that as the mechanical 
properties of the technologies differ (principally the stiffness), this would affect the CF.  
The experiment also investigates CF distribution in different areas of the WACA lines, 
to characterise the interaction between the CF delivered, the technology used to deliver 
the catheter and the left atrial location.  This regional assessment is further extended by 
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examining sites of immediate and delayed reconnection in the WACA lines.  The aim 
here is to observe differences in the sites of reconnection between transseptal sheath 
technologies and to then compare this with differences in CF during ablation.  With 
these data one would also hope to gain further insight into thresholds of CF necessary 
during ablation to reduce the risk of reconnection (in other words, give an indication of 
how to improve ablation efficacy). 
While sites of reconnection in a WACA line and the CF delivered during the 
initial ablation of those sites can give important information regarding targets for 
ablation, the difficulty here is that the ability to correlate a site of reconnection with a 
particular ablation is limited.  This is mainly because ablations in regions are generally 
overlapping, and it is challenging to know at what exact location a reconnection is 
present within an ablation line.  In experiment 4, a different approach to this question is 
adopted.  Here, rather than assessing the efficacy of ablation based on regional 
reconnections relating to regional ablations, other consequences of ablation are studied 
for individual, non-overlapping, static ablations: in this case the attenuation of the 
electrogram and the impedance drop from ablation.  These indices are known to 
correlate with histological lesion parameters in preclinical studies
166,189,190
 and so are 
used as surrogates for lesion parameters to gauge ablation efficacy.  The hypothesis for 
this chapter is therefore that CF is a significant determinant of clinical ablation efficacy 
as judged by biophysical and electrogram parameters.   Secondly, on the basis that a 
plateau in the change of the latter lesion surrogates with increasing levels of CF during 
ablation represents a plateau in lesion maturation, it is hypothesised that if such a 
plateau is observed, it is possible to establish target CF parameters for ablation.   
The contact between the ablation catheter and myocardium can be described in 
terms of its magnitude but also its duration: both of these measures are incorporated in 
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the FTI and this would seem the optimum descriptor of catheter contact during ablation.  
An important question explored in Chapter 4 is whether the constituent parts of the FTI 
or the actual FTI achieved itself are more important to the efficacy of ablation.  Previous 
work suggested 10g of contact force was necessary for effective ablation
179
: therefore 
the hypothesis here is that the mean CF is a significant determinant of the efficacy of 
ablation (more so than the FTI).   
Chapter 5 builds on the work of the preceding chapters.  The first part of the 
chapter examines the factors affecting the catheter’s contact with the myocardium.  
Specifically this is an examination of the stability of contact in terms of CF and catheter 
location.  These factors are studied not just in terms of the catheter delivery technology 
but also the atrial rhythm, LA location and catheter orientation.  The interaction 
between the catheter and different parts of the atrium also gives important indicators as 
to the mechanical properties of the underlying atrial tissue. 
In the second portion of Chapter 5, the impact of differences in catheter contact 
on the efficacy of ablation is assessed using the impedance drop with ablation as a 
surrogate of lesion parameters.  As with Chapter 5, the assessment is at the single 
ablation level using static, non-overlapping ablations.  The hypothesis explored here is 
that the efficacy of ablation would be affected more than just by the FTI but also other 
factors affecting the contact between the catheter and myocardium such as the atrial 
rhythm and location. 
The overarching aim of the thesis is to explore the effect of catheter contact on 
left atrial electrical and mechanical properties as well as on the efficacy of ablation.  
The general hypothesis is that such relationships exist and are significant.  If this is 
proven to be the case, then understanding the relationships may assist in the 
establishment of optimal target parameters for left atrial ablation and mapping.  In so 
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doing, the aim is the optimisation of clinical AF ablation procedures in order to improve 
procedural success rates and safety.  
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2. Methods 
The specific methods used vary for each chapter are presented in detail 
separately.  Prior to such discussion, points of commonality in the methods will be 
discussed. 
2.1 Study Institutions and Personnel 
In the case of all of the chapters other than Chapter 4, patients were exclusively 
recruited from St Bartholomew’s Hospital, part of Bart Health NHS Trust, which serves 
a population of 2.5 million.  For Chapter 6, patients who had procedures at a further two 
hospitals: London Bridge Hospital and the London Independent Hospital were also 
included.  These two hospitals are private London hospitals, though the operators whose 
patients were included in the study are those based at St Bartholomew’s Hospital.  
There are differences in the ethical approval under which the work in the different 
chapters was conducted. 
 Chapter 3 involved assessment of the impact of changes in contact force on 
electrogram parameters in patients undergoing AF ablation.  The study was 
approved by the institutional Cardiac Peer Review Committee and by National 
Research Ethics Committee London – West London (reference 11/LO/1861).  
The sponsor for the study was the Barts NHS Foundation Trust. 
 Chapter 4 assessed ablation outcomes from an electrogram and impedance drop 
perspective with respect to the contact force during ablation for persistent AF.  
The work in this chapter was covered by the same ethics application as Chapter 
3. 
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 Chapter 5 involved a detailed assessment of contact force characteristics in the 
left atrium and their impact on ablation efficacy.  This work was also covered by 
the same ethics application as Chapter 3.   
 Chapter 6 was a retrospective analysis of the effect of steerable sheath 
technology on the quality of ablation catheter contact during persistent AF 
ablation, as well as how this impacted on reconnection sites in pulmonary vein 
isolation lines acutely and at the time of repeat ablation procedures.  As this was 
a retrospective analysis of anonymised data, formal ethical approval was not 
required. 
All of the studies were conceived and designed by the author and Professor Richard 
Schilling.  Co-investigators for the work were Drs Ross Hunter, Simon Sporton, Mehul 
Dhinoja Ling Liang-han and Mark Earley. 
 
2.2 Patients  
 The patients enrolled in the study all had their AF ablations performed on 
clinical grounds.  In most cases this would mean they had failed at least one anti-
arrhythmic drug.  The exclusion criteria for enrolment in the research conducted were as 
follows: 
 Inability or unwillingness to consent to enrolment 
 Age <18 years 
 Contraindication to anticoagulation or transoesophageal echocardiography 
 Contraindications to AF ablation such as unresolved intracardiac thrombus 
2.3 Cardiac Catheter Laboratory Setup  
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Multiple systems are incorporated into the setup for AF ablation.  During the procedure, 
the patient’s vital signs are monitored (oxygen saturations through pulse oximetry and 
non-invasive blood pressure).  Two different forms of anatomic visualisation system are 
Figure 2.1 Cardiac Catheter Laboratory Control Room at St Bartholomew’s Hospital.  The 
haemodynamic monitoring system allows non-invasive systemic blood pressure and 
invasive pressures to be monitored.  The electroanatomic mapping system (Carto3) and 
fluoroscopy screens as well as the electrogram recording system (LabSystem Pro) can all be 
monitored from the control room. 
Figure 2.2 Cardiac Catheter 
Laboratory at St 
Bartholomew’s Hospital.  
During a case, the viewing 
screens display the 
fluoroscopy, electroanatomic 
mapping, haemodynamic and 
electrogram data for the 
operator.  The intracardiac 
electrical signals from the 
patient pass through the 
Carto3 Patient Information 
Unit (PIU) and are fed into the 
breakout box connector for 
LabSystem Pro.   
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Table 2.1 Part of a Carto3 contact force data export for a point.  Index here refers 
to the measurement number for a point (so for contact force measurements 
which were sampled over a 10 second window at 20Hz, there would be 200 
measurements).   
 
Index  
Reference 
time (ms) 
Time 
(ms) 
Force Value 
(g) 
(Contact) Axial 
Angle (˚) 
(Contact) 
Lateral Angle (˚) 
1 -7485 4051675 11.5813 -175 68 
2 -7435 4051725 14.2221 -179 65 
3 -7385 4051775 15.133 -178 66 
4 -7335 4051825 15.2849 -174 66 
5 -7285 4051875 15.0851 -177 73 
6 -7235 4051925 14.9851 -174 74 
7 -7185 4051975 15.3761 -172 69 
8 -7135 4052025 14.4308 -174 79 
9 -7085 4052075 15.0131 -173 69 
10 -7035 4052125 15.4966 -172 64 
 
 
utilised: fluoroscopic for radiographic visualisation (mainly to guide placement of the 
coronary sinus catheter and trans-septal puncture), and electroanatomic navigation 
systems for non-fluoroscopic visualisation (used to guide catheter manipulation during 
mapping and ablation).  The surface ECG and intracardiac electrograms are recorded 
using an electrogram recording system.  To allow for pacing and ablation, stimulator 
and ablation units are also included in the setup.  Figures 2.1 and 2.2 illustrate the set up 
in the cardiac catheter laboratory control room and in the laboratory itself respectively 
at St Bartholomew’s Hospital. 
 
2.4 Electroanatomic Navigation System 
 In the case of all of the procedures in this thesis, the SmartTouch contact force 
sensing ablation catheter from Biosense Webster Inc. was used.  This has been 
described in the introduction and incorporates with the Carto 3 electroanatomic 
navigation system from the same company. 
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 The Carto3 system uses a hybrid of magnetic location technology and current-
based visualisation to localise catheters within the heart.  The magnetic component uses 
a miniature passive magnetic field sensor which is incorporated in the distal element of 
the ablation catheter. A locator pad is placed beneath the patient and produces ultralow 
magnetic fields from three coils
198
.  These fields decay with distance from the source.  
Based on the strength of each of these fields at the location of the sensor, the distance 
from each source coil in the location pad can be determined.  Assessment of the in vitro 
and in vivo accuracy of the magnetic localisation has demonstrated that location 
measurements are highly reproducible with very little measurement error
198
.  For 
current-based visualisation, two sets of reference patches are affixed to the front and 
back of the patient’s thorax.  The magnetic technology is complementary to the current-
based technology, as the former is used to calibrate the latter, minimising distortions at 
the peripheries of electrical field
199
.  The system generates a small current which goes 
from the electrodes of the catheters and is localised to the surface patches.  Each 
electrode emits a different frequency of current which means they can be distinguished 
from one another.  The strength of the current is measured for each electrode at each 
patch and using this information a current-ratio is produced for each electrode location, 
and by indexing this to the magnetic location data, the locations of the electrodes in 
three dimensional space are determined
199
.   
 The Carto3 system is capable of generating a data export file including the 
geometries collected, electrode locations, CF, electrogram and ablation biophysical 
data.  The export consists of separate text files for each element for each point: typically 
over 3,500 separate files constitute each export.  The CF data (magnitude and vector), is 
collected at 20Hz.  For a mapping point the window of recording is 10 seconds (9.5 
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seconds retrospective to a point being acquired and 0.5 seconds prospective), while 
during ablation, CF data is stored throughout (Table 2.1). 
In addition to this data, it is also possible to export location data for each 
electrode as well as the passive magnetic sensors.  This export is limited to 2.5 seconds 
(2 seconds retrospective to a point being acquired, 0.5 seconds prospective) and in this 
case the sampling rate is 60Hz (Table 2.2).   
During ablation, as well as the CF data, the system also records biophysical data 
Table 2.2 Part of a Carto3 location data export for a point.  The X, Y and Z co-ordinates for 
the position of the mapping catheter magnetic location sensor at each time point are given.  
Here the sensor number refers to the location sensor for the catheter. 
 
Sensor# 
Time 
(ms) X Y Z 
1 5 21.1298 25.9182 95.933 
1 22 21.1636 25.8995 95.9143 
1 39 21.1937 25.8778 95.8934 
1 55 21.2396 25.8583 95.869 
1 72 21.271 25.8464 95.8522 
1 89 21.3109 25.8325 95.818 
1 105 21.3504 25.814 95.7924 
1 122 21.383 25.8042 95.772 
1 139 21.4126 25.7965 95.7406 
 
Table 2.3 Part of a Carto3 ablation biophysical data export. 
 
AblTime 
(ms) 
Power 
(W) 
Impedance 
(Ω) 
Distal 
Temperature 
(˚C) 
Proximal 
Temperature 
(˚C) 
8215324 0 164 37 0 
8215418 2 163 37 0 
8215518 2 166 37 0 
8215618 2 167 37 0 
8215718 2 166 37 0 
8215818 2 167 37 0 
8215918 2 168 37 0 
8216018 2 169 37 0 
8216118 4 168 36 0 
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including the catheter tip temperature, ablation power and the impedance - all sampled 
at 10Hz (Table 2.3).   
 The Carto3 system is also able to record electrogram data.  Incorporated in this 
is an automated CFAE grading system.  The basis for this system is the identification of 
deflections in the fibrillatory electrogram and certain criteria are set for a deflection to 
fulfil, otherwise it is discounted as noise.  To be counted as a deflection, its width must 
fall within a certain range (15-30ms are default settings).  There is also a range of 
deflection amplitudes that must be fulfilled (0.05-0.15mV by default).  Based on the 
identified deflections, the system then generates three different scores: 
 
 The interval confidence level (ICL) counts the number of intervals between 
deflections falling within a range (70-120ms is suggested).   
 The average complex interval (ACI) is the mean time interval between 
deflections (within a specified range). 
 The shortest complex interval (SCI) is the shortest interval between deflections 
falling within the specified range. 
 
The automated CFAE analysis scores are not part of the general Carto3 data 
export and therefore had to be taken from the point log for each study.  This was 
performed by acquiring image files for each point log manually and then using optical 
character recognition software (ABBYY FineReader 11, ABBYY, Moscow, Russia), 
the data from the image files were then extracted for further analysis.   
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2.5 Electrogram Recording System 
A limitation of the Carto3 electrogram recordings is that the recording window is 
limited to 2.5 seconds.  Therefore, the electrogram data used in the current study were 
taken from LabSystem Pro (Bard Electrophysiology Division).  This system 
continuously records the electrograms and allows the required data to be manually 
exported for analysis.  For each contact force mapping point therefore, the 
corresponding electrogram data were exported from LabSystem Pro (the Carto3 
electrogram export was not used in view of the 2.5 second limitation in its duration).     
The LabSystem Pro electrogram export values are exported in a raw unit-less 
decimal number representing a signed 16-bit analogue-to-digital converter (ADC) value 
where the iso-electric point or zero potential is “0”.  
The numeric limits of the 16-bit value are: 32,767 to -32,768.  As the Clearsign 
ADC hardware that is part of the system measures to the saturation point, the full binary 
value in the positive range is 32,768. Therefore, the equation for the conversion to 
millivolts used was: 
 
 [mV] = [ADC value] * [Range in mV] / 32768 
 
 Here the “Range” value represents the positive range of the 
amplifier and was given as part of the LabSystem Pro electrogram 
output for each point. 
 
 In order to be able to export the required electrogram duration for a point, the 
LabSystem Pro Registry file had to be edited to adjust the export window.  Each 
electrogram was manually exported and the data in the resulting text files subsequently 
converted to mV using the above equation. 
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2.6 Co-ordinating Electroanatomic Mapping and Electrogram 
Recording Systems 
 For the purposes of Chapters 4-6, it was necessary to acquire data from Carto3 
and LabSystem Pro simultaneously.  This was either to be able to compare contact force 
and electrogram data (Chapter 6) or post-ablation and pre-ablation mapping point 
electrogram data (Chapters 4 and 5).  For a minority of the cases, the LabLink data 
interface (Bard Electrophysiology Division) was available.  This allows automated, 
simultaneous, acquisition of data by both systems.  Where this system was not available 
though, a methodology was sought to co-ordinate the two systems.  As all of the data 
collected by both systems has a time stamp, one possibility was to co-ordinate based on 
the system time stamps.   
To assess the reliability of the co-ordination between the time logs of the two 
systems, in 3 patients the time stamps for points simultaneously acquired manually (by 
a single researcher pressing the acquisition buttons on both systems) were compared.  
As a further comparison, the time stamps were compared for a further 4 patients for 
points simultaneously acquired using the LabLink interface.  The hypothesis here was 
that if the time stamps between the two systems remained comparable throughout the 
case, then any difference between the two systems’ time stamps at baseline should 
remain constant throughout the procedure.  Therefore in all cases, the gap between 
timestamps was also referenced to the difference in time at baseline.   
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Results 
Figure 2.3 Comparison of 
timestamps of Carto3 and 
LabSystem Pro for 
simultaneously acquired 
points. 
 
 
Top – the gap between the 
timestamps for the two 
systems varies over the 
course of each procedure in 
the non-LabLink cases. 
 
 
Middle – Comparing the gap 
between the time stamps 
for LabSystem Pro against a 
reference timer, one can see 
that the gap varies without 
LabLink but varies very little 
when LabLink is used. 
 
 
Bottom – When the Carto3 
timestamps are compared 
to the reference timer, 
there is very little variation 
in the time logs, regardless 
of LabLink use. 
 
LL=LabLink 
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The results of this analysis are presented in Figure 2.3 (upper panel).  As can be 
seen, during the course of a procedure there is a varying gap between the two time 
stamps, with a greater difference for the non-LabLink rather than LabLink cases 
(median(range): 2 (-45-51)s versus 0(0-4)s respectively, p<0.0005).   
Based on these data, it was unclear whether the problem was with the time log 
for either or both systems, and consequently in which system the LabLink interface was 
improving the timestamp consistency.  Therefore in 6 of the cases, an external reference 
timer was used and the time on this recorded when points were taken on the two 
systems.  As can be seen in Figure 2.3 (middle panel), this analysis suggests the issue is 
with the LabSystem Pro internal timer drifting during the procedure and that the 
addition of the LabLink software rectifies this problem (-4(-11 41)s versus 0(-4-4)s 
respectively, p<0.0005).  The Carto3 timestamp was unaffected by the presence or 
absence of the LabLink interface (Figure 2.3, lower panel).   
Conclusion 
 The LabSystem Pro timer drifts during the case unless used with LabLink.  
These findings were confirmed by the manufacturer of LabSystem Pro and are under 
investigation.  For the purposes of the experiments in this these, where LabLink was not 
available, synchronicity of the two systems was ensured by manually acquiring study 
data points simultaneously in both systems (as the time-logs from the two systems could 
not be relied upon to do this).   
 
2.7 Data Analysis 
The analysis of the data in all of the studies was performed using custom written scripts 
in the Matlab (MathWorks, MA, USA) programming environment.  These scripts were 
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written for the purposes of this research from the ground up by the thesis author.  
Aspects of this analysis that were shared between experiments are explained in more 
detail here, while analyses used which were unique to a particular experiment are 
detailed in the relevant chapters. 
 In the case of all of the experiments, CF data were processed in order to 
determine the mean contact force and FTI.  The latter is the area under the force/time 
curve.  This was determined by the process of dividing the waveform into a series of 
trapezoids, establishing the area of each of these and then summating them to give the 
Figure 2.4 Trapezoid 
integration of a contact 
force waveform. (A) 
Contact force waveform 
over 10 seconds (black 
solid line) with mean 
contact force displayed 
as a dotted line.  The 
shaded area under the 
curve is the force time 
integral.  The portion of 
the waveform boxed in 
red is shown in more 
detail in (B).  In (B), each 
contact force 
measurement is 
displayed as a blue 
circle.  The trapezoids 
making up the 
waveform area are 
highlighted.  The 
formula to establish the 
area of one trapezoid is 
displayed.  Summating 
the areas for each of the 
trapezoids under the 
curve will give the area 
under the curve which is 
the force time integral. 
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FTI for the waveform (trapezoidal integration, Figure 2.4).  The advantage to this 
approach is that it only uses the data collected (essentially a series of trapezoids) and 
makes no assumptions regarding the nature of the waveform between measurements. 
 Experiments 4 and 5 analysed impedance drop over the course of static 
ablations.  Impedance was sampled at 10Hz and the waveforms produced were found to 
suffer from a lot of noise.  In order to remove this noise, to appreciate better the change 
in impedance over the course of the ablation, the waveform was filtered using a 
Savitzky-Golay filter (Figure 2.5).  This is a digital least squares smoothing filter, 
described by Savitzky and Golay in 1964
200
, applied with the intention of increasing the 
signal-to-noise ratio without excessively distorting the waveform.   
   To assess the effect of the FTI of ablation on the impedance, an incremental 
analysis was performed in experiments 4 and 5 (Figure 2.6). All ablations were divided 
into consecutive, cumulative, 10g.s FTI intervals.  Using the filtered impedance 
waveforms, the maximum impedance drop was then compared with the initial 
impedance at the ablation’s start.  Consequently, a 600g.s ablation yielded 60 
Figure 2.5 Impedance waveform.   Impedance measurements sampled at 10Hz, recorded 
for a 30 second ablation.  The black line is the original data while the broken red line is 
the filtered waveform. 
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incremental measurements, with the maximum impedance drop assessed from 0-10g.s, 
0-20g.s and so on up to 0-600g.s.     
 
 Where mapping points were acquired (in the experiments in chapters 3 and 5), 8 
seconds of data were analysed.  This was despite the catheter being held at a location for 
10 seconds.  The reason for this was that the first and last second of the latter period 
were discarded to ensure the catheter was stable for the data collection. 
For the experiments detailed in chapters 3 to 6, the requirement was for scripts 
that were capable of identifying and measuring complexes within an electrogram.   
The first step was converting the raw ADC electrogram data exported by 
LabSystem Pro into mV, using the equation detailed in the previous section.  The 
Figure 2.6 Incremental FTI analysis. The impedance curve for a single static ablation is 
presented with the ablation FTI rather than time on the x-axis.  The ablation is then split 
into FTI segments.  Here a 100g.s increment is used.  The different coloured dotted lines 
highlight the area within which the impedance curve is being analysed for each 
increment, the first (blue) is 0-100g.s while the last (black) is 0-600g.s.  Within each 
subdivision, the minimum impedance value is then found (highlighted by the coloured 
squares.  The percentage impedance drop is then derived for each increment to allow 
comparisons to be drawn regarding the change in impedance over the course of the 
ablation. 
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electrograms analysed in this study were bipolar electrograms (set up between the distal 
adjacent electrodes on the ablation catheter).  Signals in the electrogram recording 
system were recorded at a low cut-off of 30Hz and a high cut-off of 250Hz.  The peaks 
and troughs in the signal were identified using a 70ms cut off prevent double counting 
of complexes
98
.  Complexes less than 0.05mV (peak to trough) were assigned as 
noise
201
.   
The angles of the rising and falling signal were determined for the dominant 
peak or trough in a complex, from a point at one-third of the complex size from the peak 
or trough of the signal.  A correction factor for angle measurements was used to make 
the signal equivalent to that displayed on LabSystem Pro at a sweep speed of 100mm/s 
and a 32x scale.  The reason a correction factor was needed is because the sharpness of 
the waveform is affected by the ratio of the two axes displayed.  Therefore if the y-axis 
was kept unchanged but half as much of the x-axis displayed on the same screen, the 
Figure 2.7 Electrogram 
analysis.  Shaded area is 
0.05mV noise window.  
Empty circles are 
dominant deflections in 
the complex, empty 
squares are the 
opposite extent of the 
measured complex.  
Inset figure is a zoomed 
in view of the complex 
highlighted in blue.  
Shaded circles here are 
points between which 
the complex size is 
measured.  Angles 
shown are the falling 
and rising angles to the 
points 1/3 the height of 
the complex from the 
dominant deflection 
(yellow circles). 
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electrograms would be stretched out and appear less sharp.  This is analogous to 
increasing the sweep speed of the electrograms displayed.  Similarly, increasing the 
scale of the signal also affects the displayed signal sharpness.  As judgements regarding 
the sharpness of signals are based on assessing the signals at a fixed sweep speed and 
fixed scale, a correction factor was needed to make the results of the angle analysis 
analogous to what is observed clinically.   
The complex size was measured from the dominant peak to trough of a complex.  
The electrogram amplitude was then defined as the mean amplitude of these complexes 
(Figure 2.7).   
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3. The Impact of Catheter Contact Force on Human Left 
Atrial Electrogram Characteristics in Sinus Rhythm and 
Atrial Fibrillation 
3.1 Abstract 
Background: During LA mapping, optimal contact parameters minimizing variation 
secondary to catheter contact are not established. 
Methods and Results: Across 30 patients undergoing first-time ablation for AF, 1,965 
stable mapping points (1,409 AF, 556 SR), comprising 8s of CF and bipolar 
electrogram data were analysed.  Points were taken in groups at locations with CF or 
catheter orientation actively changed between acquisitions.  There was no correlation 
between CF and electrogram complex size (Spearman’s rho p>0.3, both rhythms).  
Complexes were less positive at higher CF (Pearson’s correlation -0.2, p<0.005, both 
rhythms).  Increasing CF at a location significantly increased complex size, but only 
where the initial CF was <10g, and if the change was ≥4.5g in SR and ≥8g in AF 
(p<0.0005, both).  Atrial ectopics during SR were observed more frequently when CF 
was ≥10g (p<0.0005).  Increasing CF at a location was associated with an increase in 
the CFAE interval confidence level score, but only if the initial CF was <10g and CF 
increased ≥8g (p=0.003).  The DF and organisation index (OI) were unaffected by CF 
(p>0.1 for both).  Changing the catheter orientation from perpendicular to parallel was 
associated with smaller, more positive complexes (p=0.001 for both), but no change in 
CFAE scores, DF or OI (p>0.08 for each).  
Conclusions:  During LA mapping, including CFAE but not spectral parameter 
mapping, CF and catheter orientation influence results: consequently, mapping CFs 
should be ≥10g to negate the influence of CF.   
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3.2 Introduction 
Global atrial stretch alters the electrical properties of the human atrium
122,202
, 
and human ventricular myocytes in vitro demonstrate stretch-induced depolarisations 
and extrasystoles
130
.  During mapping of the atrium, the CF applied by the mapping 
catheter may affect the measured electrical properties of the LA by affecting the 
physical relationship between the electrodes and tissue (affecting electrogram 
measurement) and by applying a local stretch stimulus to the myocardium (affecting the 
underlying substrate).  In this context, the optimal contact characteristics minimizing 
such effects, if apparent, are undetermined. 
As part of the ablation procedure for persistent AF, CFAE have been targeted 
with varying success
79,203
.  Assessment of the electrogram is clearly a pivotal part of 
CFAE ablation but, until recently, data regarding CF have not been available and hence 
the impact of this on CFAE parameters unexplored.   Data from spectral analysis of 
electrograms to guide ablation
101,204
 may also be of utility, but the effect of catheter 
contact on these measurements is similarly unknown.  In man, a higher CF is weakly 
correlated with increasing electrogram amplitude in the LA
187,205
 and left ventricle
140
.   
In porcine studies, the orientation of the catheter also impacts on the bipolar electrogram 
morphology observed
141
.  The effect of changing catheter contact on electrogram 
parameters at a fixed location has not previously been investigated. 
In this study we investigated the relationship between a change in CF and 
catheter orientation on LA electrogram characteristics, atrial ectopic burden, CFAE and 
spectral analysis parameters in SR and AF, to try to determine if there is an optimal CF 
for mapping to minimise any evident changes. 
~ 79 ~ 
 
3.3 Methods 
All participants gave informed consent to participate in the study.  The study had 
ethical approval from the UK National Research Ethics Service.  Consecutive patients 
with persistent AF or PAF undergoing their first ablation were enrolled.  Procedures 
were performed with patients under moderate (‘conscious’) sedation.   CF was 
measured at 20Hz using a Thermocool SmartTouch catheter (Biosense Webster Inc., 
Diamond Bar, CA, USA).   
Mapping points were prospectively taken at evenly spaced LA locations.  No 
ablation was performed in these regions until mapping was completed.  At each 
location, three to four 8s recordings of CF and electrograms were taken with the 
catheter in a stable location, with a minimum CF of 1g.  At alternate locations, the CF 
was deliberately changed by the operator for the second two readings (data being 
collected once the catheter was stable at the new CF).  In a subset of locations, the 
orientation of the catheter (the catheter itself rather than the contact orientation) was 
changed from perpendicular to parallel and a further two 8s readings taken.   
The Carto3 electroanatomic mapping system (Biosense Webster Inc.) recorded 
CF and location data.  Electrograms were recorded simultaneously using LabSystem 
Pro (Bard Electrophysiology Division, Lowell, MA, USA).  Synchronicity between CF 
and electrogram measurements was ensured by manually taking points at the same time 
or through the LabLink LabSystem Pro module (Bard Electrophysiology Division), 
which synchronizes the two systems.   
Catheter tip and electrode location data were recorded over a 2.5s window for 
each point, sampled at 60Hz.  Catheter tip displacement was referenced to the averaged 
location of the 20 electrode poles of a circular PV catheter, positioned in a PV (to 
account for movement secondary to respiration).  Displacement >7mm (over twice the 
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length of the catheter tip electrode) between points excluded that pair from the paired 
analysis, as did the presence of more than a single atrial ectopic in SR.   
Electrograms analysed were bipolar and filtered at 30-250Hz.  In SR, the 
incidence of atrial ectopics was determined for each 8s electrogram on visual review of 
the surface ECG and intracardiac bipolar and unipolar (referenced to an indifferent 
electrode in the inferior vena cava) signals.  
Electrogram data were processed and analysed using custom written Matlab 
Figure 3.1 Electrogram analysis.  Shaded area is 0.05mV noise window.  Empty circles 
are dominant deflections in the complex, empty squares are the opposite extent of the 
measured complex.  Inset figure is a zoomed in view of the complex highlighted in 
blue.  Shaded circles here are points between which the complex size is measured.  
Angles shown are the falling and rising angles to the points 1/3 the height of the 
complex from the dominant deflection (red broken lines).  Modified from Figure 2.7, 
page 81. 
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scripts (MathWorks, Natick, MA, USA).   
The peaks and troughs in the signal were identified using a 70ms cut off to 
prevent double counting of complexes
98
.  Electrogram complex size was measured from 
the dominant peak to trough of a complex using previously described methods
206
, and 
averaged for the signal, Figure 3.1. 
 
 Complexes <0.05mV (peak to trough) were assigned as noise
201
.  The angles of 
the rising and falling signal were determined for the dominant deflection in a complex, 
from a point at one-third of the complex size from the dominant peak or trough.  A 
correction factor for angle measurements was used to make the signal equivalent to that 
displayed on LabSystem Pro at a sweep speed of 100mm/s at 32x scale.  A total of 
Figure 3.2 Histogram of the rising or falling angle for all of the complexes identified 
(based on deflection size and activation time criteria).  The x-axis here is the rising or 
falling angle of the dominant deflection in a complex – the former where the dominant 
deflection is positive and vice versa.  The y-axis is the number of such dominant 
deflection angles observed.  A greater number of complexes were identified in the atrial 
fibrillation cases, hence the larger numbers in the atrial fibrillation chart. 
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89,105 complexes were identified based on the complex size and 70ms double counting 
cut off.   Histograms constructed demonstrated the majority of complexes had a rising 
or falling angle ≤15˚ (with the difference more pronounced in the SR signals), Figure 
3.2.  For the data as a whole, 60% of the rising or falling angles in the complexes were 
≤15˚.  This value was taken as the farfield cut off: complexes with a rising or falling 
angle >15 ˚ were therefore excluded.  Points with no identifiable complexes based on 
the above criteria were excluded from further analysis (other than the automated CFAE 
score analysis). 
The polarity ratio was determined by the ratio of the positive deflection in a 
complex to the total complex size.  These values were then averaged for a signal to give 
the mean polarity ratio.  To determine the non-noise level in the signal, the proportion 
of the total waveform outside a 0.05mV window centred at 0mV was determined. 
DF analysis was performed for the AF points using previously described 
methods to pre-process the electrograms
95,207
: the signal was bandpass filtered at 40-
250Hz, rectified and lowpass filtered at 20Hz.  A Hanning window was then applied to 
the signal.  Following this, an 8,192 point fast Fourier transform (FFT) was performed 
on the signal and the DF determined as the largest peak from 3 to 15 Hz
101
. The 
organization index (OI) was determined from the ratio of the area under the DF peak 
and its (up to 3) harmonic peaks compared with the area under the power 
spectrum
204,207
.  A 4,096 point FFT was performed over a 4 second sliding window 
every second on the processed 8s signal
208
.  The OI for each 8s signal was then derived 
from the mean of the values for each window.  High DF points were taken as those 
where the DF was ≥20% the mean DF for that patient104.  
Automated CFAE analysis was performed at each point for the persistent AF 
patients using the Carto3 system with intervals of interest between deflections specified 
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as a minimum of 70ms, maximum of 120ms and voltage thresholds left at factory 
settings (0.05- 0.15mV)
98
.  In this analysis, the SCI is the shortest interval between 
electrogram deflections falling within this range, the ACI is the average duration of all 
intervals falling within this range, and the ICL is the number of intervals within this 
range.  High-grade CFAE were designated as those with an ICL ≥7 based on previous 
validation work comparing automated CFAE measurements with the degree of visually 
assessed fractionation of the electrogram
98
.  As the CFAE analysis is conducted over a 
2.5s window, where CF was compared with CFAE scores, the CF data for the same 2.5s 
period (rather than the whole 8s of data collected at a point) was used. 
3.3.1 Statistics 
Statistical analysis was performed using SPSS (IBM SPSS Statistics, Version 20 IBM 
Corp, Armonk, NY, USA) and Matlab V7.12 with Statistics Toolbox V7.5.  A p-value 
of <0.05 was taken to indicate statistical significance.   Correlations were assessed using 
a Pearson’s correlation where the relationship appeared linear and a Spearman’s rank 
correlation otherwise.  Point-Biserial correlation was used to correlate continuous with 
binary variables.  Normally-distributed data were analysed using a t-test or ANOVA 
and non-normally-distributed data analysed using a Mann-Whitney U test or Kruskal-
Wallis test.  Paired data were analysed using a paired t-test or Wilcoxon signed-rank 
test.  Data are presented as mean±standard deviation or median [interquartile range].    
 
3.4 Results  
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The baseline characteristics of the study patients are presented in Table 3.1.   
3.4.1 Contact Force and the Electrogram 
1,945 data points were collected (1,396 in AF, 549 in SR), and the spread of CFs 
is shown in Figure 3.3.  
 
Table 3.1 Study Population Baseline Characteristics 
Number of Patients 30 
Age, mean±SD 61±8 years 
Gender 21 Male (70%) 
Persistent AF 15 (50%)  
Duration of Persistent AF 20±12 months 
CHA2DS2-VASc Score, mean±SD 1.4±1.0 
Left Atrial Diameter, mean±SD 4.4±0.6cm 
Severe Left Ventricular Impairment 
(Ejection Fraction<35%) 
2 (7%) 
 
Figure 3.3 Histogram of mean CF of the study points.   
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For both SR and AF points, there was a weak correlation between the CF and 
mean electrogram waveform amplitude (Spearman’s rho 0.19 and 0.13 respectively, 
p<0.005 for both) as well as the amount of the waveform outside the 0.05mV noise 
window (Spearman’s rho 0.21 and 0.18 respectively, p<0.005 for both).  To determine 
if the size of the complexes in the waveform (rather than just the waveform as a whole) 
was related to the CF, the individual complexes in the signals were identified and 
measured using automated analysis.  44,888 complexes were analysed across all the 
data points: there were a median of 29 [18-41] complexes per 8s data point in AF and 8 
Figure 3.4 Complex size versus left atrial location in (A) AF and (B) SR.   
LPV=Left pulmonary vein; RPV=Right pulmonary vein; LAA=Left atrial appendage 
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[7-9] in SR.  In this case, there was no significant correlation between the CF and 
electrogram complex size in either rhythm (Spearman’s rho p>0.2 for both). 
There was a significant difference by location for both AF and SR points in 
complex size (p<0.005 for each, Figure 3.4).  There was a correlation between the 
polarity ratio of the complexes observed and the CF in AF and SR (Pearson’s 
correlation -0.2, p<0.005 for both), such that the complexes became proportionately less 
positive at higher CF.   
To assess whether changing the CF at a location was associated with a change in 
electrogram parameters, the data were analysed in pairs for points taken at the same 
location.  There were 2,515 pairs of CF/electrogram readings (2,117 in AF, 398 in SR). 
As shown in Table 3.2, if the starting CF was <10g, the difference between a 
pair of electrograms was only significant if the increase in CF between measurements 
was >4.5g in SR, but not if the change in CF was below this.  If the starting CF was 
≥10g, there was no significant change between pairs, even if the change in CF was 
>4.5g.  In AF, a similar relationship was found, though in this case, the electrogram 
Table 3.2 Change in mean complex size by atrial rhythm, initial CF and increase in CF between pairs of 
measurements at a location. 
Rhythm 
Initial 
CF in 
a pair 
Increase in CF between paired measurements  
<4.5g SR and <8g AF ≥4.5g SR and ≥8g AF 
Change in 
Mean CF 
(g) 
Median 
Change in 
complex 
size (%) 
Number 
of pairs 
p Change in 
Mean CF 
(g) 
Median 
Change in 
complex size 
(%) 
Number 
of pairs 
p 
SR 
 
1-10g 
 
0.8 
[0.4-3.1] 
6 [-8 – 34] 81 0.06 10.9 
[7.1-16.8]* 
13 [-16 – 60]  181 <0.005 
≥10g 
1.7 
[0.8-3.1] 
3 [-8 – 22] 51 
0.28 
10.8 
[7.8-15.3]* 
-0.3 [-29 –26] 
85 
0.43 
AF 
 
1-10g 
 
1.8  
[0.7-4.4] 
0 [-12 – 
16] 
466 
0.28 
14.3  
[10.9-
21.7]~ 6 [-11 – 41] 
223 
<0.005 
≥10g 
2.1 
[0.9-4.5] 
2 [-13 – 
18] 
965 
0.09 
13.2 
[10-19.4]~ 0 [-16 – 24] 
463 
0.12 
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only changed significantly at a location when the initial CF was <10g and the change in 
CF was >8g and not if the change in CF was below this.  In the case of both rhythms, 
the difference in the response to an increase in CF when the initial CF was <10g rather 
than ≥10g was not explained by a lesser overall increase in the CF in the latter group 
between measurements as the increase in CF was not significantly different between 
groups – in other words, there was a similar increment in the CF between measurements 
in the <10g and >10g initial CF groups.  
The likelihood of observing at least one atrial ectopic in SR during the 8s 
electrogram window significantly increased with the mean CF, Figure 3.5, with a 
significantly higher incidence of at least one ectopic if the CF was ≥10g compared with 
<10g (p<0.0005).  On sub-analysis by location, the correlation between the CF and 
Figure 3.5 Percentage of 8s SR electrograms with ≥1 atrial ectopic observed versus 
mean CF. 
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observation of at least one atrial ectopic was strongest at the inferior LA (Point-Biserial 
correlation 0.35, p=0.006).   
There was a weak positive correlation between the change in CF between points 
at a location and the change in the number of complexes observed in AF, but only if the 
starting CF was <10g  (Spearman’s rho 0.11 p= 0.003), and not if it was ≥10g 
(Spearman’s rho p=0.05).    
3.4.2 Contact Force and CFAE 
1,549 AF points had automated CFAE parameters recorded.  There was a very 
weak negative correlation between the CF at a point and the SCI (Spearman's rho -0.08, 
Table 3.3 Change in CFAE and spectral analysis measurements at a location by initial CF and increase in CF 
between pairs of measurements at a location. 
Measure Initial 
CF in a 
pair 
Increase in CF between paired measurements 
<8g ≥8g 
Initial 
Value 
Repeat 
Value 
Number 
of pairs 
p Initial 
Value 
Repeat 
Value 
Number 
of pairs 
p 
ICL 
 
1-10g 
 
5 
[3-7] 
5 
[3-7] 
573 0.83 4 
[2-6] 
5 
[3-7] 
256 0.003 
≥10g 
 
5 
[3-7] 
5 
[3-7] 
945 
0.62 
5 
[2-7] 
5 
[3-7] 
488 
0.4 
SCI 
 
1-10g 
 
77 
[73-87] 
76 
[72-86] 
573 
0.3 
78 
[73-88] 
76 
[72-85] 
256 
0.16 
≥10g 
 
76  
[72-84] 
75  
[72-83] 
945 
0.57 
76  
[72-83] 
76  
[72-84] 
488 
0.2 
ACI 
 
1-10g 
 
93  
[88-100] 
92  
[87-99] 
573 
0.43 
93  
[88-101] 
93  
[88-99] 
256 
0.42 
≥10g 
 
92 
[87-98] 
92 
[85-98] 
945 
0.65 
91 
[85-98] 
92 
[87-98] 
488 
0.16 
DF 
 
1-10g 
 
6 
[5.5-6.6] 
Hz 
6 
[5.5-6.7] 
Hz 
466 0.88 6 
[5.4-6.6] 
Hz 
6 
[5.5-6.7] Hz 
223 0.11 
≥10g 
 
6 
[5.4-6.7] 
Hz 
6 
[5.2-6.6] 
Hz 
965 0.14 5.6 
[5-6.5] 
Hz 
5.7 
[5-6.3] Hz 
463 0.83 
OI 
 
1-10g 
 0.17 
[0.15-0.2] 
0.17 
[0.15-0.2] 
466 
0.44 
0.18 
[0.15-
0.2] 
0.18 
[0.15-0.21] 
223 
0.13 
≥10g 
 0.17  
[0.15-0.2] 
0.17  
[0.15-0.2] 
965 
0.71 
0.17  
[0.15-
0.21] 
0.17  
[0.15-0.21] 
463 
0.75 
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p=0.002) and ACI (Spearman's rho -0.07, p=0.01), and a very weak positive correlation 
with the ICL (Spearman’s rho 0.05, p=0.034).  The proportion of high-grade CFAE was 
420/1,549 (27%).  High-grade CFAE points had a statistically significant slightly higher 
CF than non-high-grade CFAE points: high-grade 16.7[10.2-26.2]g, non-high-grade 
15.3[9.3-24]g, p=0.034.   
The effect of changing the CF at a location on CFAE scores was assessed in 
2,262 pairs of points, Table 3.3.  There was a significant (though small) increase in the 
ICL score at points where the starting CF was <10g and the change in CF was >8g.  If 
the change in CF was ≤8g, there was no significant difference.  Conversely, if the 
starting CF was ≥10g, then there was no significant change in the ICL score, even if the 
change in CF was >8g.  There was no significant change in the ACI or SCI between 
pairs of measurements regardless of the initial CF or change in CF between pairs of 
measurements. 
3.4.3 Contact Force and Dominant Frequency 
 Across all the AF points, the dominant frequency was 5.9[5.4-6.6] Hz.  There 
was a significant correlation between the dominant frequency and ICL (Spearman’s rho 
0.14, p<0.0005), and weaker correlations with the SCI and ACI (Spearman’s rho -0.06, 
p=0.04, both), as well as between the ICL and OI (Spearman’s rho 0.07, p=0.024), and 
the OI with the SCI and ACI (Spearman’s rho 0.12 (SCI), 0.21 (ACI), p<0.0005, both).  
Compared with non-high-grade CFAE points, high-grade ones had a significantly 
higher DF, though the difference was negligible (high-grade CFAE: 6.1[5.6-6.8]Hz, 
non-high-grade: 5.9[5.2-6.6]Hz, p<0.0005), but there was no difference in the OI 
between CFAE grades (p=0.08).  44 points in 10 patients qualified as high-DF points.  
The median DF for these points was 8.9[7.8-10.5]Hz.  High-DF points were not more 
likely to be high-grade CFAE points (24% high-DF points were high-grade CFAE while 
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27% low-DF points were high-grade CFAE points, p=0.7).  There was no significant 
difference in the CF of high-DF points compared to low-DF points (high-DF 16.4[11.7-
27.4]g, low-DF 16.8[10.2-24.8]g, p=0.6).   
There was no correlation between the dominant frequency or OI and the contact 
force (Spearman’s rho p>0.05 for each).  A change in the CF between pairs of 
measurements at a location in the 2,120 AF point pairs assessed did not correlate with a 
change in the dominant frequency or OI, even where the initial CF was <10g and 
change in CF was >8g, Table 3.3.     
Table 3.4 The change in electrogram properties with a change in catheter orientation between 
measurements taken at the same location. 
Group Measure 
Catheter Orientation Median 
Change 
p 
Perpendicular Parallel 
Electrogram  
(70 pairs)* 
Mean 
Electrogram 
Size (mV) 
0.026 
[0.019-0.03] 
 
0.023 
[0.017-0.027] 
 
-13.4% 0.001 
Proportion of 
signal 
>0.05mV noise 
window (%) 
37.2 
[24.4-42.8] 
32.6 
[19.4-39.8] 
-12.5% 0.001 
Median 
Complex Size, 
(mV) 
0.144 
[0.111-0.206] 
0.137 
[0.095-0.19] 
-5.1% 0.029 
Number of 
Complexes 
36 
 [15-45] 
24 
[17-38] 
-32.4% 0.039 
Polarity ratio 0.48 
[0.4-0.59] 
0.57 
[0.45-0.63] 
17.3% 0.001 
Dominant 
Deflection 
Angle (˚) 
12.5 
[8.4-15.6] 
14.1 
[11.3-15.7] 
13.2% 0.022 
CFAE  
(98 Pairs)* 
SCI 75 [71-84] 74 [71-79]  0.13 
ACI 93 [87-98] 91 [85-96]  0.16 
ICL  5.5 [4-7] 5 [3-7]  0.24 
Spectral 
Analysis  
(140 Pairs) 
DF (Hz) 5.7[5.2-6.3] 5.9[5.1-6.5]  0.58 
OI  0.18[0.16-0.2] 0.18[0.16-
0.21] 
 0.09 
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3.4.4 Catheter Orientation 
 The effect of catheter orientation was assessed by observing the difference in the 
electrogram, CFAE and spectral analysis parameters on changing the catheter from a 
perpendicular to parallel orientation in a subset of AF points (Table 3.4).  In the case of 
the electrogram and CFAE pairs, only those where the difference in CF between 
orientations was <8g were used to minimize differences secondary to CF for the 
electrogram and CFAE analysis due to the influence of CF on these measurements.  On 
changing orientation, complexes became smaller and more positive but without any 
change in CFAE or spectral measures. 
 
3.5 Discussion 
This study examined the relationship between CF and catheter orientation with 
electrogram parameters.  The main findings were: 
1) An increase in CF at a location was associated with an increase in the 
complex size in both AF and SR, but this difference was only apparent if the 
initial CF was <10g and for changes in CF >4.5g in SR and >8g in AF. 
2) Increasing CF at a location was associated with a small increase in ICL 
scores, though only if the initial CF was <10g and change in CF was >8g.   
3) Changing the CF at a location did not affect spectral measurements.   
4) Changing from a perpendicular to parallel orientation was associated with a 
reduction in the electrogram complex size and more positive complexes but 
no change in CFAE or spectral measures. 
3.5.1 Catheter contact and the electrogram 
A previous study used manual assessment of the SR electrogram around the PV 
antra, averaging five complexes per location and found a modest relationship between 
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CF and electrogram amplitude
187
.  In another study, a very weak relationship was found 
between these parameters throughout the LA in PAF patients, around half of whom 
were in AF, though the authors did not give details of how the electrogram parameters 
were measured 
205
.  The current study examined this relationship in both AF and SR 
throughout the LA and used automated analysis of 8s of electrogram data at each 
location.  No relationship between the electrogram complex size and CF was observed, 
likely due to the much larger effect of LA location on complex size.    
One would expect that the thickness of the tissue under the catheter and its 
compliance affect the size of the electrogram: a larger mass of tissue produces a larger 
electrogram, and a more compliant area would deform around the catheter tip to contact 
the bipoles more effectively.  The thickness of the tissue around the LA
209
 and the 
compliance of different parts of the LA
45,210
 are known to differ.  During an ablation 
procedure, the whole of the atrium is potentially mapped and ablated and therefore the 
current data are in keeping with previous work
187,205
 suggesting electrogram size cannot 
be used as a reliable surrogate for real-time CF measurement in either AF or SR.   
The morphology of the bipolar electrogram was also affected by CF, with 
complexes becoming more negative at higher CF.  This may be a function of the 
proximal bipole having increased contact with the tissue at higher CF (study points were 
generally taken in a perpendicular orientation).  Interestingly, when the catheter was 
changed from a perpendicular to parallel orientation (whereby the proximal pole would 
have a similar degree of contact to the distal), the complexes became more positive: at 
the same time, there was also a reduction in the electrogram complex size (including 
when changes in CF between measurements were minimized to address any 
confounding from this).  This suggests that for a bipole, it is not just the degree of 
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contact that affects both the size and morphology of the observed complexes but also its 
orientation.  
The influence of changes in CF on the electrogram is an important 
consideration, especially where mapping studies are conducted with electrodes at a 
stable position for a prolonged period of time within the LA, such as recent work with 
rotor mapping where electrograms are collected for over 10 minutes
211
.  Moreover, the 
effect of a change in CF and catheter orientation on the electrogram is also an important 
consideration when comparing pre and post-ablation electrograms to judge ablation 
efficacy based on electrogram attenuation
190
 and morphology changes
141
 (criteria which 
have been used to guide clinical ablation
187,191
).  The data from the current study suggest 
that mapping with a CF ≥10g of force would minimize CF related changes in the 
electrogram, as would ensuring the difference in the CF between appraisals of the 
electrogram are ≤4.5g in SR and ≤8g in AF.  The higher threshold in the case of AF 
signals is likely secondary to the higher intrinsic variance in the AF electrogram making 
CF-related changes more difficult to appreciate. 
The observation of increased atrial ectopy in SR at higher CF is consistent with 
findings of increased excitability of atrial tissue from global atrial stretch in animal 
models
212
 and humans
122
, as well as the observation of stretch-induced depolarisations 
of human myocytes
130
.  It is also consistent with the increased susceptibility to AF in 
those with hypertension
213
.  The differential locational vulnerability to stretch induced 
ectopy suggested by the current study is interesting and may reflect the 
electromechanical sensitivity of the tissues themselves: the inferior wall demonstrated 
the strongest correlations between CF and ectopic incidence.  It may also be that nearby 
structures are being affected by the stretch stimulus from the catheter, for example the 
inferior right and left ganglionated plexi are in proximity to the inferior wall
214
.  One 
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would expect that points taken within the PVs would demonstrate an even higher 
stretch-related ectopic vulnerability in view of these being common trigger sites for 
PAF (in the current study, points were taken at the PV antra rather than deep within the 
PVs, hence this was not assessed).   
Interestingly, at the 10g CF level, there was a change in the behaviour of the 
tissue – ectopics were more frequently observed above 10g of CF than below this 
threshold.  This also appears to be a threshold for observing an effect on the electrogram 
from a change in CF and may be related to the electrical or compliance properties of the 
tissue changing above this threshold.  At a CF below 10g, the tissue may not be 
particularly stretched and therefore exhibits less ectopics and incompletely envelops the 
catheter bipole.  The tissue has capacity for stretching and therefore if from this point 
the CF is increased, more stretch-related activations manifest and the tissue becomes 
more closely apposed to the bipole.  If the starting CF is ≥10g the tissue is likely already 
enveloping the bipole to an extent that further increases in CF make little difference to 
this and so the electrogram.  Moreover, the excitability threshold for stretch-related 
activations has already been exceeded so further increases in CF have little effect on 
further increasing the frequency of ectopy.   
3.5.2 Catheter contact and CFAE parameters 
There was a weak relationship between automated CFAE scores and CF, with 
the scores suggesting higher CF was associated with greater fractionation.  Increasing 
the CF at a location may be associated with an increase in the detection of low 
amplitude deflections by the automated CFAE algorithms – an increase in CF was 
associated with an increase in mean electrogram waveform size with more of the 
electrogram outside of the noise window, meaning a greater possibility of farfield 
signals being identified as true activations.  Alternatively, it may be that increasing CF 
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is associated with increasing tissue stretch and is directly causing an increase in 
activations and therefore influencing CFAE measurements in this manner.  Importantly, 
while the effect of CF on CFAE scores was small, the relationship was no longer 
apparent if the starting CF was ≥10g.  It is therefore possible that a proportion of the 
variation previously observed in CFAE maps
88,90
  is contributed to by changes in 
catheter CF during mapping. 
3.5.3 Catheter contact and Spectral Analysis Parameters 
A relationship between DF measurements and CFAE scores has previously been 
observed
105
.  Regions harbouring CFAE have also previously been noted to be more 
extensive than those with high DF
105
, as was the case in the current study.   Previous 
investigators have also noted that fractionated electrograms tend to occur adjacent to 
high DF areas rather than directly superimposed on them
96
.  The latter is the likely 
explanation for high DF points not being significantly more likely to be high-grade 
CFAE points in the current study. 
Spectral analysis parameters were not affected by CF or catheter orientation.  
The changes in complex morphology and size secondary to changes in CF would not be 
expected to affect a frequency-based analysis.  An increase in the number of activations 
observed in a time period as observed here with increasing CF (and having a small 
effect on CFAE measurements) evidently does not affect spectral analysis parameters.  
This may be because such extra activations are not consistent enough to have a 
significant effect in the frequency domain.  This also suggests the changes in CFAE 
scores with changes in CF may be more related to changes in the measurement of the 
electrogram rather than changes in the electrical properties of the substrate.  Therefore, 
the temporal instability observed in dominant frequency maps is not explained by 
differences in mapping CF
215
.   
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3.6 Conclusions 
Changes in catheter contact force and orientation affect electrogram complex 
size and morphology, and this most likely reflects changes in the physical relationship 
between the catheter bipoles and atrial tissue.  Complex size is not affected by increases 
in CF if the starting CF is ≥10g or if the change in CF is ≤4.5g in SR and ≤8g in AF.  
Higher CF is also associated with atrial ectopy, likely thorough stretch-sensitive 
depolarisations, and this has a greater effect for CF ≥10g.  CFAE parameters are 
affected by CF (again, if the initial CF is <10g), while spectral analysis parameters are 
unaffected by this or catheter orientation.  This suggests that in AF, the measurement of 
the electrogram is predominantly being affected by CF, through greater contact between 
the bipole and the tissue, without greatly affecting the underlying substrate (based on 
the lack of impact on spectral parameters).  Therefore, during mapping of the LA (and 
electrogram-guided ablation), it is important to be aware of the effects of CF and 
catheter orientation as these influence the results: conversely, substrate-based ablation 
targeting spectral parameters is unaffected by catheter contact and orientation.  Based 
on these results, an optimal CF during mapping of ≥10g is suggested, as below this 
value the CF has a significant influence on the electrogram and CFAE scores. 
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4. Target indices for clinical ablation in atrial fibrillation: 
insights from contact force, electrogram and 
biophysical parameter analysis 
4.1 Abstract 
Background: In animal studies of radiofrequency ablation, lesion sizes plateau as the 
maximum lesion size is reached for an ablation.  Lesion parameters are not available in 
clinical ablations, but preclinical work suggests that these correlate with impedance 
drop and electrogram attenuation.  Characterisation of the relationship between catheter 
CF, ablation duration and these surrogate markers of lesion formation may allow us to 
define targets for effective ablation. 
 
Methods and Results: Fifteen patients undergoing first-time radiofrequency ablation 
for persistent AF were studied.  All were in atrial fibrillation at the time of the 
procedure.  Ablations were performed with an irrigated-tip CF-sensing catheter in 
temperature-controlled mode (temperature limited to 48˚C, power to 30W).  Included 
were 285 left atrial static ablations, 247 with additional impedance data.  The ablation 
FTI correlated with the attenuation of the electrogram with ablation (p=0.02, 
Spearman’s rho -0.14), the relationship plateauing from 500g.s, a reduction in the 
electrogram amplitude of 20%.  The FTI also correlated with the impedance drop during 
ablation (p<0.0005, Spearman’s rho 0.79): the relationship was logarithmic, the 
reduction in the impedance with an increasing FTI also plateauing from 500g.s, an 
impedance drop of 7.5%.  The ablation duration impacted on the impedance drop at an 
FTI if the duration was less than 10 seconds.  Beyond this time point, the FTI achieved 
rather than the ablation duration or mean CF applied determined the impedance drop.  
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Conclusions: During ablation for persistent AF, an FTI of 500g.s should be targeted 
with ablation duration of at least 10 seconds. 
 
4.2 Introduction  
The aim of ablation for AF is the generation of a transmural lesion.   In animal 
studies, a plateau is observed between lesion size and delivered ablation energy, with no 
significant change in lesion size at a fixed ablation power for ablation beyond 20 
seconds
216
.  The relationship between catheter CF and lesion depth
166
 also plateaus at 
higher values in studies of temperature-controlled ablation.  These plateaus therefore 
represent the maximum lesion size that can be attained for a particular set of ablation 
parameters.  During clinical ablation, one would also expect lesion parameters to 
plateau as this maximum is reached for an ablation, but in clinical procedures lesion 
parameters are not known.   
In animal studies, a correlation has been observed between lesion dimensions 
and impedance drop during ablation
164,166,168
.   Such studies also demonstrate that 
electrogram amplitude reduction is significantly greater in transmural than non-
transmural lesions 
141,190
.  Therefore, these measures can be used as surrogates of lesion 
parameters. 
  Detailed measurements of tissue CF during clinical ablation have now become 
possible using CF-sensing catheters.  The impact of this controllable factor can 
therefore be assessed on indicators of the effect of ablation on tissue: electrogram 
amplitude and impedance change.  In animal studies, the tissue CF has been found to 
correlate with both lesion depth
161,166,168
 and impedance drop
166,168
.  Examination of the 
interrelationships between these factors may allow us to optimise our ablations, in 
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particular the identification of a plateau point in man beyond which further ablation has 
no or minimal effect on the tissue would be especially useful.   
The aim of this study was therefore to establish, based on the biophysical and 
electrogram changes, target indices for radiofrequency ablation. 
 
4.3 Methods  
All participants gave informed consent to participate in the study, which was 
approved by the UK National Research Ethics Service.  Consecutive patients 
undergoing their first ablation procedure for persistent AF were enrolled in the study.  
All patients were in AF at the start of the procedure and all procedures were performed 
with the patients under conscious sedation.  The majority of the procedures were 
performed by a single operator.  A Thermocool SmartTouch catheter (Biosense 
Webster, Inc., CA, USA) was used to measure tissue CFs, at a sampling rate of 20Hz.  
Remote robotic navigation (Sensei Robotic Catheter System, Hansen Medical Inc., CA, 
USA) was used in a majority of procedures, though this was at the discretion of the 
operator.  Tissue CF and electrogram characteristics were recorded using the Carto3 
electro-anatomic mapping system (Biosense Webster, Inc.) and LabSystem Pro 
electrophysiological recording system (Bard Electrophysiology Division, MA, USA) 
respectively.   
During WACA of the ipsilateral pulmonary veins in pairs and CFAE ablation, 
thirty second static study ablations were performed, with the ablation catheter in a stable 
position at least 2.5 seconds prior to the onset of ablation, and for at least 8 seconds 
after ablation.  In all cases, ablations were performed in temperature-controlled mode 
with temperature limited to 48˚C, and power to 30W.  The irrigation flow rate was set to 
2ml/minute during mapping and 17ml/minute during ablation.  All ablations were 
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performed at a CF of between 5g and 40g.  During ablation, the pulmonary vein catheter 
was kept in either a pulmonary vein or the left atrial appendage.  Ablations where there 
was visually evident macro-displacement of the ablation catheter were excluded from 
the analysis.  All study ablations were non-overlapping so that previously ablated tissue 
was not included in the analysis and, once they were completed within a lesion set, 
further ablation was at the operator’s discretion, and generally performed as continuous 
“drag” ablations. 
Pre-ablation electrograms were collected on the electrophysiological recording 
system for 2.5 to 8 seconds - the former for points in the WACA and the latter for the 
CFAE ablation points.  The longer period for the CFAE points was used due to the 
potential greater complexity of the electrogram at these locations.  Post-ablation 
electrograms were collected for 8 seconds and the first 0.5s discarded to reduce the 
effects of post-ablation noise.  Synchronicity between the mapping and electrogram 
recording system was ensured by either manually acquiring points simultaneously or, in 
the last eight patients, through the use of the LabLink data interface (Bard 
Electrophysiology Division).   In a subset of ten patients, impedance during ablation 
was also recorded.   This was measured using a 50kHz current between the tip of the 
ablation catheter and the ground patch (positioned on the patient’s left thigh) and was 
sampled at 10Hz.  The ablation power was also recorded at this sampling rate. 
The electrogram data was exported from LabSystem Pro, while the CF, location, and 
ablation biophysics data were exported from Carto3.  The data were processed and 
analysed using custom written Matlab (MathWorks, MA, USA) scripts as described in 
Chapter 2.7. 
Stability during radiofrequency ablation was assessed by comparing the average 
position of the ablation catheter tip relative to the averaged location of the poles of the 
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pulmonary vein catheter in three dimensional space over 2.5 seconds (location data 
recorded at 60Hz).  The pulmonary vein catheter was chosen as a reference to allow for 
movement secondary to respiration to be taken into account.  If the average distance 
between the ablation catheter and pulmonary vein catheter changed by more than 
3.5mm (the length of the ablation electrode) between the pre- and post-ablation points 
taken on Carto3, the catheter was deemed to have been excessively unstable and the 
ablation excluded from the analysis.   
The electrograms analysed in this study were bipolar electrograms (set up 
between the distal adjacent electrodes on the ablation catheter).  Signals in the 
electrogram recording system were recorded at a low cut-off of 30Hz and a high cut-off 
of 250Hz.  Electrograms which on inspection suffered from excess noise were 
discarded.   After export, the signals were filtered with a 10
th
 order 100Hz Butterworth 
low pass filter.  The peaks and troughs in the signal were identified using a 70ms cut off 
as used in previous published work to prevent double counting of complexes
98
.  
Complexes less than 0.05mV (peak to trough) were assigned as noise
201
, and a 1mV 
upper cut-off for the atrial electrogram size adopted based on review of the signals and 
previous work
217
.  The angles of the rising and falling signal were determined for the 
dominant peak or trough in a complex, from a point at one-third of the complex size 
from the peak or trough of the signal.  A correction factor of 1000 (500 if the 
electrogram was sampled at 2Khz) for angle measurements was used to make the signal 
equivalent to that displayed on LabSystem Pro at a sweep speed of 100mm/s and a 32x 
scale.  A rising or falling angle of over 45˚ meant the complex was discarded as 
farfield
98
.   The complex size was measured from the dominant peak to trough of a 
complex.  The electrogram amplitude was then defined as the mean amplitude of these 
complexes.   
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If a pre-ablation electrogram had less than 2 complexes identified or a post-
ablation electrogram had only 1 complex identified, it was not included in the analysis 
(as an isolated complex could be spurious).  In a previous study of ablation in 
paroxysmal AF patients, an increase in the electrogram with ablation was taken to 
represent micromovement
150
: in the case of patients in AF, the inherent variability of the 
electrogram  was felt to renders this criterion less reliable and therefore in the current 
study, the electrogram more than doubling in size with ablation was felt to be  a 
reasonable indicator of micro-displacement.     
The FTI and impedance data were analysed as described in Chapter 2.7.  In the 
case of the former, in order to examine the dynamic relationship between the FTI and 
impedance drop, all of the ablations were divided into consecutive, cumulative, 10g.s 
FTI intervals.  The maximum impedance drop was then compared with the initial 
impedance at the start of ablation.  The maximum percentage impedance drop during an 
ablation was determined from the waveform after a Savitzky-Golay filter had been used 
to remove noise: the initial impedance was compared to the maximum drop recorded 
during ablation (or portion of ablation in the case of the incremental FTI).  
In order to develop a clinically useful parameter that predicted an adequate 
lesion, we sought a point of ablation where continuing energy application had minimal 
effect on the lesion parameters, using the impedance drop as a surrogate for the latter.  
Qualitatively, this would be represented by the point at which a plateau develops in the 
relationship between the FTI and impedance drop.  Quantitatively, we defined this as 
the point in the fitted curve for this relationship where the impedance drop was 0.5% 
per 100g.s of FTI.  The first derivative of the fitted curve formula was used to determine 
where the instantaneous gradient of the curve fell to this value.  
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4.3.1 Statistics 
Statistical analysis was performed using SPSS (IBM SPSS Statistics, Version 20 IBM 
Corp Armonk, USA) and Matlab V7.12 with the Statistics Toolbox V7.5.  A p-value of 
<0.05 was regarded as significant.   Non-normally distributed data, as assessed by a 
Jarque-Bera test, were analysed using a Mann-Whitney U test or, if correlated samples, 
a Wilcoxon Signed Ranks test.  Correlation was assessed for non-linear relationships by 
Spearman’s rank correlation. 
 
4.4 Results 
The baseline characteristics of the study patients are presented in Table 4.1.  In 
the fifteen patients there were 420 study ablations (ablations performed after the study 
ablations were completed in a region were not included in the analysis).  After exclusion 
of ablations based on the displacement and electrogram criteria, there remained 285 
pairs of pre-and post-ablation electrograms. 
 In the ten patients with biophysical parameters recorded, 247 static ablations 
were included in the analysis.  On average it took 9±2 seconds for the ablations to first 
reach the power limit of 30W with no relationship between the time taken and the mean 
ablation CF (p=0.9).  At thirty seconds of ablation, there was a significant correlation 
Table 4.1 Study Population Baseline Characteristics 
Number of Patients 15 
Age, mean±SD 62±8 years 
Gender 12 male (80%) 
CHA2DS2-VASc Score, mean±SD 1.6±1 
Left Atrial Diameter, mean±SD 4.5±0.6cm 
Duration of Non-Paroxysmal Atrial 
Fibrillation 
20±12 months 
Severe Left Ventricular Impairment 
(Ejection Fraction<35%) 
2 (13%) 
Remote Robotic Navigated Ablation 11 (73%) 
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between the ablation mean CF and the absolute and filtered percentage (comparing the 
minimum to initial impedance of the filtered impedance waveform) impedance drop 
(p<0.0005 for both, Spearman's rho 0.38 and 0.51 respectively). 
The incremental FTI analysis generated 11,502 separate measurements for all of 
the study ablations combined.  There was a strong correlation between both the absolute 
maximum impedance drop and filtered percentage maximum impedance drop and the 
incremental FTI: p<0.0005 for both, Spearman’s rho 0.66 and 0.79 respectively.  As the 
relationship was stronger with the percentage filtered impedance drop, this was used for 
the subsequent analysis.  Figure 4.1 presents the relationship between the percentage 
impedance drop and the incremental FTI.  There was an initial plateau until 20g.s and 
then following this there was an increase in the impedance drop with an increasing FTI 
until a plateau starting from 500g.s, corresponding to a mean impedance drop of around 
7.5%.    
Figure 4.1  Maximum Percentage Impedance Drop versus Incremental Force Time Integral. 
Black squares are mean values for at least 20 readings.  Error bars represent one standard 
deviation.  11,441 measurements represented in the chart. 
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In order to determine quantitatively the FTI at which the rate of change in the 
impedance drop engendered by an increasing FTI becomes significantly reduced, a 
logarithmic curve of best fit was fitted to the dataset (y=2.57*ln(x)-8.89, adjusted R
2
 
0.56): from this curve, the relative plateau was found to develop from an FTI of 514g.s.  
At this point, the impedance drop determined from the formula of the fitted curve was 
7.2%.   
The FTI is a function of tissue CF during ablation and the duration of the 
ablation.  The relative importance of mean tissue CF and ablation duration on lesion 
formation as assessed by impedance drop was investigated.  
Figure 4.2 is a plot demonstrating the influence of the components of the FTI on 
the impedance drop where each line is an FTI target and each point on the line is the 
(grouped) mean CF to get to that target FTI.  As the mean CF during an ablation 
increased, the time taken to reach the target FTI reduced.  Looking firstly at the 100g.s 
curve, the longer it took to reach the FTI target, and so the lower the mean CF, the 
greater the impedance drop.  In fact, for each curve until the 400g.s curve, there was a 
Figure 4.2 Influence of Mean Contact Force and Ablation Duration on Impedance Drop 
at a Target Force Time Integral.   
Each point is the average of at least ten ablations. 
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significant heterogeneity in the impedance drop based on the CF group (p<0.025).   
Beyond ablation durations of 10 seconds, the curves relatively flattened, suggesting the 
influence of the ablation duration (and so mean CF) on the impedance drop at an FTI 
was no longer evident.  If ablations less than 10 seconds long were excluded, there were 
no longer any significant differences in the impedance drop at each FTI secondary to the 
mean CF group.  
4.4.1 The electrogram and ablation 
There was a significant difference between the pre and post ablation mean 
complex sizes (p<0.0005, pre-ablation median 0.12mV (range 0.05 to 0.59mV), post-
ablation 0.09mV (range 0 to 0.43mV), median decrease of 21% (range 100% decrease 
to 72% increase).   
There was a significant correlation between both the FTI and mean CF and the 
change in the electrogram complex size (p=0.02, Spearman’s rho = -0.14 for both).  The 
Figure 4.3 Force Time Integral versus Percentage Change in Electrogram Complex Size.   
Black squares are mean value.  Error bars represent one standard deviation. 
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percentage impedance drop during ablation also correlated with the latter (p<0.0005, 
Spearman’s rho = -0.33).   
There was a linear increase in the amount of electrogram attenuation with an 
increasing FTI until around 500g.s after which a plateau occurred, at around a 20% 
reduction in the complex size (Figure 4.3).   
A quantitative assessment of the plateau was not performed as the fitted 
logarithmic curve was only weakly predictive of the decrease in the complex size 
(adjusted R
2
 0.03).  This was reflective of the high degree of variability in the 
attenuation of the electrogram observed.  To allow for a quantitative comparison, the 
electrogram attenuation above and below the point from which there was a qualitative 
plateau suggested by the data was compared.  The percentage reduction in the complex 
size was significantly lower for FTIs under 490g.s than equal to or above this value 
(p=0.03: <490g.s median -18% (-70 to 72%); ≥490g.s median -23% (-100 to 31%)).   
 
4.5 Discussion 
This study prospectively assessed the relationship between catheter CF and 
biophysical and electrogram parameters in patients undergoing NPAF ablation.   An 
increasing FTI was associated with a greater impedance drop with this relationship 
plateauing from 500g.s.   There was also a relationship between the FTI and the 
attenuation of the fibrillating electrogram, with a relative plateau again from around 
500g.s.  The amplitude of the fibrillating electrogram had a more variable response to 
ablation than the impedance drop and so may not be as useful as a surrogate for lesion 
formation as the percentage impedance drop, particularly at the level of the individual 
ablation.  The ablation duration impacted on the impedance drop at an FTI if the 
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duration was less than 10 seconds.  Beyond this time point, the FTI achieved rather than 
the ablation duration or mean CF applied determined the impedance drop.     
During temperature-controlled radiofrequency ablation, the maximum 
temperature reached within the tissue correlates linearly with lesion volume
218
.  Catheter 
tip temperature is less reflective of this maximum temperature with irrigation as this 
cools the catheter tip
218
.   The maximal tissue temperatures can therefore reach higher 
levels in irrigated than non-irrigated temperature-controlled radiofrequency ablation, 
though in both types of ablation a plateau occurs in the tissue temperature over the 
course of the ablation
218
.  A linearly increasing fall in impedance with an increasing 
catheter tip temperature has been described for non-irrigated ablation
164,167,219
.   This has 
been suggested to be due to increased conductivity of cardiac tissue with heating
166
.  
Therefore, we have assumed that during irrigated radiofrequency ablation, the 
occurrence of a plateau in the impedance drop reflects a plateau in the size of the lesion.   
In this study, the CF during ablation correlated with impedance drop.  This has 
been described previously in animal studies (using non-irrigated ablation
166
), and 
recently during clinical ablation in paroxysmal atrial fibrillation (PAF) and atrial flutter 
patients
220
, and in another study of almost exclusively PAF patients
169
, with both 
clinical studies using temperature-controlled, power limited irrigated ablation.  The 
current study and previous work
166,169,220
 have demonstrated that for a given ablation 
duration, the CF during ablation significantly affects the impedance drop.  This is not 
unexpected as greater contact for the same ablation duration would result in more 
efficient energy delivery to the myocardium, an increase in the tissue temperature and 
therefore a greater impedance drop.  The FTI is a measure that incorporates both 
ablation duration and mean CF and therefore includes two important factors impacting 
on impedance drop.   
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Previous work has demonstrated a weaker relationship between the impedance 
drop and FTI
220
 than the current study.  The current study was conducted in a different 
patient cohort (NPAF rather than PAF or atrial flutter patients).  Also, in the current 
study, the impedance data were sampled at a higher frequency (10Hz rather than 0.2 Hz 
during ablation) and the resulting waveform filtered, which would have contributed to 
the stronger relationship, as well as the use of the percentage rather than absolute 
impedance drop.  Regardless of the improved strength of the relationship observed in 
the current study, we would concur with previous work
220
 that impedance drop cannot 
be used reliably in place of real time CF measurement to judge contact during ablation 
due to the point by point variability.  This was even more so the case for electrogram 
attenuation.  The focus of the current study though was the dynamics of the 
relationships between the CF and these surrogates of lesion dimension to establish 
targets for ablation, rather than using these surrogates as an alternative to measuring the 
CF during ablation.   
Another recent study has investigated the dynamics of the relationship between 
the impedance and the overall ablation mean CF rather than FTI
169
.  The sampling rate 
of the impedance in that study was every 10 seconds.  For ablations at a mean CF of 
≤5g, there was no real impedance drop after the initial 10 second measurement during 
ablation and the group therefore recommended a minimum of 5g of contact for ablation.  
The lower CF cut off in the current study was 5g and so we have not studied the 
dynamics of the relationships below this level.   
This study is the first to correlate catheter CF with electrogram attenuation and 
impedance parameters during NPAF ablation.  In this case, there was a plateau in the 
degree of electrogram attenuation related to the FTI at around a 20% reduction.  This is 
less than the 62% reduction secondary to the production of transmural lesions seen in a 
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pacing induced AF sheep model
190
, and the 48-65%
150,152
 reduction seen in sinus rhythm 
patients undergoing ablation.  With regard to the paced sheep model, it may be that 
there is greater ablation sensitivity to CF in that model than in man.  The chaotic nature 
of AF makes changes in the electrogram amplitude less consistent.  This would suggest 
that electrogram attenuation is an unreliable surrogate for lesion size at the individual 
ablation level in AF. 
The relationship between the FTI and electrogram attenuation plateaued at 
around 500g.s: this was consistent with the impedance data, though the relationship was 
stronger in the latter case.  The identification of a plateau in the relationships between 
the FTI, electrogram attenuation and impedance drop is the key finding of this study as 
it represents the lesion approaching the maximum possible size at those ablation 
settings.  The observation that these two surrogates of lesion size, despite the variability 
in their response to ablation at a single lesion level, are in agreement regarding the 
existence of this plateau and where this occurs provides internal validation for this 
finding.  Beyond this 500g.s plateau, continued ablation is likely to yield minimal 
further gains.  Such diminishing returns need to be weighed against the potential for 
complications from continued application of radiofrequency energy at a point such as 
perforation, steam pops and damage to extra-cardiac structures such as the oesophagus. 
The current study demonstrates that for a given FTI, the efficacy of ablation as 
judged by the impedance drop is affected by the former’s constituents: the mean CF and 
the ablation time.  Ablation for less than 10 seconds appears suboptimal regardless of 
the CF applied or FTI, whereas beyond 10 seconds the FTI (rather than its constituents) 
becomes the overriding determinant of the impedance drop.  This time dependence may 
be secondary to the progressive ramping up of the power in the temperature-controlled, 
power limited ablations performed in this study: on average it took around this time 
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frame for the ablation power to first reach the maximum power cut off.  This finding is 
clinically important, as, if one uses an FTI target for ablation without accounting for the 
ablation duration, suboptimal lesions could be delivered if the duration is less than 10 
seconds, regardless of the FTI achieved.  This is especially important with the advent of 
newer iterations of three dimensional mapping systems (for example the Carto3 Visitag 
module, Biosense Webster, Inc.) which are able to place lesion markers in an automated 
manner based solely on reaching an FTI threshold at a point. 
Previous work to establish CF targets for ablation has focussed on comparing 
CF parameters retrospectively based on reconnections in the pulmonary vein isolation 
lines.  A mean segment CF during ablation of at least 19.6g was less frequently 
observed to be associated with acute reconnection
177
, and at 3 months follow up, 
segments within a WACA ablated with a minimum FTI below 400g.s had a greater 
chance of being reconnected
178
.     These previous studies subdivided the ipsilateral 
pulmonary vein ablation lines into seven
177
 or eight
178
 segments and judged the 
adequacy of the multiple ablations in these segments based on whether the whole 
segment reconnected.  The current study differs in approach as we investigated at the 
level of the individual lesion, using biophysical and electrogram parameters, rather than 
against the wider segment outcome.  In so doing, we were able to explore the 
parameters for the successful creation of an ablation lesion.  Based on segment 
reconnection data, a recommendation has been made that the optimal mean CF during 
ablation should be 20g
178
: the current study suggests that the duration of ablation and 
FTI reached are more important determinants of the efficacy of ablation.  Within the 
limits of the contact force and duration parameters investigated, radiofrequency energy 
applied for a longer period with CF below 20g appears to have the same impact in terms 
of lesion formation as long as the same FTI is attained and ten seconds of ablation 
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exceeded.  This study therefore suggests that it is more clinically relevant to focus on 
FTI and ablation duration targets to generate adequate lesions.  
4.5.1 Limitations  
The gold standard for establishing the effectiveness of an ablation is the 
histological assessment of the lesion produced.  This is not available in humans and 
therefore the current study utilised parameters previously shown to correlate with 
histological lesion parameters.  Conclusions are therefore necessarily based on these 
surrogate markers of lesion formation.  Electrode orientation is known to affect lesion 
size
162,163
.  In this study, the catheter orientation was not included in the analysis and 
may have contributed to some of the variance observed.  The majority of patients in this 
study had ablations performed using remote robotic navigation.  This may also have 
influenced the results of this study.  All of the ablations were performed with the same 
power setting, and the irrigation flow rates were those recommended by the ablation 
catheter’s manufacturer for the power setting used in the study.  In preclinical studies, 
irrigation flow rates have been demonstrated to affect the size of lesions produced
159,221
.  
It is likely that the use of different power or irrigation settings would alter the energy 
delivered during ablation and affect lesion formation.   
 
4.6 Conclusions 
The results of this study suggest that during NPAF ablation, impedance drop may be a 
more accurate surrogate of adequate lesion formation than fibrillatory electrogram 
attenuation.  End points in terms of biophysical parameters for optimal lesion formation 
include an impedance drop of 7.5% and electrogram attenuation of 20%.  However, 
there was considerable variation in these biophysical parameters on a point by point 
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basis.  A more pragmatic primary target for ablation lesions is therefore an FTI of 
500g.s, beyond which there appears to be minimal incremental benefit from further 
ablation.  Additionally, ablations should be at least 10 seconds in duration, regardless of 
CF or FTI.  The clinical impact of adopting such targets for ablation requires further 
prospective evaluation.  
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5. Catheter contact characteristics and ablation efficacy 
in the human left atrium 
5.1 Abstract 
Introduction: Pre-clinical work suggests factors including catheter orientation and 
contact consistency during individual radiofrequency ablations influence lesion size.  
Our aim was to investigate factors affecting catheter contact in LA and their effects on 
ablation.  
Methods and Results: 2,298 eight second static LA mapping points were studied in 30 
patients undergoing ablation for AF (16 in AF, 14 SR, 18 RRN procedures) using a CF 
sensing catheter.  Contact force variability (CFV: difference between 20Hz-sampled CF 
waveform mean peak and trough) increased with mean CF, Spearman’s rho 0.6, 
p<0.005.  Catheter drift correlated weakly with CF (Pearson’s Correlation -0.06, 
p=0.005). CFV was higher in SR than AF and with RRN (p<0.001).  In AF there was 
less catheter drift for RRN than manual navigation points but the converse was true in 
SR.  In 747 static 30s LA ablations the influence of contact parameters on ablation 
efficacy was compared by multivariate analysis of impedance drop during ablation: a 
lesser drop suggesting reduced efficacy.   For FTI, increased CFV (>5g) and locational 
drift (>3.5mm), perpendicular contact, SR and RRN usage were associated with a lesser 
impedance drop with ablation (p<0.005 for each), suggesting reduced efficacy.   
Conclusions: Beyond the FTI, the quality of catheter contact influences ablation 
efficacy, and clinical catheter contact is affected by multiple factors, including the atrial 
rhythm and catheter navigation mode.  Maximal efficacy is provided by parallel contact 
with CFV ≤5g, catheter drift ≤3.5mm and manual navigation. 
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5.2 Introduction 
 In preclinical studies, the degree of contact between the ablation catheter and 
myocardium influences the size of the subsequent lesion produced by a radiofrequency 
energy application
166
.  The consistency of this contact also affects this
171
 as does 
catheter orientation
222
.  The importance of catheter CF to clinical ablation has been 
investigated in studies looking at the reconnection of segments in the WACA line 
during AF ablation 
177,178
.  A limitation of this approach is that rather than assessing the 
efficacy of ablation by examining the response to individual radiofrequency 
applications, conclusions are drawn based on the response of regions subjected to 
multiple applications.   
 In clinical ablation, an approach to assess individual ablations is challenging due 
to a lack of access to histological lesion parameters.  Impedance drop with ablation 
correlates with the latter
164,166
, and the nature of the impedance drop relationship with 
the FTI during clinical ablation has been used to draw conclusions about ablation 
efficacy
169,206
.  Electrogram attenuation
190
 or morphology change
141
 can also be used 
similarly
187
.  As discussed above, the quality of the contact, such as its consistency and 
orientation, not just the FTI achieved may impact on ablation efficacy.  An 
understanding of these factors may therefore help further optimize ablations, especially 
in concert with automated lesion annotation software
223
. 
 In the current study, we examined factors affecting catheter contact in the LA, 
investigating the locational and catheter CF stability, contact orientation, anatomical 
location, and manual versus robotic catheter navigation.  Furthermore, as a corollary to 
preclinical studies assessing individual radiofrequency applications, we examined how 
these factors affected the impedance drop and electrogram with ablation to determine 
contact parameters to optimize clinical ablations. 
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5.3 Methods  
All participants gave informed consent to participate in the study.  The study had 
ethical approval from the UK National Research Ethics Service.  Consecutive patients 
with AF undergoing their first ablation were enrolled.  Procedures were performed with 
patients under moderate conscious sedation.   CF was measured using a Thermocool 
SmartTouch catheter (Biosense Webster Inc., Diamond Bar, CA, USA).  In a subset of 
cases, at the discretion of the operator RRN (Sensei Robotic Catheter System, Hansen 
Medical Inc., Mount View, CA, USA) was used, in which case, the trans-septal sheath 
used for the ablation catheter was an Artisan sheath (Hansen Medical Inc.), otherwise a 
Mullins sheath (Medtronic, Minneapolis, MN, USA) was used.  Carto3 (Biosense 
Webster Inc.) was used to record CF, location and biophysical data and LabSystem Pro 
(Bard Electrophysiology Division, MA, USA) was used to record electrogram data. 
Using the ablation catheter, mapping points were taken at evenly spaced 
locations throughout the LA prior to any ablation.  At each location, three to four 8s CF 
readings (sampled at 20Hz) were taken with the catheter not moved by the operator.  At 
alternate locations, CF was deliberately changed for the second two readings.  Location 
data for the catheters were recorded for each point over a 60Hz sampled 2.5s window.   
In the ablation phase, study ablations were performed during WACA and, for 
patients with persistent AF, complex fractionated atrial electrogram ablation.  All study 
ablations were 30s in duration, with the catheter in a stable position for at least 2.5s 
prior to radiofrequency energy delivery, and at least 8s after cessation.  Ablations were 
performed in temperature-controlled mode with the temperature limited to 48˚C, and 
power to 30W.  The irrigation flow rate was 2ml/minute during mapping and 
17ml/minute during ablation (manufacturer’s recommendations).  All ablations were 
performed at a CF of 5-40g.  Locations where there was macro-displacement were 
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discarded.  Location markers were manually applied pre and post-ablation on Carto3, as 
well as lesion markers during ablation.   All study ablations were non-overlapping and, 
once completed within a lesion set, further ablation was at the operator’s discretion. 
Respiratory gating was not used as data during the whole sampling period were 
analysed for each point.  Impedance during ablation was measured between the tip of 
the ablation catheter and the ground patch (on the patient’s left thigh), using a 50 kHz 
current, and recorded at 10Hz.   
All data were processed and analysed using custom-written Matlab 
(MathWorks, Natick, MA, USA) scripts as described in Chapter 2.7.   
Electrogram, impedance and FTI data were processed using previously 
described methods (Chapter 2.7)
206
.  Impedance data were processed to remove noise 
using a Savitzky-Golay filter.  The percentage impedance drop during ablation was 
determined using the filtered impedance waveform, comparing initial impedance to the 
minimum recorded during an ablation.  FTI was determined by the area under the CF 
curve derived using trapezoidal integration.  To investigate the relationship between FTI 
and impedance drop, all ablations were divided into consecutive, cumulative, 10g.s FTI 
intervals.  The maximum impedance drop was then compared with the initial impedance 
at the ablation’s start.   
Electrogram attenuation was assessed by comparing the median complex size 
(each complex in the signal being identified by a custom-written script, Chapter 2.7
206
).  
The electrograms analysed in this part of the study were bipolar electrograms (set up 
between the distal adjacent electrodes on the ablation catheter).  Signals in the 
electrogram recording system were recorded at a low cut-off of 30Hz and a high cut-off 
of 250Hz.  The peaks and troughs in the signal were identified using a 70ms cut off as 
used in previous published work to prevent double counting of complexes
98
.  
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Complexes less than 0.05mV (peak to trough) were assigned as noise
201
   based on 
Figure 5.1 Catheter stability and orientation analysis. (A) Change in distance between the 
ablation catheter and pulmonary vein catheter location over time at two locations.  
Catheter drift is the difference between the minimum and maximum distance between 
these catheters.  (B) Contact force (CF) waveform over time at two mean contact forces – 
the contact force variability (CFV) is the difference between the mean trough and peak CF.  
The mean CF is indicated by the solid line while the mean peak and trough CFs are indicated 
by the dotted lines.  On the left of the image is a waveform at low mean CF with low CFV, 
while on the right is a waveform at higher CF with higher CV.  (C) The angle of catheter 
contact with myocardium.  The shaded parts of the circle were considered perpendicular 
contact zones, the unshaded portions parallel contact.  Arrows represent vector of contact.  
Left is an example of parallel contact, right perpendicular contact. 
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review of the signals and previous work
217
.  The angles of the rising and falling signal 
were determined for the dominant peak or trough in a complex, from a point at one-third 
of the complex size from the peak or trough of the signal.  A correction factor of 1000 
(500 if the electrogram was sampled at 2Khz) for angle measurements was used to make 
the signal equivalent to that displayed on LabSystem Pro at a sweep speed of 100mm/s 
and a 32x scale.  A rising or falling angle of over 45˚ meant the complex was discarded 
as farfield
98
.   The complex size was measured from the dominant peak to trough of a 
complex.   
Electrogram morphology change
141
 was assessed manually using bipolar and 
unipolar (referenced to an indifferent electrode in the inferior vena cava) electrograms. 
Unipolar signals were analysed in preference for this analysis but bipolar signals were 
used where the unipolar signals were poor quality or where the unipolar morphology did 
not conform to the morphology scheme. The electrogram analysis was conducted only 
for the SR points in view of the unreliability of assessing electrogram attenuation in the 
fibrillatory signal
206
, and as electrogram morphology criteria have been histologically 
validated only in SR
141
.   
The circular PV catheter was kept in a stable position in a pulmonary vein 
during acquisition of mapping or ablation data.  The drift of the ablation catheter was 
determined by referencing the displacement of the sensor to an averaged PV electrode 
to correct for respiratory motion.  The averaged electrode was derived by averaging the 
location of all 20 PV electrodes.  The drift was taken as the range of the distance to this 
averaged electrode over the recording window (Figure 2. 5).  To increase the accuracy 
of the drift measurement for an ablation, this was taken as the average of the 
displacements for the pre-ablation, ablation and post-ablation marker points.   
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 The absolute CF range would be influenced by outlier values, therefore, to 
quantify the peak to trough variation in the CF waveform, (the contact force stability) an 
averaged measure, the CF variability (CFV), was used (Figure 5.1).  This was 
determined by first identifying all the peaks and troughs in the waveform using an 
automated script.  The peaks were averaged to give an average peak value and the same 
done for the troughs.  The difference between these averaged values gave the CFV. 
To define parallel and perpendicular catheter contact, the direction of the CF 
vector was considered relative to the catheter’s axial plane.  The contact angle was 
sampled at 20Hz and recorded as 0-360˚, with 0˚ as the direction the catheter was 
pointing.  Contact was assigned as perpendicular by an automated script if 315˚ to 45˚ 
or 135˚ to 225˚: otherwise it was assigned as parallel (Figure 2.5).      
5.3.1 Statistics 
Statistical analysis was performed using SPSS (IBM SPSS Statistics, Version 20 
IBM Corp, Armonk, NY, USA) and Matlab V7.12 (Statistics Toolbox V7.5).  A p-value 
of <0.05 was taken to indicate statistical significance.   Correlations were assessed using 
a Pearson’s correlation where the relationship was linear and a Spearman’s rank 
correlation otherwise.  Point-Biserial correlation was used where a continuous variable 
was compared with a binary one.  Normally-distributed data were analysed using a t-test 
or ANOVA and non-normally-distributed data using a Mann-Whitney U test or 
Kruskal-Wallis test.  Data are presented as mean±standard deviation or median(range).  
Multivariate regression analysis was used to assess the influence of different factors on 
the CFV and impedance drop.  In the case of impedance drop, the observation that the 
relationship between the FTI and impedance drop is logarithmic
206
 was used to perform 
linear regression. 
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5.4 Results 
Baseline characteristics of the study patients are presented in Table 5.1.   
Figure 5.2 Contact Force Versus Contact Force Variability. (A) Comparison of mean contact 
force with contact force variability.  Points are mean values for at least 5 measurements 
(2897 measurements represented in chart).  Error bars represent standard deviation.  (B) 
Factors affecting contact force variability.  Points are mean values for at least 30 
measurements.  The linear portions of the curves are shown with lines of best fit.  The 
significance of each factor is displayed in Table 5.2. 
Table 5.1 Study Population Baseline Characteristics 
Number of Patients 30 
Age, mean±SD 61±8 years 
Gender 21male (70%) 
Persistent Atrial Fibrillation 15 (50%)  
Duration of Persistent Atrial Fibrillation 20±12 months 
CHA2DS2-VASc Score, mean±SD 1.4±1.0 
Left Atrial Diameter, mean±SD 4.4±0.6cm 
Severe Left Ventricular Impairment (Ejection 
Fraction<35%) 
2 (7%) 
Manual Navigation 12 (40%) 
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 All persistent AF patients were in AF at the time of the procedure, as was one of 
the paroxysmal AF (PAF) patients. 
5.4.1 Mapping Results 
The mean CF was compared to the contact force variability (CFV: the difference 
between the mean peak and trough CFs in the CF waveform) for 2,298 points (1714 AF; 
631 manual, 77±41 points per patient).  As the former increased, there was an increase 
in the CFV (Figure 5.2A, p<0.0005, Spearman’s rho 0.6).  The relationship was linear 
until 25g of mean CF, above which the rate of increase levelled off before a further rise 
from 45g.    
To explore factors influencing the relationship between the mean CF and CFV, 
multivariate regression analysis was performed where the mean CF was <25g (1,805 
points), allowing comparison of the linear portions of the curves (Table 5.2).  The use of 
RRN and being in SR rather than AF was associated with greater CFV (Figure 5.2B).  
Table 5.2 Multivariate analysis of factors affecting contact force variability 
Co-factor Unstandardized β 
(95% Confidence Interval) 
Number of 
points 
p-value 
Mean contact force (g) 0.05 (0.05 to 0.06)  <0.0005 
Perpendicular Contact  -0.03 (-0.07 to 0.02) 835 0.2 
Remote Robotic Navigation 0.45 (0.41 to 0.5) 1288 <0.0005 
Sinus Rhythm 0.29 (0.24 to 0.34) 497 <0.0005 
Left pulmonary vein antrum 0.17 (0.09 to 0.25) 287 <0.0005 
Left atrial appendage ridge 0.21 (0.13 to 0.29) 260 <0.0005 
Postero-inferior wall 0.17 (0.09 to 0.25) 259 <0.0005 
Antero-septal wall 0.2 (0.13 to 0.27) 338 <0.0005 
Posterior wall 0.24 (0.15 to 0.33) 178 <0.0005 
Roof 0.35 (0.26 to 0.44) 150 <0.0005 
Left lateral wall 0.36 (0.23 to 0.5) 56 <0.0005 
 
Dependent Variable: Ln(Contact force variability)  
Reference location: Right Pulmonary Vein Antrum (277 points) 
Adjusted R2: 0.45 
A positive β value for a co-factor means that if all the other co-factors are unchanged, the contact force 
variability will be higher as it increases or is present (and vice versa)  
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Location had a significant influence on the CFV: the right PV antrum had the lowest 
CFV, the roof and left lateral wall the highest.  
There was a weak correlation between the catheter drift and mean CF 
(Spearman’s rho -0.07, p=0.001) but not CFV and drift (Spearman’s rho, p=0.9).   No 
difference in locational stability was afforded by perpendicular or parallel contact 
(p=0.34).  There was no difference in the drift by atrial rhythm for manual navigation, 
but with RRN, drift was higher in SR than AF; drift was lower in SR for manual rather 
than RRN points, with the converse true in AF (Figure 5.3). 
5.4.2 Ablation Results 
Figure 5.3 Catheter drift by navigation mode and atrial rhythm.  
*p<0.02 
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The impact of catheter contact orientation, CFV, catheter drift, atrial rhythm and 
location on impedance drop was assessed.  747 ablations were analysed (395 RRN, 352 
manual) - ablations performed after the study ablations were completed in a region were 
not included in the analysis.  .  The FTI was higher for RRN ablations (440( 85-
1362)g.s, manual: 329(117-1024)g.s p<0.005), parallel contact (412(85-1179)g.s, 
perpendicular: 365(121-1362)g.s p=0.005) and ablations in AF (395(86-1362)g.s, SR: 
374(85-1123)g.s, p=0.036).   The incremental FTI analysis generated 32,826 
measurements.   
Figure 5.4 Factors affecting impedance drop during ablation.  (A) Navigation mode (SR 
ablations) and (B) Atrial Rhythm (RRN ablations).  Each point is the mean of at least 10 
ablations.  *p<0.0005 from Table 5.3 
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Increasing catheter drift (especially >3.5mm), CFV (especially >5g), SR and 
RRN rather than manual navigation were associated with shallower logarithmic 
relationships between the impedance drop and FTI (Figures 5.4 and 5.5).  As each 
ablation was subject to a combination of factors, and to elucidate the importance of 
these factors to the efficacy of ablation, multivariate regression analysis was performed 
(Table 5.3).  A locational drift >3.5mm, CFV >5g, perpendicular rather than parallel 
contact and RRN were associated with a lesser impedance drop per FTI as was being in 
SR rather than AF.   
Figure 5.5 Factors affecting impedance drop during ablation.  (A) CFV and (B) Catheter 
drift.  Each point is the mean of at least 10 ablations.  *p<0.0005 from Table 5.3 
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412 SR ablations were included in the electrogram analysis.  Of these, 100 were 
excluded based on the automated analysis: 3 as there were no identifiable complexes at 
the start of ablation and 97 as the post-ablation electrogram was larger than the pre-
ablation electrogram (suggesting micro-displacement).  Of these, for the morphology 
analysis, 113 ablations were excluded as the pre-ablation morphology did not conform 
to the three validated pre-ablation morphologies
141
 – generally either as the signal was 
fractionated or an RS bipolar morphology.  Of the remaining ablations, 65% were 
transmural based on electrogram morphology criteria.  On binary logistic regression, 
including the FTI, CFV, contact orientation, catheter drift and navigation mode, only 
the catheter drift (in mm) was found to be predictive of transmurality based on these 
criteria: p=0.01, odds ratio of transmural lesion 0.71 (95% confidence interval 0.55 to 
0.92).  The Nagelkerke R
2
 for the model was only 0.06 suggesting it was poorly 
predictive.  FTI was not significantly predictive of transmurality (p=0.6) in this model, 
and there was no correlation between the FTI and transmurality of lesions by these 
criteria when analysed separately (p=0.86, Point-Biserial correlation), or comparing an 
Table 5.3 Multivariate analysis of factors affecting the impedance drop with ablation 
Co-factor 
Unstandardized β (95% 
Confidence Interval) 
p-value 
Ln(Force Time 
Integral) g.s 
0.78 (0.77 to 0.78) <0.005 
Remote Robotic 
Navigation 
-0.12 (-0.14 to -0.1) <0.005 
Catheter drift 
>3.5mm 
-0.23 (-0.25 to -0.21) <0.005 
Contact Force 
Variability >5g (g) 
-0.24 (-0.25 to -0.23) <0.005 
Perpendicular 
Contact Orientation 
-0.02 (-0.03 to -0.004) 0.006 
Sinus Rhythm -0.16 (-0.17 to -0.14) <0.005 
 
Dependent Variable: Square root of percentage impedance drop 
Adjusted R2: 0.7 
A positive β value for a co-factor means that if all the other co-factors are unchanged, the 
impedance drop will be higher if the co-factor is present or increases (and vice versa)  
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FTI ≤500g.s to >500g.s (p=0.5).  The post ablation electrograms were significantly 
attenuated compared with pre-ablation (p<0.0005), with a median attenuation of 45(0-
100)%, but the degree of attenuation did not correlate with the FTI (p=0.74), with no 
significant difference in attenuation for ablations above or below 500g.s (p=0.6).  
Similarly, there was no correlation with the CFV, catheter drift or mean CF (p>0.05 for 
each). There was no significant difference in electrogram attenuation by contact 
orientation or navigation mode (p>0.05 for both).   
 
5.5 Discussion 
This study demonstrates that an increase in mean CF is associated with an 
increased CFV and this relationship varies by LA location.  An increasing CF is weakly 
associated with less catheter drift.  The use of RRN is associated with increased CFV as 
is being in SR.  The atrial rhythm does not affect catheter drift with manual navigation 
but being in SR is associated with increased drift with RRN, and in SR the use of RRN 
is associated with increased drift compared with manual navigation (while the converse 
is true in AF).  Catheter contact orientation does not affect CFV or catheter drift.  The 
impedance drop/FTI relationship is steeper for RF applications with less drift, lower 
CFV, parallel rather than perpendicular contact, and when manual navigation is used.   
CFV at a point is likely predominantly secondary to respiratory and cardiac 
motion.  Previous work assessing variability of CF using a Force Variability Index 
found that apnoea was associated with less variability
172
: as none of the cases in the 
current study were performed with general anaesthetic, this finding could not be 
explored here.  During AF, a major contributor to the CFV is ventricular contraction: in 
SR, CFV is additionally influenced by global and local (to the catheter) atrial 
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contraction.  This is likely the explanation for the higher CFV observed in SR 
recordings in the current study.   
As mean CF increases, CFV increases.  It is hypothesized this is due to a change 
in the properties of the underlying tissue: at low CF the myocardium has a large 
capacity for stretching and can buffer sources of variability such as cardiac motion from 
affecting contact with the catheter; at higher CF, CFV increases, suggesting that less of 
this variability is buffered by the tissue and more transmitted to the catheter tip.  This 
suggests LA compliance reduces with increasing applied CF.   
Contributing to the mean CF/CFV relationship is the stiffness of the ablation 
catheter and sheath, and this would be influenced by the degree and number of 
deflections undergone in reaching a location.  A stiffer sheath and catheter, as well as a 
less compliant (stiffer) myocardial region, presumably means more of the variability in 
the contact secondary to cardiac motion and respiration is transmitted to the catheter tip, 
leading to a higher CFV for a given CF.  Evidence for this is the increased CFV 
observed for points taken with the stiffer robotic sheath compared with those taken with 
the softer Mullins sheath.   
The relationship between mean CF and CFV levels off at around 25g of CF.  In 
canine LA studies, tissue tenting is visible on intracardiac echocardiography at 25g of 
CF
137
.  The levelling off observed may therefore represent the onset of tenting 
secondary to catheter contact, with the myocardium adjacent to the catheter having 
become maximally stretched and the surrounding tissue being recruited to deform by 
the continued catheter tip pressure.  Beyond 45g, there is another rise in the CFV with 
mean CF, and this may represent the capacity for the adjacent myocardium to buffer 
changes in CF being exceeded as a precursor to perforation. 
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In man, the compliance of the LA as a whole has been studied using cardiac 
catheterization
48
 and echocardiography
49
.   In canine studies, a regional difference in LA 
compliance has been observed on comparing the LAA with the LA body, with the 
former having a higher compliance
45
.  In the current study, the steepest relationship 
between CFV and mean CF was found at the roof, with the right PV antrum having the 
shallowest relationship. The LAA was between the two regions in terms of the 
relationship.  As stated earlier, we speculate this relationship would not just be related 
to the characteristics of the myocardium but also the catheter and sheath and the degree 
of respiratory motion to which an area is subject.  In the case of the right PV antrum, the 
deflection involved in accessing this region through a trans-septal puncture may lead to 
a reduction of the transmission of the variability in the CF an increased myocardial 
contact would normally cause.  One would predict the roof to be most greatly affected 
by respiratory motion which would have a major impact on the CFV here. 
The catheter drift analysis conducted in this study is novel.  By referencing the 
drift to the pulmonary vein catheter, the aim was to study drift of the catheter relative to 
the myocardium rather than secondary to respiratory motion (where the contact point 
with the myocardium may in fact not be altered).   As the CF increased there was a 
minor reduction in the amount of catheter drift observed suggesting an increased 
stability of the catheter as one would expect.  The atrial rhythm did not impact on the 
catheter drift for manual points.  This may relate to the flexibility of the Mullins sheath 
allowing it to deform with cardiac contraction and so maintain its position.  In the case 
of the RRN points, SR was associated with reduced catheter locational stability.  In this 
case, the stiffer sheath may be less able to deform with cardiac contraction and so 
maintain its position at a point.  Supportive of this hypothesis is that in AF, RRN is 
associated with increased stability, while for SR points, where cardiac contraction 
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would have a greater influence, RRN points are less locationally stable than points 
collected manually.  Previous work has suggested an increased locational stability using 
RRN rather than manual navigation during sinus rhythm
150
, but the methodology there 
was to compare the location of markers taken 30-60s apart, while the approach in the 
current study, using a 60Hz sampled 2.5s window around the time of marker placement 
analyses a higher volume of data. 
In preclinical studies, a correlation has been observed between impedance 
drop
164,166
 and FTI
171
 during ablation with lesion size.  During clinical ablation, 
impedance drop has been used as a surrogate for lesion dimensions and correlates with 
CF during ablation
169,206
.  The variability of the impedance drop for a single 
measurement makes it an unreliable marker of the effect of an individual clinical 
ablation
206
.  On the other hand, multiple impedance measurements are taken during an 
ablation allowing an incremental analysis of the effects of ablation (and by extension, 
lesion maturation).  By combining multiple ablations and analysing them incrementally 
to produce a large volume of data, the variability in impedance measurements is 
mitigated to allow the underlying relationships to be explored.  Accordingly, the effect 
of different contact parameters on the impedance drop relationship as a whole was used 
to assess the effect on ablation efficacy. 
 Ablations were less effective for patients in SR, even when the CFV and 
catheter drift were included in the model.  This may be due to differences in the 
underlying atrial tissue itself between patients with persistent AF and PAF, though as all 
of the former patients in the cohort were in AF and all but one of the latter in SR, it is 
not possible to rule out that the difference was related to the rhythm itself (and not 
accounted for completely by differences in catheter drift and CFV). 
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CFV significantly impacted on the relationship between FTI and impedance 
drop: a greater CFV led to a shallower relationship, suggesting less effective ablation.  
The impact of the variability of CF on lesion size has been studied in vitro
171
: in that 
study more variable contact resulted in smaller lesions, but of note, it also resulted in a 
lower FTI.  In the current study, the FTI was controlled for using multivariate analysis 
and the CFV found to independently affect ablation.  It is possible that a high degree of 
CFV leads to a cooling effect on the tissue through stretching and unstretching, 
attenuating the tissue heating from radiofrequency energy delivery, and so reducing the 
effect of ablation.  Consequently, it seems advisable to reduce CFV where possible 
during ablation. 
An increased locational drift (>3.5mm) was associated with reduced ablation 
efficacy.  It is unsurprising that locational stability would impact on ablation efficacy– 
more instability would result in inconsistent RF energy delivery to tissue and over a 
wider area, leading to less efficient tissue heating and so a smaller lesion.  3.5mm is the 
length of the ablation element for the catheter used in the study and may be why the 
impedance drop relationship changes markedly beyond this.  During ablation, an 
observation of greater locational instability should therefore encourage an operator to 
either ablate to a higher FTI or, preferably, adjust the catheter position. 
The impedance drop was higher with parallel contact, though the impact was of 
a lower magnitude than other parameters.  The effect of orientation observed is the 
opposite of what one might expect as in vitro work suggests that with irrigated ablation, 
lesions  are larger with a perpendicular catheter orientation
222
.   While the latter work 
made comparisons based on the orientation of the catheter as a whole, the current study 
had the benefit of access to the orientation of contact itself, as measured at the catheter 
tip, and measured the CF directly at the contact point rather than extrapolating this.  As 
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the ablation element is based in the catheter tip, we would suggest assessing contact 
parameters in this region is more relevant to ablation.  Another group examined the 
effect of contact orientation on impedance drop and also found that impedance drop was 
lower in a perpendicular orientation: they speculated this might be because  less of the 
catheter tip was in contact with the tissue than when the contact orientation was 
parallel
169
.  A limitation of that study was that CF was lower in the perpendicular 
orientation ablations.  Such confounding was avoided in the current work by factoring 
in the FTI through multivariate analysis.   
RRN was associated with a shallower impedance drop/FTI relationship than 
manual ablation.  This suggests there are factors related to the quality of contact when 
using RRN rather than manual ablation which means that the impedance drop is lower 
for the same FTI.  This difference is not explained fully by differences in CFV and 
catheter drift as it remains even when these are present in the model, and suggests FTI 
targets may need to be adjusted for each navigation mode.  The CF for RRN ablation 
was higher than for manual ablation, and it may be that the ease of attaining a higher CF 
(and so FTI) with this stiffer sheath outweighs the disadvantages in terms of efficacy 
when using this. 
Previous clinical work has found a very strong relationship between changes in 
SR electrogram morphology and attenuation and FTI
187
.  In the current study, we did 
not observe this relationship, and in fact none of the other contact parameters other than 
catheter drift were found to correlate.  Part of the explanation for these results is likely 
the small amount of catheter motion present during the electrogram recording period 
affecting the electrogram observed, especially in the attenuation analysis where 8s of 
electrograms were compared.  An electrogram-based analysis would be very sensitive to 
catheter drift, especially as it can only be performed at two time points (pre- and post-
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ablation).  In the current study it was also found that a reasonable proportion of 
electrograms observed did not strictly correspond to the morphologies validated 
histologically as corresponding to transmural or non-transmural lesions which made 
these criteria more difficult to apply to the data.  Based on previous work
164,166,171
 it 
seems unlikely that the lack of correlation with electrogram parameters reflects the FTI 
and impedance drop having no correlation with lesions size. 
5.5.1 Limitations 
Contact orientation was treated as a binary rather than continuous variable and 
assessed in only one plane – the simplifications were used to facilitate analysis.  Study 
ablations were performed with unchanged temperature and power settings: it is not clear 
how applicable the results would be to other ablation settings.   
 
5.6 Conclusions 
This study highlights the complexities of catheter contact within the LA and 
expands on previous work focusing on the ablation FTI to further explore contact 
parameters affecting the efficacy of ablation.  In this regard, an increased catheter drift 
and CFV reduce ablation efficacy, as does perpendicular catheter contact and RRN.  
Therefore, this work suggests the quality of catheter contact, not just its magnitude and 
duration, affects efficacy.  The establishment of target contact parameters is becoming 
increasingly relevant to clinical ablation with the release of automated lesion marker 
placement software able to place markers on fulfilment of user-specified contact and 
ablation parameters
223
, with the current study contributing to establishing optimum 
values for such parameters.  The clinical impact of adopting the targets suggested by the 
current work requires further prospective evaluation, but by optimizing every delivered 
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radiofrequency application, one would hypothesize the outcomes from AF ablation 
procedures would improve.   
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6. Contact Force and Pulmonary Vein Reconnection in 
Persistent Atrial Fibrillation Ablation: Impact of 
Steerable Sheaths 
6.1 Abstract 
Background: Catheter CF during ablation is predictive of sites of pulmonary(PV) 
reconnection.   The impact of steerable-sheaths on ablation CF and PV reconnection 
sites was investigated. 
 
Methods and Results: 5464 ablations were analysed in 60 patients undergoing first-
time persistent AF ablation using a CF-sensing catheter: 19 manual non-steerable sheath 
(Manual-NSS), 11 manual steerable-sheath and 30 robotic steerable-sheath procedures.  
Individual WACA lesions were localised using clock-face segmentation and locations 
of PV reconnections noted acutely and at repeat procedures (26, at a median 8(2-17) 
months).   CFs were higher in the steerable sheath groups (p<0.0005), but less 
consistent per WACA segment (p<0.005).  There were significant differences in the 
mean CFs around both WACAs by group: in the left WACA, CFs were lower with 
Manual-NSS other than at the anterior-inferior and posterior-superior regions, and lower 
in the right WACA, other than the anterior-superior region.  CF was significantly lower 
for ablations in reconnecting segments acutely and at repeat procedures.  There was a 
significant difference in the proportion of segments chronically reconnecting across 
groups: Manual-NSS 26.5%, manual steerable sheath 4.6%, robot 12%, p<0.0005.  The 
left atrial appendage/PV ridge and right posterior wall were common sites of 
reconnection in all groups. 
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Conclusions: WACA ablation CFs during ablation for persistent AF are predictive of 
reconnection both acutely and chronically.  Steerable-sheaths are associated with 
increased ablation CF but lower consistency, and there are segments where they fail to 
increment CF.  Certain WACA regions remain prone to reconnection regardless of 
steerable sheath usage. 
 
6.2 Introduction 
Steerable sheath technology aims to improve the AF ablation procedure by 
providing increased control over catheter manipulation.  Such technologies include 
RRN (Sensei Robotic Catheter System, Hansen Medical Inc., CA, USA) and manual 
steerable sheaths.  Use of steerable sheath technologies may fundamentally affect the 
quality of contact with the myocardium compared with manual non-steerable sheaths in 
view of their increased stiffness and potentially greater consistency of contact.   
Recent work suggests the adoption of CF-sensing catheters may improve 
procedural parameters in AF ablation
180,181,224
.  Catheter CF during ablation may be 
important for safety, as excessive contact can lead to myocardial perforation
186
.  CF is 
also important from the viewpoint of efficacy, with higher contact during ablation 
associated with increased lesion size
153
.  From a clinical perspective, reconnecting 
segments in pulmonary vein isolation lines are more likely to have been ablated at lower 
CF
172,177,178
. 
In this study, we therefore sought to examine the impact of steerable sheath 
technology on CF, and its consistency, around the WACA lines.  Such a study has now 
become possible in vivo due to the availability of CF information when using CF-
sensing catheters.  The WACA lines were analysed using a segmental model in order to 
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facilitate detailed regional comparisons in accordance with previous work
172,177,178
.  The 
patterns of immediate and late WACA-segment reconnection were also between 
technologies: as chronic reconnection was investigated at clinically indicated redo-
procedures, a persistent AF population was studied (since these patients are more likely 
than PAF patients to require repeat ablation
86
).   
Our hypothesis was that the technology used to deliver the catheter to the left 
atrium would impact on the contact forces exerted during ablation and this in turn 
would directly affect the pattern of WACA reconnection. 
 
6.3 Methods  
The study conforms to the guiding principles of the Declaration of Helsinki and 
all procedures were performed with the patients’ informed consent in accordance with 
local institutional guidelines.  Consecutive patients with persistent AF having their first 
ablation for persistent AF were included in the study.  A Thermocool SmartTouch 
catheter (Biosense Webster Inc., Diamond Bar, CA, USA) was used for ablation guided 
by the Carto3 electroanatomical mapping system (Biosense Webster Inc.).  Patients 
were divided into 3 groups: 
1. Manual-NSS group – using a non-steerable trans-septal sheath (Mullins 
sheath, Medtronic, MN, USA). 
2. Agilis group – using the Agilis NxT steerable trans-septal sheath (St Jude 
Medical, MN, USA). 
3. RRN group  
Patients who had crossed over between groups during ablation were excluded.   
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Procedures were performed in the post-absorptive state under intravenous 
moderate sedation.  Percutaneous access for all catheters was through the right femoral 
vein.   A catheter was placed in the coronary sinus.  In the non-RRN groups, two 
sheaths were positioned in the left atrium, for the SmartTouch (Agilis or Mullins 
sheath) and circular PV catheters (Mullins sheath).   For the robotic group, the 
SmartTouch catheter was passed through an Artisan sheath (Hansen Medical Inc.) and 
the circular PV catheter through a Mullins sheath.   
Ablations were performed with ablation settings at the discretion of the operator, 
generally in temperature-controlled mode with the temperature limited to 48˚C, and 
power to 30W.  WACA was performed to encircle the left- and right-sided PVs as a 
pair, aiming for entrance block with the initial encirclement, and with exit block 
confirmed subsequently when the patient was in sinus rhythm (generally through 
ablation or cardioversion).  The ablation of lines of block beyond pulmonary vein 
isolation and the targeting of fractionated activity subsequent to WACA was at the 
discretion of the operator.  If arrhythmia persisted as an organized atrial tachycardia, 
Figure 6.1 Clock face scheme for assigning ablation location in wide area circumferential 
ablation lines.   
Left Side – Left Pulmonary Veins; Right Side – Right Pulmonary Veins 
A=Anterior; P=Posterior 
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this was mapped and ablated.  If arrhythmia could not be terminated, external 
cardioversion was performed. 
Throughout the procedure, operators had access to the CF data.  While the force 
used was at the discretion of the operator, a target 5-40g force range was used.   
The location of each ablation was determined from the ablation points recorded 
on Carto3.  Each ablation was assigned a clock face location within a WACA.  To do 
this, the PV pair was viewed in a lateral orientation (left lateral for the left veins and 
right lateral for the right side).  The orientation was then tilted in the cranial-caudal 
plane so that the intervenous ridge was in the centre of the view.  The circumference of 
the PV pair (along which the WACA lesions were placed) was then divided by a clock-
face (Figure 6.1).  This meant that 6 o’clock and 12 o’clock were the floor and roof of 
the left atrium respectively.  For the left WACA, 9 o’clock was anterior, while on the 
right side, 3 o’clock was anterior. 
A minimum waiting time of 30 minutes was used in order to judge whether a 
vein had acutely reconnected
225,226
.   Where veins were assessed prior to this time-point, 
they were excluded from the acute reconnection analysis.  Where reconnection occurred 
acutely, the sites of reconnection were noted using the clock-face method discussed 
above, based on the signal on the PV catheter and response to ablation.   
CF was sampled at 20Hz and the data exported from Carto3 analysed using 
custom written scripts in Matlab (MathWorks, MA, USA).  Where the mean CFs for a 
WACA or for the procedure were required, CF measurements for the relevant ablations 
were combined into one long ablation and the average taken of the combined value (to 
prevent shorter ablations from being given equal weight to the mean as longer 
ablations).  Where drag lesions were performed during WACA, a single ablation would 
commonly have multiple ablation lesion markers on Carto3 which crossed multiple 
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WACA segments.  To obtain regional CF data, the ablation was subdivided between 
these marker points.  Accordingly, the ablation was temporally subdivided from when 
the lesion marker point in question was applied to when the next location point was 
collected on the system.  From these subdivided data, the mean CF was established for 
each point and the mean for a segment of the WACA then derived from the mean of 
these points in a segment.  The ablation FTI was determined by trapezoidal integration 
of the CF waveform (Figure 2.5).   
The consistency of the achieved CF within a WACA was quantified by 
examining the variability of the mean CFs per segment during the initial encirclement.  
This was established by assessing the standard deviation (SD) of the ablation mean CFs 
achieved in a segment for each patient individually.  These values were then compared 
between segments and groups.  
The patients’ follow up after the procedure was according to the normal 
practices of the operator.  In the case of patients from the cohort who went on to have 
repeat procedures for recurrent arrhythmia, the sites of reconnection were noted using 
the clock-face method discussed above.   
6.3.1 Statistical Methods 
The groups were compared using parametric or non-parametric testing based on the 
distribution of the data.  Normality of this distribution was assessed using a Jarque-Bera 
test, and appropriate transformations carried out to normalize the data.  Parametric 
(ANOVA, t-test) or non-parametric tests (Mann Whitney U, Kruskal-Wallis) were used 
to compare the data.  Categorical variables were compared using a Chi-squared or 
Fisher’s exact test.  A p-value <0.05 was considered statistically significant.  Data is 
presented as mean±SD or median (range).  Statistical analysis was performed using 
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SPSS (IBM SPSS Statistics, Version 20 IBM Corp Armonk, USA) and Matlab V7.12 
with the Statistics Toolbox V7.5.   
6.4 Results 
Sixty patients were included in the study.  The baseline demographics are presented in 
Table 6.1.   
There were no significant differences across the three groups.  In terms of 
procedural complications these were all in the RRN group: one pseudoaneurysm and 
two minor  (based on guideline criteria
1
) pericardial effusions, the latter diagnosed on 
routine post-procedure transthoracic echocardiography.  The success rates at 12 months 
(off anti-arrhythmic drugs, as per guideline definitions
1
) were: Manual-NSS 9/19 
(47%); Agilis 2/11 (18%), RRN 16/30 (53%) - p>0.05 for all comparisons. 
 
Table 6.1 Study Population Characteristics 
 Total Group 
Manual-
NSS 
Agilis RRN p-value 
comparing 
groups 
Number 60 19 11 30  
Age (years±SD) 60±10 62±10 60±16 59±7 0.9 
Male Gender   52 (87%) 16 (84%) 9 (82%) 27 (90%) 0.7 
LA diameter in cm, 
(range) 
4.0 (4-6) 4.0 (4-6) 4.0 (4-5) 4.0 (4-6) 0.6 
Ischemic heart disease 11 (18%) 1 (5%) 3 (27%) 7 (24%) 0.19 
Diabetes 6 (10%) 3 (16% 1(9%) 2 (7%) 0.6 
Hypertension 20 (33%) 8 (42%) 3 (27%) 9 (30%) 0.6 
Cerebrovascular 
disease 
3 (5%) 1 (5%) 0 2 (7%) 0.7 
Severe left ventricular 
impairment (Ejection 
Fraction<35%) 
3 (5%) 1 (5%) 0 2 (7%) 0.6 
CHA2DS2-VASc Score 1.3±1.2 1.5±1.5 1.3±1.2 1.1±0.9 0.4 
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6.4.1 Procedural Mean Contact Forces 
There were 5464 individual radiofrequency applications in the study.  Mean total CF in 
the Manual-NSS group was significantly lower than in other groups (p<0.0005), but 
there was no difference between the steerable sheath groups (p=0.5), Figure 6.2.  The 
CFs in the left WACA were significantly lower than the right WACA for the whole 
cohort (p<0.0005) and also for each group individually (p=0.01 Manual-NSS, p=0.03 
Agilis, p<0.0005 RRN).   
 
6.4.2 WACA Segmental Contact Forces 
There were 2,970 radiofrequency applications in the WACAs in the study, with 5,534 
ablation points taken in Carto3.  There was a variation in the locations of the peak and 
trough CFs in the WACAs in each group (Figure 6.3).  Within each of the three groups, 
for each WACA, there was a significant heterogeneity of CFs between segments 
(p<0.0005).   
Figure 6.2 Mean contact force during ablation. 
Error bars are standard deviation. *=p<0.006 compared with other groups 
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In the left WACA, the CF was highest for all three groups at the superior-
posterior segment.  The lowest CF was at the left atrial appendage (LAA)/PV ridge in 
the Manual-NSS group, and the anterior-inferior region (7-8 o’clock) in both the Agilis 
and RRN groups.  While the use of the RRN or the Agilis sheath led to a significant 
increase in the CFs in most of the left WACA compared with the Manual-NSS group, 
there was no significant impact on the anterior-inferior (7-8 o’clock) region.  The Agilis 
group had significantly higher CFs than the RRN group at 3 and 6 o’clock (p<0.0005).  
Figure 6.3 Distribution of contact force in the right and left WACA. 
Upper half: Radar plots demonstrating the distribution of contact forces during initial 
pulmonary vein encirclement.  The outer edge represents the clock face segment.  The 
further from the centre of the plots, the higher the median contact force in grams.  Lower 
half: Comparison of median contact forces during intervenous ridge ablation 
*=Significant difference between Manual-NSS and steerable sheath groups (p<0.05); 
#=Significant difference between RRN and Manual-NSS groups (p=0.009); ~= Significant 
difference between RRN and Agilis group (p<0.05); +=Significant difference between 
indicated groups (p<0.05) 
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In the right WACA, the highest CFs for all modalities were at the inferior 
quadrant (4-8 o’clock).  The use of steerable sheaths was associated with an increased 
CF during ablation in all regions other than the anterior-superior segment where the 3 
groups were approximately equal.   Agilis sheath use was associated with significantly 
higher CFs than RRN use from the anterior-inferior to mid posterior segments (p<0.05, 
4-9 o’clock).   
There were significant differences between the consistency of mean ablation CF 
between the left and right WACA (SD of mean CF per segment per patient: left WACA 
3.8(0.02-16.3)g, right WACA 4.7(0-33.3)g, p<0.0005), a lower SD on the left 
suggesting greater consistency.  There was also a significant difference between the 
groups: Manual-NSS 3.3(0.4-33.3)g, Agilis group 4.4(0.02-26.2)g, RRN 4.6(0-21.7)g, 
with the Manual-NSS group’s ablations having a more consistent mean CF (lower SD 
of mean CF per segment per patient) than the other two groups’ ablations (p<0.005 for 
both comparisons), but no difference between the steerable sheath groups (p=0.9).   
Figure 6.4 Percentage of wide area circumferential ablation segments reconnecting 
(A) Acute Reconnection (B) Chronic Reconnection *=p<0.004 
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6.4.3 Reconnections 
The mean time between completion of the initial WACA isolation and testing 
for reconnection was 128(±50) minutes for the left WACA and 88 (±51) minutes on the 
right side (> 30 minutes in all cases).  There were no significant differences in the 
waiting time in the three groups for either left or right WACA (p=0.4 and p=0.1 
respectively).   
In terms of whole WACA reconnections, excluding for the acute analysis 
WACAs where the 30 minute waiting time was not fulfilled, 35/112 (31%) PV pairs 
reconnected acutely (15/59, 25%, left WACAs and 20/53, 38%, right WACAs, p=0.22).  
There was no significant difference in the rate of acute WACA reconnection between 
the three groups (Manual-NSS 38%, Agilis 15%, RRN 33% p=0.2).  At the time of 
analysis, 26 patients (9 Manual-NSS, 5 Agilis and 12 RRN) had had a repeat ablation 
procedure at a median of 8 months (range 2 to 17 months) from the index ablation. In 
one case, the right PV was electrically silent at the index procedure and had remained so 
and therefore that vein pair was not included in the analysis.  For the left WACA, 16/26 
(62%) PV pairs were reconnected, while on the right side, 17/25 (68%) reconnected: 
there was no significant difference between the two sides in terms of the incidence of 
Table 6.2 Contact Force and Wide Area Circumferential Ablation Segment Reconnection 
 Acute Chronic 
Ablation 
Mean CF 
Ablation FTI Ablation 
Mean CF 
Ablation FTI 
Non-reconnecting 
segments (median(range)) 
13.3g (1.1-
66.4g) 
266g.s (3-
3340g.s) 
 
12.5g (1.6-
54.4g) 
251g.s (4-
2552g.s) 
Reconnecting  segments 
(median(range)) 
12.8g (2-
45.6g) 
291g.s (22-
1641g.s) 
11.5g (1.1-
52.5g) 
231g.s (3-
1429g.s) 
p-value 0.046 0.59 <0.005 0.006 
 
 
~ 146 ~ 
 
WACA reconnection (p=0.78) and no differences between the groups for chronic 
WACA reconnection (Manual-NSS 78%, Agilis 57%, RRN 63% p=0.48).   
At the segment level, there was a significant difference in the proportion of 
segments acutely or chronically reconnecting per group (Figure 6.4).  In both cases, the 
Agilis group had the lowest rate of segment reconnections. 
The mean CF for an ablation within a segment was significantly lower in 
segments that reconnected acutely or chronically (Table 6.2).  The FTI was lower for 
ablations in chronically reconnecting segments than those that did not reconnect. 
 
The reconnection site data for the WACAs are presented in Figure 6.5.  The 
anterior quadrant of the left WACA (where the ridge with the LAA would be located) 
was a common site of acute and chronic reconnection across groups.  Steerable sheaths 
Figure 6.5 WACA reconnection plots.   
Radar Plots: The plot outer edge represents the clock face WACA  segment and the further 
from the centre of the plot, the higher the percentage of that segment reconnecting as a 
proportion of all assessed segments at that location in that group.  Bar Charts: Acute and 
chronic intervenous reconnections.  *=Quadrant where difference in proportions of 
reconnections between indicated groups is significantly different (p<0.05). 
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significantly reduced the rate of left posterior quadrant reconnection acutely.  They did 
not significantly affect the rate in other portions of the left WACA acutely or in any Left 
WACA portion chronically.  On the right side, the RRN group had higher acute 
posterior quadrant reconnections but there was no difference chronically.  The use of 
steerable sheaths significantly reduced the proportion of chronic right anterior quadrant 
reconnections. 
 
6.5 Discussion 
This study demonstrates that the CFs during persistent AF ablation procedures 
were higher using steerable sheaths than a non-steerable manual sheath.  The increase 
was evident both as a mean across the whole procedure, but was also evident at specific 
regions around the WACA line. However, there was reduced consistency of the CF 
achieved in a WACA segment using steerable sheaths compared with the non-steerable 
sheath procedures.  As a corollary to the increased CF with steerable sheaths, there were 
also fewer segments reconnecting acutely and chronically when these were utilized, 
though this was not reflected in a significant difference in pulmonary vein reconnections 
as a whole.  CF parameters during WACA ablation were predictive of segment 
reconnection both acutely and at the time of redo-procedures and the distribution of 
reconnecting WACA regions varied between the groups. 
The use of steerable sheaths led to higher CFs for the ablations as a whole and 
specifically for the WACAs compared with ablations performed using a non-steerable 
sheath.  This is likely secondary to the increased stiffness of these sheaths compared 
with manual non-steerable sheaths.  The increase in CF observed was not uniform 
throughout the WACAs but displayed regional variance.  While there were areas such as 
the left PV/LAA ridge and the right posterior wall where steerable sheaths were 
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associated with a higher CF, there were others such as the left anterior-inferior quadrant 
and right antero-superior quadrant where the CFs were no higher using steerable 
sheaths.  These latter sites are ones which it is challenging to access using a non-
steerable sheath and even with the increased control over catheter manipulation with a 
steerable sheath, difficulties evidently persist.  Another important observation is the 
increased CF variability when using steerable sheaths.  While steerable sheaths facilitate 
access to different parts of the atrium, and are generally associated with increased CF at 
those locations, it appears that there is there is less consistency in the CF attained in a 
segment when using them.  Whether this is a function of the higher CFs achieved or the 
stiffness of these sheaths compared with the Mullins sheath is unclear.   
The finding that ablation CF parameters are predictive of acute and chronic 
WACA segment reconnection in persistent AF patients is consistent with previous work 
in acute reconnection in a predominantly persistent AF ablation cohort
177
 and chronic 
WACA reconnection in PAF patients
178
.   In the current study, the ablation FTI was not 
predictive of acute reconnection, suggesting that a sub-optimal FTI may be adequate to 
cause tissue oedema and acutely isolate a vein, but not to achieve lasting vein isolation. 
This suggests that adherence to FTI targets might have additional value beyond aiming 
for the conventional procedural end-point of PV isolation.  
Previous studies have examined sites of PV reconnection following WACA both 
acutely
175,177
 and chronically
175,178
.  This study expanded on this by examining the 
impact of steerable sheaths on sites of reconnection.  The RRN group was associated 
with significantly more reconnections at the right posterior wall acutely, despite being 
associated with higher applied CFs in this region.  This may be due to operators 
curtailing the duration of ablation in this region in response to higher CFs.  Chronically, 
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this region was associated with a relative peak in the incidence of reconnections for all 
groups (without a disproportionate representation from the RRN group).   
There were areas with a predilection for reconnection in all three groups such as 
the LAA/PV ridge and right inferior wall.  This is despite the CFs being significantly 
increased, on average, in these regions by the use of sheath technology.  The reason for 
this may be that other factors beyond the mean CF attained may be of importance in 
these regions such as the characteristics of the underlying tissue or catheter stability.  
Alternatively, it may be the case that the CFs, while being incremented by these 
technologies in these regions, are not being incremented enough to consistently deliver 
an effective lesion – in other words, the optimal CF required for effective ablation may 
be higher in these regions.   
It is interesting that the proportion of acutely and chronically reconnecting 
segments was lowest in the Agilis group, and this was also the group with the highest 
CFs.  At the same time though, steerable sheaths were not associated with a significant 
difference in the pulmonary vein reconnection rate overall in the current study.  These 
findings suggest that while reconnections rates at the level of the PV pair are overall not 
affected by the use of steerable sheaths, the burden of reconnection in each reconnecting 
WACA is lower.  The question therefore arises as to why the PV reconnection rate was 
not significantly reduced by the use of steerable sheaths despite the overall higher CFs.  
Clearly for a PV pair to not reconnect, all segments of the WACA line isolating it must 
remain disconnected.  From the current data, at a WACA segment level, the increment 
in CF with the use of steerable sheaths is not uniform.  Moreover, the consistency of 
ablation CF per segment is lower with steerable sheaths.  For these two reasons, there is 
the possibility of delivering suboptimal ablations to WACA segments even with 
steerable sheaths.  Consequently, outcomes in general are likely being affected, which 
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may be an explanation for the lack of improvement in success rates described with 
RRN
144,147
 or the mixed reports for the Agilis sheath
143,227
.   Additionally, there are 
regions likely more prone to reconnection as discussed above.  Certainly the former two 
potential weaknesses can be overcome by the adoption of strict CF targets for ablation.   
In the current study, the success rates for the Agilis group at 12 months were in 
fact the lowest.  The reasons for this likely relate to the factors discussed above but it is 
also important to bear in mind that this was a non-randomised comparison with 
asymmetrically sized groups (the Agilis group also being the smallest).  Therefore, it is 
not reasonable to use the study data as a comparison of clinical efficacy between the 
different sheath technologies. 
The operators in the current study, while ablating within a consensus CF range 
that was felt to ensure catheter-tissue contact (minimum 5g) and prevent excessive 
contact (maximum 40g), were not targeting a particular CF or FTI (there were few data 
available at the time of these ablations regarding CF targets).  The lesser stiffness of 
manual non-steerable sheath (and lower associated CF) may mean that attaining the 
same CF as that with steerable sheaths in all WACA regions is challenging.  This 
should not be the case for the FTI (as a lower CF could be counteracted by a longer 
ablation resulting in the same FTI), and there is a suggestion that the FTI of ablation 
achieved is of greater importance to ablation efficacy
206
.  Based on the higher CFs 
associated with the use of steerable sheaths, attaining FTI targets is likely to be easier 
and less time consuming with steerable rather than non-steerable sheaths though.   If the 
same FTI targets are used with different technologies then one would expect segmental 
reconnection rates to become similar between groups.  If appropriate targets are used, 
then it may be the case that outcomes are improved as well.  This of course assumes that 
there is no clinically significant difference in the quality of contact delivered (regardless 
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of similar FTIs being achieved) between the steerable and non-steerable sheath 
technology.   
  
6.5.1 Limitations 
This was a non-randomized study, the numbers in each group were not equal 
and ablation beyond WACA was not protocolised.  As the aim of the study was to 
investigate the influence of steerable sheaths on CF parameters and WACA 
reconnection, rather than compare success rates, these limitations were accepted.  The 
CF-consistency assessment assumes that for a given WACA segment in a patient, an 
operator would be generally aiming for the same ablation CF with each radiofrequency 
application.  For lesions that were drag lesions, there would be some inaccuracy in 
assigning CF to a particular point in the WACA (as the CF was measured continuously 
during ablation and so the measurements would have to be split between locations 
where a drag ablation was performed). 
 
6.6 Conclusions 
Steerable sheaths are associated with an increase in CF during persistent AF 
ablation.  Despite steerable sheath technologies increasing CFs in the WACA, this 
increase is not uniform, with some WACA segments areas showing no increment in CF 
with steerable sheaths; additionally, these sheaths are also associated with a lower 
consistency of achieved CF in a WACA segment.  Certain WACA regions retain a 
predilection for reconnection despite higher applied CF with these sheaths, suggesting 
regional differences in optimal required ablation parameters.  Overall PV reconnection 
rates are not significantly affected by steerable sheath use (though the burden of 
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reconnection in a WACA is reduced), likely secondary to the weaknesses of this 
technology described above.  The adoption of CF targets may overcome these 
weaknesses and improve outcomes.  The current study suggests achieving CF targets for 
ablation may be easier with steerable sheaths due to the potential for attaining higher 
CFs.   
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7. Conclusions and Future Directions 
The aim of this thesis has been to study factors affecting the contact between the 
catheter and left atrial myocardium in man, and to investigate how this affects the left 
atrium mechanically, electrically and with respect to radiofrequency ablation. The work 
gives insight into the mechanical and electrical properties of the in vivo human left 
atrium.  It is of direct clinical relevance as the findings shed light on the role of catheter 
contact in affecting the results of cardiac mapping and ablation efficacy. 
The left atrium is not a uniform structure and this affects the behaviour of the 
catheter within the left atrium.  The stability of contact, in terms of the variability of the 
CF waveform and catheter positional stability, varies by left atrial location, as 
demonstrated by the experiment in Chapter 5.  The former finding gives interesting 
insight into the nature of the mechanical relationship between the catheter and different 
parts of the left atrium: not only the compliance properties of the tissue but also the 
accessibility of the tissue for the catheter.  This combination of influences on the 
mechanical relationship observed cannot be untangled to allow the relative contributions 
of each to be established.  While not an unadulterated reflection of the compliance 
properties of the tissue, this mixed mechanical relationship is what is observed in vivo 
during catheter ablation, and therefore is of clinical relevance.   It would be interesting 
to directly assess the compliance properties of different left atrial regions in explanted 
hearts to establish how far the results here agree with those from the in vivo assessment. 
The quality of contact is also affected by the atrial rhythm as demonstrated in 
the experiment described in Chapter 5.  The increased instability secondary to local 
atrial contraction during sinus rhythm is not surprising but has been quantified in the 
current work.   
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Beyond the mechanical properties of the left atrium, the equipment used to 
deliver the catheter is also an important determinant of the quality of contact.  The 
influence of the catheter delivery mode on contact force is examined in Chapter 6.  The 
work suggests that stiffer, steerable sheaths are associated with higher contact forces.  
This is important from the viewpoint of safety during the procedure.  It is also important 
for ablation efficacy, as the correlation between reconnecting areas (suggesting 
inadequate ablation) and low CF during ablation has been highlighted by this 
experiment and in previous reports
172,177,178
.   Chapter 5 examines further the 
relationship between the mode of catheter delivery and the effect this has on the quality 
of contact.  Stiffer sheaths are likely associated with a reduction in the stability of the 
catheter as measured by the variability of the contact force waveform.  While there may 
be advantages for positional stability to the use of such sheaths in AF, the converse 
appears to the case in SR.  Overall, for the same FTI, the impedance drop is actually 
lower with the use of a stiffer robotic sheath.  These disadvantages highlighted in 
Chapter 5 are counterbalanced by the increased ease in obtaining higher CF (and so FTI 
during ablation) using a stiffer sheath, as shown in Chapter 6.   Importantly, Chapter 6 
also suggests that the CF during ablation may not be the only determinant of an 
effective ablation, as there are WACA regions that reconnect despite the mean CF being 
incremented by the use of steerable sheath technology.  This suggests factors impacting 
on ablation efficacy beyond the FTI in Chapter 5, for example the stability of contact, 
may play a role. 
In Chapter 4, the relationship between ablation efficacy and the FTI is explored.  
This leads to the generation of an FTI target for ablation.  Targets have also been 
suggested in other reports
178,179
 but these were based on regions electrically 
reconnecting and so may not be applicable to individual radiofrequency applications.  
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While in other work the impedance drop relationship with contact force over time has 
been examined
169,220
, the incremental analysis performed in this experiment is unique.  
The advantage of this method is that it effectively makes each ablation into multiple 
sub-ablations.  By increasing the data available, the inherent variability in impedance 
measurements is compensated to allow the underlying relationships to become more 
apparent.  A fall in impedance is in this case being used as a surrogate for lesion 
dimensions but, in itself, the fall in impedance is also an outcome of ablation.  In that 
sense, the relationship between the FTI and impedance drop during an ablation is a 
direct reflection of ablation efficacy per se, though in this case biophysical efficacy.  
Importantly, the work in Chapters 4 and 5 suggests changes in the electrogram correlate 
poorly with ablation CF parameters compared with impedance drop.  This is important 
as electrogram attenuation is a commonly used surrogate of clinical ablation efficacy 
clinically
175,191
.   
The impedance drop/FTI relationship is further used to compare ablations under 
different contact conditions in Chapter 5.  One could also envision this methodology 
being used for other types of comparison, such as between ablation power settings or 
different catheter irrigation technologies.  In such an analysis, a steeper relationship 
between the impedance drop per FTI would suggest a more effective ablation.  A 
comparison of ablation power settings would be an important one: in the current work, 
for simplicity of analysis, all study ablations were performed at the same temperature 
and power settings.  Power is an important component of radiofrequency 
applications
216
, and how this influences efficacy clinically would be of great interest.  
Additionally, this methodology could also be used to compare temperature controlled 
with power controlled ablation.  Ongoing work by the thesis author is investigating the 
latter, as well as the predictive benefit of incorporating the ablation power into the FTI 
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and using the impedance drop/FTI relationship to compare the efficacy of surround flow 
irrigation compared with standard irrigation. 
The implication of comparing impedance drops at different FTIs using the above 
methodology is that depending on its constituents, the same FTI can be associated with 
different efficacies.  In Chapter 4, this was investigated by looking at the components of 
the FTI (the mean contact force and ablation duration).  The findings suggest that once 
10 seconds of ablation is exceeded, the mean contact force applied does not affect the 
impedance drop achieved beyond the FTI.  This is important with respect to optimizing 
ablations and suggests that beyond this time point the FTI achieved determines efficacy 
rather than the mean contact force applied.  In turn this suggests that FTI targets should 
take precedence for ablations. 
The findings of Chapters 4 and 5 suggest that factors beyond the FTI affect the 
efficacy of ablation.  An important future area of study would be the nature of the 
FTI/impedance relationship in different LA regions.  It may be that the plateau point for 
the curves, as studied for ablation in general in Chapter 4, may vary by location, and so 
the target FTI would also be different.  A regional variation in ablation CF sensitivity 
may be one explanation for the observation in Chapter 3 of regions reconnecting in 
wide area circumferential ablation lines even in the face of CFs being incremented in 
those regions through the use of steerable sheath technology: it may be that these 
regions require higher CF targets than those achieved using steerable sheaths, for 
example due to greater wall thickness.  It would be very useful for clinical ablation to 
establish target FTI’s for each left atrial region.  Similarly, it may also be the case that 
the FTI targets required for ablation differ between different sheath technologies, as 
these certainly have a bearing on the nature of contact with the myocardium. 
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The quality of contact with the myocardium in terms of catheter location and CF 
waveform stability also had an important influence on the efficacy of ablation, as did 
the orientation of catheter contact.  These, along with the duration of ablation and the 
achieved FTI are all within the control (or can be adjusted for) by the operator.  If these 
measures are taken into account then every delivered radiofrequency application could 
be optimised, which one would hope would improve the efficacy of the AF ablation 
procedure.  Such detailed optimisation is now possible with the introduction of 
automated lesion marker placement software such as the Visitag upgrade for Carto from 
Biosense Webster.  In a study by Anter et al.,
223
 such an algorithm was used and found 
to be associated with lower rates of acute pulmonary vein reconnection but not 
improved success rates at 6 months.  The limitation of that study though was that only 
catheter displacement and impedance drop were used by the annotation algorithm.  The 
results from this thesis could be used to further refine the targets for ablation to include 
contact parameters which increase ablation efficacy (though contact force variability is 
not included in Visitag at present).  Based on the findings of the current work, a 
randomised trial expanding on the work of Anter et al., and incorporating the findings 
of this thesis could be envisaged – the control group being ablated without the 
automated lesion placement software being used, and the intervention group with this 
software being used in conjunction with the proposed contact settings.  From Chapter 4, 
a target FTI of 500g.s and ablation duration of at least 10 seconds would be suggested.   
Based on the data presented in Chapter 5, in addition to the FTI and ablation duration 
targets, a catheter drift of <3.5mm, a contact force variability of <5g and a parallel 
orientation of catheter contact would be recommended.  It may be that if the correct 
optimisation parameters are used for ablation, the single procedure success rates for AF 
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ablation will improve.  Certainly, for clinical ablation at St Bartholomew’s Hospital the 
aim is now for ablations to exceed 10 seconds and target a maximum FTI of 500g.s. 
As a precursor to a trial investigating the impact of ablation targets on AF 
ablation, the thesis author is currently involved with a prospective, multicentre, 
randomised trial studying the impact of having access to CF data on PAF ablation.  This 
follows on from a multicentre retrospective analysis in this area conducted by the thesis 
author in patients with persistent AF
149
.   
  The above work suggests catheter contact affects the efficacy of ablation.  
During clinical ablation, electrogram parameters are used to guide ablation: whether this 
is in the identification of targets such as highly fractionated areas or high dominant 
frequency regions or in the assessment of electrogram attenuation.  In Chapter 3, the 
results suggest that electrogram size is not correlated with CF.  This is unexpected but is 
likely because of the influence of atrial location on the baseline electrogram size.  It also 
means that electrogram size cannot replace real-time contact force measurement for 
assessing catheter contact clinically.  In order to better understand the relationship 
between CF and the electrogram, a paired analysis was undertaken.  This is useful as it 
mitigated any baseline differences in electrogram parameters and allowed thresholds to 
be established where these parameters are no longer affected by CF.  For the 
electrogram size and fractionated electrogram scores, this experiment allowed threshold 
values beyond which the CF no longer has a significant influence on the results to be 
successfully established: in the case of spectral analysis parameters though, catheter 
contact was not found to have an effect.  As catheter contact affected fractionation 
scores but not spectral parameters, this experiment offered guidance for the contact 
forces that should be applied during mapping of the left atrium to reduce any CF-related 
variability.   
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With respect to catheter contact affecting atrial electrophysiology, there was 
some evidence for this.  Certainly in sinus rhythm, the incidence of atrial ectopics 
increased with increasing CF.  In the AF cases, no changes in spectral parameters were 
observed with catheter contact but there was a change in fractionation scores.  This 
could reflect a lower sensitivity of the former to pick up any changes from catheter 
contact or that the changes in the latter are driven purely by changes in the size of the 
recorded electrogram leading to more complexes being identified and so a higher 
automated score (without an actual alteration of the underlying electrophysiology).   
One would have expected a more significant role for CF in affecting the clinical 
fibrillatory electrogram based on the prior animal and cellular work discussed in 
Chapter 1.9.  The important difference here though is principally that previous work has 
not been performed in fibrillating tissue.  In a fibrillatory atrium, the electrogram at a 
point is subject to signals emanating from a multitude of sources, whether local or 
farfield.  If the contact force is affecting these signals, then it may well be that the effect 
is too subtle to be appreciated by the tools used to investigate it in the current work.  
Also, if a site is purely passive to the fibrillatory process then changes in contact force 
at that point may not have a significant effect regardless.   
One reason for the modest effects of CF on electrogram parameters seen in vivo 
in these experiments is that, in the context of the moving heart, the contact force applied 
is a waveform rather than an absolute value.  This is well illustrated by the work on 
contact force variability in Chapter 5.  Therefore, the actual contact force applied at the 
time when an action potential is generated by a myocyte may vary markedly from the 
mean contact force.  Further complicating matters is that the stretch stimulus is being 
applied not just to the contact point with the catheter but to a region (especially at 
higher contact forces when greater amounts of the surface are recruited to deform as the 
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local myocardium approaches  its maximal strain capacity).  Therefore, it is possible 
that CF is affecting the observed signals but that the actual force applied at the time of 
action potential generation is not be reflected by the mean CF during the 8 second 
recording period. 
In order to investigate the relationship between the fibrillatory electrogram and 
contact force in more detail therefore, one approach would be to focus purely on regions 
actively driving the arrhythmia.  These could be identified using the recently described 
contact
66,211
 or non-contact methodologies
228
.  In this context, recent work suggests that 
CFAE signal grades do not identify stable driver sources (identified by panoramic left 
atrial contact-based electrogram analysis)
229
.  Changing the contact force at driver sites 
may have a more easily identifiable effect on the electrogram due to their importance to 
the fibrillatory signal.  In both AF and SR cases, the use of electrogram data 
synchronized to the millisecond with the contact force data, and possibly a higher 
sampling rate of contact force measurements may allow the actual contact force at the 
time of (or just prior to) the generation of a complex to be established which may 
improve the ability to detect changes secondary to this.  Certainly, the newer version of 
the Carto electroanatomical mapping system has the capability of continuous 
electrogram recording (beyond the 2.5 second window).  This would allow for the two 
types of measurement to be synchronized beyond what is possible using two 
independent systems. 
In conclusion, these data demonstrate that multiple factors, including the 
catheter delivery technology and atrial location, affect the contact between the catheter 
and the left atrium and that catheter contact has a significant impact on the efficacy of 
radiofrequency ablation.  Electrogram parameters are not a reliable surrogate for real-
time catheter contact force measurement, including catheter contact during ablation.  
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Catheter contact affects electrogram parameters during sinus rhythm and atrial 
fibrillation, though it does not affect spectral measurements, and there is a threshold for 
the observed effects.  The data presented in this thesis can therefore be used to improve 
the efficacy and reliability of clinical left atrial mapping and radiofrequency ablation. 
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